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5Professor Dan Blazer looking back at the research progress in the 
field of old age psychiatry:
…”In this editorial, I will review the findings of seven studies published here (Aging & 
Mental Health, ed.) and compare these studies with the state of the field in terms of 
empirical research when I wrote my 1982 book.”…“Collard et al. (2014) explored 
late- life depression and vulnerability to frailty. The authors found that the frequency of 
this vulnerability was 27% among a depressed sample of persons 60+ years of age 
compared to non-depressed. Many, if not most, investigators will include depression 
in their list of symptoms of frailty, yet this study turns the tables, namely examining 
the association of the vulnerability for frailty among the depressed. Frailty has been 
recognized for centuries as a companion of aging, yet only in the past 20 years or 
so has it taken a central place among the conditions to which geriatricians specifically 
focus, a defined phenotype with clear symptoms, signs, biomarkers, and course 
(Fried, Tangen, & Walston, 2001). In 1982, I could not find any empirical studies 
of the association of frailty with late-life depression (and to be honest, the association 
did not occur to me at that time).”…
From:
Blazer DG. Late-life depression: a historical perspective upon a maturing field of 
inquiry. Aging & Mental Health. 2014;18:538-539.
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In old age, somatic diseases, disability, depres- 
sion, cognitive impairment and frailty often appear 
simultaneously, all reciprocally and adversely 
influencing health outcomes. In research into old 
age phenomena, these concepts are intertwined 
and sometimes they are used interchangeably. 
In this thesis we aim to unravel two of these 
concepts, i.e. frailty and depression. 
One striking myth about aging is that aging and 
depression go hand in hand or, in other words, 
that aging is inevitably accompanied by depres-
sion.1, 2 For many years, this myth has been taken 
for granted by clinicians, researchers and older 
persons themselves. The result was a neglect of 
late-life depression in research programs and 
therapeutic nihilism.4 Facing the challenge of 
an aging society, clinical and scientific interest 
in old age psychiatry has gradually grown 
between 1950 and 1990 and almost exploded 
during the past few decades.5 As a consequence, 
accumulating evidence has been found for both 
the predictive value of depression with regard to 
adverse health outcomes, and the effectiveness 
of treating mental health problems in later life, 
particularly depression.7-9
Pioneers of old age psychiatry fought against 
ageism, pointing to similar treatment results in 
older and younger patients.10, 11 This optimism, 
however, was not shared by the entire old age 
psychiatry community. As research into late-life 
depression progressed, it became apparent that 
these critics of effectiveness of late-life depression 
treatment may have had a point, because the 
course of late-life depression is characterized 
by high recurrence and relapse rates.12-14 This 
indicates that the course and treatment of late-life 
depression are complicated.15, 16
Depression (major depressive 
disorder: MDD) is a multi-causal 
disorder that is characterized 
by a depressed mood and/ 
or a loss of interest in normally 
enjoyable events (anhedonia).3 
For a diagnosis of depression, 
these symptoms have to persist 
for >two weeks, most of the 
day, almost every day, and are 
accompanied by at least five of 
the following symptoms: fatigue, 
or loss of energy, changes in 
appetite or weight, sleep 
disturbances, psychomotor 
agitation or retardation, feelings 
of worthlessness or excessive 
guilt, diminished ability to 
concentrate or indecisiveness, 
and thoughts of death or suicide.3 
Subthreshold depression is 
characterized by elevated 
depressive symptoms that do not 
meet diagnostic criteria for MDD, 
and includes clinically relevant 
depressive symptoms and minor 
depression.6
Frailty is a condition of decreased 
reserve and resistance to stressors, 
resulting from cumulative declines 
across multiple physiologic 
systems, and causing vulnerability 
to adverse health outcomes, 
operationalized as physical 
frailty: weight loss, weakness, 
exhaustion, slowness and low 
activity.17
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A closer look at these findings puzzled me. First, most observational studies on late-life 
depression have used depression severity rating scales instead of psychiatric inter- 
views to diagnose depressive disorder. The predictive value with regard to adverse 
health outcomes however, is not restricted to major depressive disorder. Subthreshold 
depression also predicts negative health outcomes. This is generally explained by 
a dose-response effect, pointing to the relevance of subthreshold depression in later 
life and/or the need for age-specific criteria.18 The latter is specifically important in 
old age, since it is known that depression severity scales, especially when scores are 
lower, pick up signs and symptoms of physical illnesses.19 This raises the question 
whether depression, and especially depressive symptoms, can be confounded by 
physical frailty (see below)?
Second, the growing number of randomized controlled trials on the effectiveness of 
antidepressants in later life, enabled meta-analyses. A thought-provoking study showed 
that effect-sizes for antidepressant drug therapy are smaller in older, compared to 
younger depressed persons.20 Recently, meta-regression of 34 randomized controlled 
trials including depressed patients of 65 years and older, showed that even in an 
older sample, increasing age is associated with a less favorable outcome.21 Can this 
age-related effect be explained by physical frailty?
Little is known about age-related mechanisms, such as frailty, underlying late-life 
depression. This thesis contributes to the current body of knowledge of intertwined 
old age phenomena, as we aim to disentangle part of the association between frailty 
and late-life depression. 
Frailty
“I am 70 years old, but I look and feel like I am 85 years”, said ms E with a 
gloomy voice. Glancing at ms E while she shared this with me, I could only 
agree with her. I wondered, where does this discrepancy between her presen-
tation and her real age come from? Why does her neighbor that has the same 
age still babysits her grandchildren and has an independent life, while ms E is 
obviously struggling with active aging? Should we consider ms E frail?
The case of ms E demonstrates the mystery of aging. Why do some persons look 
older than others, despite a similar chronological age? Why do some, apparently 
healthy, persons react resilient to a stressor like a hip fracture, while other, also see-
mingly healthy persons, experience several complications that may even culminate 
in death?
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Normal aging is inevitably associated with functional and physical changes and 
even damage. For some persons, these changes are emphasized and lead to 
decreased levels of well-being and susceptibility to diseases and disability.17 Frailty 
is a concept that attempts to capture the increased vulnerability of older people to 
the stressors they face.22
During the last half of the 20th century, life expectancy rapidly increased and marked 
the appearance and growth of a vulnerable group of older persons. This shift in age 
distribution resulted in the introduction of the term frailty in 1968 by O’Brien and 
colleagues.23 They outlined frailty as an excessive, disproportionate reaction of older 
persons to adverse events. Their concept of frailty, however, remained rather subjective 
and was based on retrospective case-analyses of only 48 older persons.23 In this 
paper and in most papers that followed in the subsequent years, frailty was used 
to describe a population that nowadays would be considered “typical geriatric 
patients” who need more complex (medical) care than standardly delivered in 
traditional hospitals. 
A first attempt to quantify frailty was undertaken by Winograd and colleagues in 
1988,24 by defining frailty as the presence of one or more of fifteen common geriatric 
clinical conditions (multi-causal health problems which are common in later life). 
Frailty was placed as an intermediate state on a continuum that ranges from indepen-
dence to severely impaired.25 
Considerable progress in the evolvement of the concept of frailty was made by Fried 
and colleagues, with their introduction of a standardized phenotypical definition of 
frailty in 2001.17 This purely physical definition of frailty was based on a large sample 
of community-dwelling older persons participating in the Cardiovascular Health Study 
(CHS). In this study, a decade of research into age-associated risk factors of adverse 
health outcomes, such as declines in balance and lean body mass were combined 
in a theoretical model. Analogue to the metabolic syndrome in cardiovascular 
medicine, physical frailty was defined as the presence of three out of five criteria, 
i.e. unintended weight loss, weakness, exhaustion, slowness and low activity level. 
This model was tested for predictive validity with regard to negative health outcomes, 
such as falls, disability and mortality over three and seven years of follow-up. In the 
past century, frailty has often been confused with disability, comorbidity, or advanced 
old age.26, 27 The predictive value of frailty regarding adverse health outcomes 
however, was independent of activities of daily living (ADL) functioning and somatic 
comorbidities. 
Despite this breakthrough in frailty research, controversy remained about both 
13
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the conceptualization and the operationalization of frailty. While there is implicit 
agreement that frailty is a condition conferring vulnerability to poor physical health 
outcomes, there is little consensus about what factors, physical or otherwise, may 
contribute to this vulnerability. As a consequence, a range of symptoms, including 
biological, psychological, and sensory deficits have been incorporated into extant 
frailty definitions.28 Different operationalizations emerged in medical literature, mostly 
supported by good predictive validity with regard to negative health outcomes.29, 
30 Since psychological and social conditions also predict negative health outcomes, 
some researchers included these aspects into their frailty concepts (e.g.31-33). Parallel 
to this discussion, the relevance of frailty was increasingly acknowledged by findings 
such as the higher usage of community resources, nursing homes and hospitalization 
by frail persons, whereas early intervention was shown to improve quality of life 
and reduce costs of care.34 Albeit the operationalization of frailty was still subject of 
discussion,35, 36 in 2012, after the start of the research described in this thesis, four 
major consensus points were created on physical frailty by six international societies 
and seven other frailty experts. They agreed that physical frailty is an important 
medical syndrome for geriatric health care that can be prevented or treated, for 
which screening tests are available that should be applied to all persons aged 
70 years and over, or those with significant weight loss due to chronic disease.37 
Although the concept of frailty has been proven relevant in different medical (somatic, 
e.g. cardiology, neurology) disciplines,38, 39 to date no studies have been conducted 
in old age psychiatry. Broad definitions of frailty (including also psychological 
components)31-33 largely overlap with the criteria of psychiatric disorders and limit its 
use within a psychiatric population. This may have contributed to the neglect of frailty 
in old age psychiatry. A requirement for research into the potential benefit of frailty 
for depressed older patients is to select the most appropriate operationalization of 
frailty (see Chapter 2 of this thesis), and prevalence rates in the community should 
be summarized (see Chapter 3) enabling interpretation of findings among depressed 
older patients. 
Depression
“I am 70 years old, but I look and feel like I am 85 years”, said ms E with a 
gloomy voice. Glancing at ms E while she shared this with me, I could only 
agree with her. I wondered, where does this discrepancy between her presen-
tation and her real age come from? Why does her neighbor that has the same 
age still babysits her grandchildren and has an independent life, while ms E is 
obviously struggling with active aging? Should we consider ms E depressed?
14
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The difficulty of diagnosing depression in later life is demonstrated in ms E’s case. 
Does ms E suffer from depression or should we consider these symptoms part of her 
aging process? Depression can be classified according to formal and strict psychiatric 
criteria, although a dimensional approach is gaining more and more attention in 
modern psychiatry.40, 41 Are we able to discern late-life depression from frailty or can 
we only make best guesses?
Depression is the most common psychiatric disease worldwide.42 Globally, more 
than 350 million people of all ages suffer from depression (www.who.int). The World 
Health Organization (WHO) predicted that by 2020, depression will be second 
only to heart disease as a cause of disability and premature death in established 
market economies.43 
Severity of depression ranges from some clinically relevant depressive symptoms 
to minor depression and eventually, major depression. Subthreshold depression 
(including clinically relevant depressive symptoms and minor depression) can be 
operationalized according to the research criteria of the Diagnostic and Statistical 
Manual of Mental Disorders-Fourth Edition (DSM-IV-TR) for minor depression,3 as 
well as based on a score above the cutoff of a (self-report) questionnaire assessing 
depressive symptoms.6 Meanwhile the fifth edition of the DSM is already available. 
With regard to depressive disorder no major alterations were incorporated, as 
compared to DSM-IV.
With demographic balance shifting towards an older population, the number of 
older adults with a lifetime history of depression or subthreshold depression will 
be significant over the next decades.44 Although direct comparisons are lacking, 
subthreshold depression is assumed to be more prevalent in older persons than in 
persons aged <65 years,45 with prevalence rates of 9.8% for minor depression 
and 13.5% for clinically relevant depressive symptoms.46 The prevalence rate of 
subthreshold depression in a pooled sample of community dwelling European older 
adults was estimated at 15.2%.47 Meta-analysis has estimated the prevalence of 
major depressive disorder (MDD) among community-dwelling older persons at 1.8% 
(ranging from 1-5%).46 In older persons, major depression is less prevalent than in 
adults.48, 49
Whether subthreshold or “minor” is indeed minor in old age psychiatry is debated, 
as the burden of minor depression and major depression have similar negative 
consequences for well-being and health outcomes.50-52 Studies in later life, however, are 
often based on clinically relevant depressive symptoms, and not on a DSM-IV classi-
fication. Although most of these studies adjust their analyses for somatic comorbidity 
15
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and ADL-disabilities, the severity of the underlying somatic diseases and also frailty 
may falsely inflate the symptom scores and thus exaggerate the predictive value 
of so-called “clinically relevant depressive symptoms”. Furthermore, high recurrence 
rates and a chronic course of late-life depression are widely known,53 but again, 
most studies are based on self-report questionnaires.12, 54 Whether these findings 
might partly be explained by physical frailty, has not been examined yet (see Chapter 
7 and 8 of this thesis).
Another issue are the underlying mechanisms postulated to drive the negative health 
consequences of late-life depression. These mechanisms include somatic diseases, 
metabolic disturbances, immune-inflammatory dysregulation, autonomic dysregulation 
and hypothalamus-pituitary-adrenal axis dysregulation,55 but are primarily based on 
cross-sectional association studies. Inflammation is of particular interest for this thesis, 
as this has been reported as an underlying mechanism of both frailty and depres-
sion.56-58 Therefore, we will explore the association of physical frailty with somatic 
comorbidity as well as low-grade inflammation among depressed older patients 
(see Chapter 5 and 6 of this thesis). 
Do physical frailty and depression represent distinct syndromes 
in old age?
Even though the physical frailty phenotype described by Fried and colleagues 
attempted to define frailty in biomedical terms, two out of five criteria directly overlap 
with the criteria for major depressive disorder (unintentional weight loss and exhaustion), 
while one criterion (low activity level) may be a direct consequence of depression. 
In their hallmark study in 2001, Fried and colleagues even excluded participants 
using antidepressants, in order to prevent that these persons would be classified as 
frail on the presence of one disorder, namely major depressive disorder.17 Using data 
driven techniques (latent class analyses) in an adult sample aged >40, however, 
it was shown that depression and physical frailty are indeed distinct concepts, 
although their operational criteria identify substantially overlapping subpopulations.59 
This initial finding may suggest that physical frailty is highly prevalent in depressed 
older persons, but unfortunately, this has not been examined hitherto (see Chapter 4).
In summary, the only scientifically sound conclusion with respect to the relation 
between frailty and late-life depression is that thus far frailty has largely been ignored 
in old age psychiatry. 
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Aims and outlines of this thesis
The main aim of this thesis is to study physical frailty in late-life depression. This thesis 
consists of three parts. 
Part I: The concept of frailty and prevalence rates.
This first part focuses on the conceptualization of frailty and the prevalence of frailty 
in the general population. A necessary first step is to justify how frailty should be 
operationalized when studied within a mental health care setting for older people. 
For this purpose, two systematic reviews (one including also a meta-analysis) were 
conducted. The specific research questions that need to be answered are (numbers 
correspond with chapters):
2. Which operationalizations of the concept of frailty are available and how do 
 they relate to psychopathology?
3. What is the prevalence of frailty in the general population?
Part II: Is physical frailty associated with late-life depression?
Since frailty has not been examined within a sufficiently large and well-defined cohort 
of depressed older patients, we set-up some studies to examine whether physical 
frailty is indeed more prevalent in late-life depression than can be expected by chance. 
This was examined within the Netherlands Study of Depression in Older persons 
(NESDO). The corresponding research questions are:
4. What is the prevalence of physical frailty in depressed older patients compared 
 to a non-depressed comparison group, taking symptomatic overlap between frailty 
 and depression into account? 
5. How do late-life depression and physical frailty relate to somatic comorbidity?
6. Is the mechanism of low-grade inflammation associated with physical frailty in 
 depressed older patients?
Part III: Does physical frailty affect the incidence and course of late-life depression?
The third part of the thesis focuses on the longitudinal association between physical 
frailty and late-life depression, exploring frailty as a predictor of late-life depression. 
Frailty, as well as depression are disentangled in a community-dwelling cohort of 
older persons and in a sample of clinically depressed older persons. The following 
research questions have to be answered:
7. Does physical frailty predict a higher incidence of depressed mood, as well as a 
 less favorable course of depressed mood?
8. Does physical frailty predict depression diagnosis after two years of follow-up and 
 chronicity of depression respectively?
17
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Figure 1 The Associations That Are Studied in This Thesis (numbers refer to chapters)
Case report
To illustrate the clinical relevance of the research questions that are addressed in 
this thesis, we will take a closer look at the case of ms E. In the General discussion 
(Chapter 9) we will address the questions that arise from this case report in the light 
of the findings of this thesis.
Case description
Ms E, a 70-year-old woman was admitted to the acute ward of old age psychiatry. 
She was diagnosed with a depressive episode and a history of recurrent depressive 
disorder. She had been admitted to the ward ten years before, after the death of 
her husband. In her adult life, she had been admitted to psychiatric wards two more 
times. She fully recovered after each admission. 
Despite the absence of somatic comorbidities, a geriatrician was consulted as part 
of the multi-disciplinary procedure that was carried out when a person aged >70 
was admitted. The physical examination showed no abnormalities. Her daughter 
however, informed the nurses about how her mother had given up her Nordic 
walking activities two years ago due to a diminished physical condition, and that she 
stayed in the house more and more ever since. She did not experience pain during 
walking. 
18
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Ms E’s depressive disorders were usually successfully treated with a tricyclic anti- 
depressant, combined with cognitive behavioral therapy. After admission to the ward 
of old age psychiatry this treatment was started. After a few weeks ms E was feeling 
better. Her mood was no longer sad, however she remained wearily and exhausted. 
Her antidepressant level seemed adequate, and the intensive cognitive behavioral 
therapy did not result in complete recovery. Ms E remained admitted for almost twice 
as long as compared to previous depressive episodes. When she was discharged 
from the hospital she was visited by a mental health care nurse weekly and continued 
the anti-depressant medication.
Before ms E was discharged, the multi-disciplinary team deliberated about her 
condition. Interestingly, a trichotomy in opinions became apparent, represented by 
the psychiatrist who attributed the remaining symptoms to depression, the geriatrician 
who attributed these symptoms to frailty, and the nurse who considered ms E both 
depressed and frail. 
Who is right? To what condition should we attribute ms E’s symptoms? How do we 
distinguish between depression and frailty?
19
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Studies used in this thesis
NESDO
The Netherlands Study of Depression in Older persons (NESDO) is an ongoing cohort 
study aimed at examining the long-term course and consequences of depressive 
and anxiety disorders in older persons (aged 60 through 93 years). Baseline data 
of NESDO consists of 378 depressed subjects with a current DSM-IV3 diagnosis of 
major depressive disorder (95%), minor depression (5.6%) or dysthymia (26.5%), of 
which 26.5% have two depressive disorders, and 132 non-depressed subjects.13 
Persons with a primary diagnosis of dementia, a Mini Mental State Examination score 
(MMSE) under 18 or an organic or psychotic disorder were excluded, since the 
course of these persons will be largely determined by the primary disorder. Insufficient 
mastery of the Dutch language was another exclusion criterion. 
Depressed participants were recruited from mental health institutes (both in- and 
outpatients) and from primary care. The non-depressed comparison group was recruited 
from primary care practices. All participants were competent to consent to participation. 
Written informed consent was obtained from the participants. The ethical review 
boards of the participating institutes approved of this study. 
Assessments consisted of an examination at one of the participating clinics or at the 
homes of the participants, including a structured diagnostic interview, physical tests 
(such as blood pressure and gait speed), and paper and pencil questionnaires. These 
examinations were conducted at baseline (n=510) as well as 2 year follow-up (overall 
attrition rate: 21.4%).60
InCHIANTI
Invecchiare nel CHIANTI (aging in the Chianti area); the InCHIANTI Study is a 
prospective, population-based cohort study.61 The baseline data collection started 
in 1998 and was completed in 2000. It included an interview at the homes of the 
participants and a medical examination at the study clinic. The medical examination 
was conducted within 21 days after the home interview. Follow-up assessments took 
place at 3, 6 and 9 years after baseline. After explaining the study procedures to 
the participants, they were asked to sign informed consent. The ethics committee of 
the Italian National Institute of Research and Care on Ageing approved of the study 
protocol. The InCHIANTI study has included 1155 persons aged 65 years and 
older. 
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Chapter 2
Frailty; a fragile concept
This chapter was translated from:
Frailty; een kwetsbaar begrip
Rose M. Collard and Richard C. Oude Voshaar
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Abstract
Background- Frailty can be regarded as a condition in which the reserve capacity of 
various physical systems has sunk to a critical low, at which point minor disturbances 
can develop into serious health problems.
Aim- To review the various operationalizations of the concept of frailty and describe 
the relationship between frailty and psychopathology.
Method- We searched the literature up to October 2010 using PubMed, PsycINFO 
and CINAHL.
Results- We found 35 operationalizations of the concept of frailty; four single mea- 
surements as a proxy for frailty (e.g. muscle strength), 18 syndrome diagnoses 
which can be subdivided into single (n=5) and multiple syndrome diagnoses (n=13) 
and 13 dimensional operationalizations for which measurement instruments were 
used. Only six studies reported the relationship between frailty and psychopathology. 
The studies revealed an association between depression and psychopathology. 
An important finding was the association between depression and frailty, but the 
direction of the association is unknown.
Conclusion- No consensus has been reached regarding the operationalization of the 
concept of frailty. For the purpose of gerontopsychiatric research we recommend the 
inclusion of a syndrome diagnosis based on physical criteria (physical frailty) because 
this should make it possible to unravel the relationship between psychopathology and 
underlying aging mechanisms.
Keywords: definition, frailty, psychopathology
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Introduction
Why does one person die ‘of old age’ at the age of 75, while another person still 
independently manages her (and less often, his) household at the age of 90? This 
discrepancy between chronological and biological age is the basis of the hetero-
geneity in old age health care. The concept of frailty can be seen as a measure of 
biological age and as an attempt to explain this heterogeneity.1 However, frailty is 
not synonymous with having chronic diseases or disorders. Instead, it is an under-
lying vulnerability for the occurrence of health complications caused by a diminished 
physical reserve capacity.2-4 A diminished reserve capacity of various physiological 
systems may explain why two apparently healthy older adults have a different 
response to a hip surgery: one older person experiences a series of complications, 
while the other older person has a problem-free recovery.
Definitions and criteria
Obscurity about how this reserve capacity can be measured, has led to a variety 
of operational frailty definitions. Despite, two findings are consistently found in 
research. First, frailty prevalence increases with age. In Canada frailty prevalence 
was 7% for 65-74 years old, 18% for 75-84 years old, and finally, 37% for persons 
aged 85 and over.5 Second, frailty prevalence is higher in women than in men.2, 5, 6
Frailty definitions in clinical practice are based on cohort studies.2, 5 These studies 
assess which characteristics predict adverse health outcomes (i.e. hospitalization, 
death or institutionalization). Next, the characteristics are clustered, in order to find 
the most predictive combination. It is assumed that these characteristics together are 
more predictive of negative health outcomes than the sum of these characteristics. 
This is analogue to the procedure used with metabolic syndrome.7 
However, diversity in baseline, as well as outcome measures in these cohort 
studies, has led to a variety of frailty definitions. Moreover, the concept of frailty is 
increasingly defined as a broad concept, that in addition to physical components, 
also includes psychological and social components. A qualitative study among (inter)
national experts was conducted by Gobbens and colleagues8 and led to the follo-
wing conceptual frailty definition: Frailty is a dynamic state affecting an individual 
who experiences losses in one or more domains of human functioning (physical, 
psychological, social) that are caused by the influence of a range of variables and 
which increases the risk of adverse outcomes. Since both cognitive dysfunctioning 
and depression are associated with higher risks of disability and death,2, 9, 10 these 
variables could be included in operational definitions of frailty. However, cognitive 
decline and depression can be a risk factor for the onset of frailty as well as a 
consequence of frailty. 
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The concept of frailty is an important concept in old age psychiatry for several 
reasons. First because of the overlap between psychiatric disorders and frailty, 
especially the broad frailty definitions. Second, frailty enables the early detection of 
a group of older persons at risk of (somatic) complications and the adjustment of the 
treatment of this particularly vulnerable group of older persons. In somatic medicine, 
this distinction between frail and nonfrail older persons has led to the development of 
specific interventions and adjustments in treatment policies.11-13
 
In this paper, we aim to provide an overview of the existing operationalizations and 
various definitions of frailty, and to describe the relation between frailty and psychiatric 
disorders.
Method   
We conducted a systematic review of the literature in three databases (PubMed, 
PsycINFO and CINAHL) in the period up to October 2010. Considering the strong 
increase in the amount of articles about the concept and definition of frailty, we included 
only review articles for the first part of the aim. The following search strategy was 
applied: ‘(criteria OR definition) AND frailty AND review’. Inclusion criteria were: a 
primary focus on frailty, written in English, a study population aged 60 and over and 
access to the full-text version of the article. All operational definitions of frailty were 
extracted from these articles. When the article provided insufficient information, the 
original source was consulted. In order to prevent missing recent frailty definitions, 
the search strategy was repeated for the period of 2008-October 2010 without the 
keyword ‘review’. 
For the second aim, the following search strategy was applied: ‘frailty’ combined 
with ‘psychia*’ and ‘psycho-pathology’. Since anxiety and depression are the most 
prevalent psychiatric disorders in older adults, the search strategy was subsequently 
expanded with MeSh-terms ‘depression’ and ‘anxiety’. 
 
Results of frailty operationalizations
Regarding the first aim, the searches resulted in, after removing double articles, 78 
articles. These articles were selected on the title and the summary, and screened for 
the inclusion criteria, leaving fifteen relevant articles. The references of the included 
articles yielded 28 additional articles. Finally, three more articles were known by the 
authors to be relevant for this review and were also included. These articles were not 
found with the previous searches. 
Until the early nineties frailty measures were primarily focused on muscle strength 
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and loss of muscle mass (sarcopenia). During the following years, research into the 
various definitions of frailty was conducted. On a conceptual level, a dichotomy 
became apparent. One group of researchers primarily defined frailty according 
to physical components, the physical phenotype of frailty,2 as oppose to another 
group of researchers, who also included psychosocial components and health care 
consumption in the definition of frailty; the broad phenotype.14 
A total of 35 different operationalizations of frailty were extracted from the articles 
(Table 1). Besides the conceptual discussion about the operationalization of frailty, 
three different approaches exist. To begin with, some studies primarily focus on 
the identification of a unidimensional measure of frailty (proxy) (n=4). In the next 
approach, frailty is conceptualized on a syndromal level. This implies that frailty 
is present when for instance, three out of five criteria are met (n=18). In a final 
approach, frailty is placed within a continuum and quantified by a severity scale or 
a questionnaire (n=13).
Unidimensional measures (proxies)
All but one15 unidimensional frailty measures are based on a physical symptom. In 
literature, these measures are not frequently used and are pragmatically based. Formal 
validation studies are lacking.
Syndromal definitions
The majority of the research groups define frailty on a syndromal level. Definitions 
that define frailty as present when a minimum amount of criteria is met, varying from 
two-five criteria, are found most frequently (multiple syndromal definitions). Only four 
out of eighteen studies prefer a singular syndromal definition, that defines frailty as 
present when only one out of multiple criteria is present (Table 1). 
When determinants or consequences of frailty are studied, the frailty definition by 
Fried and colleagues2 is most frequently used.9, 16 This research group has defined 
frailty as the presence of three out of the following five criteria: weight loss, weakness, 
exhaustion, slowness and low activity level. Accordingly, this definition reflects the 
physical phenotype of frailty. Etiology of frailty is sought in changes in muscle mass, 
and hormonal and immunological changes.17 However, comparison of studies that 
used these frailty criteria remains difficult due to various operationalizations of the 
criteria. For instance, multiple definitions and measures of weakness and exhaustion 
can be found.
Because the assessment of the five frailty characteristics is often regarded impractical 
in clinical practice, a simplified ‘frailty index’ was developed.18 This simple index has 
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the same predictive value as the physical frailty phenotype2 with regard to adverse 
health outcomes, such as falls, hospitalization and emergency room visits.9
Dimensional severity scales
Since 1995 a diversity of scales was developed, varying from self-report question-
naires to screening instruments for clinicians. Some scales consist of a combination 
of physical measures and psychosocial components,3, 19 while other scales focus 
on Instrumental Activities of Daily Living (IADL).20, 21  The scales that were validated 
in clinical studies had good validity with regard to the prediction of adverse health 
outcomes.20, 22-25
Relation with psychiatric disorders
After removing double articles, the searches resulted in 98 articles. Of these articles, 
three articles were relevant with regard to the second research aim.26-28 References 
of these articles were checked and this yielded two additional articles.2, 29 One of 
the articles was an editorial advocating multidisciplinary research into frailty and 
depression.27
Three studies reported a positive association between the physical frailty phenotype 
and depression.2, 26, 29 Depression correlated with frailty according to Fried et al,2 
and with the frailty-index by Mitnitski et al.30; even when the criterion ‘trouble with 
nerves’ was deleted from the index. Hackstaff et al.29 did not mention the frailty defi-
nition that was used in their study. 
Only two studies conducted a broader evaluation of psychiatric disorders than only 
depression. It was found that frailty prevalence was higher and more characteristics 
were present among older persons with a psychiatric disorder, as compared to older 
persons with no psychiatric disorder.26 In this study, the frailty-index by Jones et al.23 
was used (Table 1). Each step of one frailty characteristic on the frailty-index, increased 
the odds of having a psychiatric disorder with 1.23 (95% Confidence Interval: 1.19-
1.26).
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Table 1 Definitions and Operational Frailty Criteria
 Author(s) Definition Criteria
 Single Measures
  
 Vellas et al. 199731  Limitation in one-leg balance  
   skills 
 Syddall et al. 200332  Diminished hand grip strength  
   (women <17.5 kg; men <30 kg)
 Cesari et al. 200533  Slow gait speed (<1.0 m/s)
 Vellas et al 200615  Score between 17 and 23.5 on  
   the MNA
Single Syndromal Diagnoses 
 
 Winograd et al. 199134 Condition in which an older  ≥1 of the following criteria:
  person is not too independent  diminished functioning, highly
  and too disabled, placing this  prevalent geriatric condition (i.e.
  person at risk of adverse health  falls, depression, cognitive
  outcomes impairment, incontinence, poly  
   pharmacy), chronic and disabling  
   diseases, social problems
 Rockwood et al. 199935 Combinations of aging, disease,  Cognitive impairment in 2
  and other factors (e.g. fitness,  domains or limited mobility, or
  nutritional status) that make  ADL-functioning, or incontinence
  some people vulnerable 
 Gill et al. 200236 Two physical parameters that  Requiring a gait speed of >10 s
  are strongly associated with the  for 6 m or not being able to stand
  development and progression of  up from a seated position with
  disability folded arms
 Studenski et al. 200337  Limited gait speed (based on  
   SPPB), or limited balance 
 Nourhashémi et al. 200120 Combination of deficits that is  Deficits in at least 1 IADL,
  seen in aging and which makes  measured by the IADL-scale
  an older person vulnerable for 
  environmental changes and 
  stressors
 
Multiple Syndromal Diagnoses 
 
 Speechley & Tinetti 199138  Classification in 3 groups: frail  
   (≥4 frailty criteria), transition  
   group (not meeting the criteria  
   of either frail or vigorous), 
   vigorous (<2 frailty criteria).  
   Frailty criteria: age>80, 
   depression, use of sedatives, 
   impaired vision, balance and  
   mobility problems, low walking  
   activity, diminished shoulder  
   strength, diminished knee   
   strength, disability at lower 
   extremities
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 Author(s) Definition Criteria
Multiple Syndromal Diagnoses  
Buchner & Wagner 199239  State of diminished physiological Deficits in 3 frailty components:
  reserve capacity, that increases  neurological control, mechanical
  the risk of disability functioning, energy metabolism
 Ory et al. 199340  Diminished strength, impaired  
   mobility, balance and endurance
 Rockwood et al. 199414 Vulnerable, dynamic condition,  Deficits in 5 frailty components:
  that is caused by a precarious  functional independence,
  balance between health  reduced mobility, low self-rated
  maintaining abilities and deficits  health, limited social contacts
  that are a health threat  
 Campbell & Buchner 199741 Syndrome that is the result of a  Limitations in 4 frailty
  diminished reserve capacity in  components: muscle and skeletal
  multiple physiological systems.  system, respiratory capacity,
  Increases the risk of disability  cognitive/ neurological and
  and death in the case of small  nutrition
  environmental stressors 
 Dayhoff et al. 199842 Diminished functioning  Score of >20 on WHO
  combined with low self-rated  ‘Assessment of Functional
  health  Capacity’ 
 Strawbridge et al. 19984 A grouping of problems and  Experiencing problems or
  losses of capability in multiple  difficulties in 2 or more of the
  domains of functioning, which  following domains:
  make the individual more  Physical functioning
  vulnerable to environmental  - Sudden loss of balance
  challenge - Weakness in arms
   - Weakness in legs
   - Get dizzy or faint when 
    stand up quickly
   Nutritive function
   - Loss of appetite
   - Unexplained weight loss
   Cognitive functioning
   - Difficulty paying attention
   - Trouble finding the right word
   - Difficulty remembering things
   - Forgetting where put something
   Sensory problems
   - Difficulty reading a newspaper
   - Recognizing a friend across 
    the street
   - Reading signs at night
   - Hearing over the phone
   - Hearing a normal conversation
   - Hearing a conversation in 
    a noisy room
 Chin et al. 199943 Inactivity combined with low  Inactivity <210 minutes a week,
  energy intake, weight loss  energy intake <7.6 MJ per day, 
  or low BMI 5 kg weight loss in the previous  
   5 years, BMI < 23.5 kg/m2
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 Author(s) Definition Criteria
Multiple Syndromal Diagnoses
 Fried et al. 20012 Biologic syndrome of decreased  The presence of 3 or more of the
  reserve and resistance to  following components:
  stressors, resulting from  Weight loss, weakness, poor
  cumulative declines across  endurance and energy, slowness,
  multiple physiological systems,  and low physical activity level
  and causing vulnerability to 
  adverse outcomes 
 Puts et al. 200544  ≥3 frailty markers with a score  
   above the cut-off out of 9 frailty  
   selected frailty markers: body  
   weight, peak expiratory flow,  
   cognition, vision and hearing  
   problems, incontinence, sense of  
   mastery, depressive symptoms,  
   and physical activity
 Rolland et al. 200645  3 operational definitions; scores  
   in the lowest quartile of:
   1. SPPB score
   2. Walking speed
   3. Handgrip strength
 Ensrud et al. 200818  SOF-index (based on the criteria  
   of Fried et al. (2001)2; ≥2 of the  
   following 3 components: 
   - Weight loss
   - Inability to rise from a chair 
    5 times without using arms
   - Reduced energy level
 Sarkisian et al. 200846 In addition to the physical  ≥4 out of the following 10
  phenotype, multiple sub- criteria:
  dimensions: cognition, IL-6 en  - Slower gait
  CRP levels, subjective weakness  - Weaker grip
  and anorexia - Lower physical activity 
   - Weight loss
   - Exhaustion
   - Lower cognitive function
   - Subjective weakness
   - Anorexia
   - Higher IL-6
   - Higher CRP
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 Author(s) Definition Criteria
 Scales 
 
 Raphael et al. 199521 Diminished ability to carry out  Measurement of the ability to
  the important practical and  carry out practical (21 items)
  social activities of daily living and social activities (9 items)
 Brown et al. 200022 Difficulty with fundamental tasks Based on an adapted version of  
   the MPPT
 Mitnitski et al. 200224 A range of symptoms/deficits  Frailty-index based on a list of
  that represent a loss of functional  21 deficits (symptoms, signs,
  activity, sensory damage and  damage and limitations),
  overall medical-, health-, and  obtained from structured clinical
  behavioral problems geriatric research into: vision,  
   hearing, mobility, vascula, gait  
   speed, vibration sense, toileting,  
   cooking, bathing, going out,  
   grooming, skin, resting tremor,  
   sleep, dressing, urinating,   
   gastro-intestinal condition, diabetes,  
   hypertension, limb tone
 Jones et al. 200423 Based on Rockwood et al 2002.47: Frailty index (FI-CGA) based on
  a vulnerable state that is caused by  the presence of 70 deficits in the
  a complex interaction between  following domains: cognitive
  medical and social difficulties,  status, mood and motivation,
  resulting in a diminished ability  communication, mobility,
  to deal with stressors and  balance, bowel and bladder
  is accompanied by diminished  function, IADLs and ADLs,
  functioning nutrition, social resources and 
   the number of comorbidities
 Mitnitski et al. 200430 Two variables: chronological age  PBA (self-report frailty-index): a
  and a frailty-index scale with a range of 0-1, based  
   on the weighted impact of 40  
   self-reported health related 
   variables
 Schuurmans et al. 20043 A loss of resources in several  GFI: a 15-item screening
  domains of functioning, which  instrument that screens for loss
  leads to a declining reserve  of function in 4 domains:
  capacity for dealing with  1. Physical (mobility
  stressors   functions, multiple health  
     problems, physical fatigue,  
     vision, hearing)
   2. Cognitive 
   3. Social (emotional isolation)
   4. Psychological (depressed  
     mood and feelings of anxiety)
 Studenski et al. 200419  CGIC-PF includes 6 intrinsic 
   domains (mobility, balance,strength, 
   endurance, nutrition, and neuro- 
   motor performance) and seven  
   consequences domains (medical  
   complexity, healthcare utilization,  
   appearance, self-perceived health, 
   activities of daily living, emotional  
   status, and social status)
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 Author(s) Definition Criteria
 Scales 
 Mitnitski et al. 200548 A proportion of deficits greater  Frailty index (0-1) as a proportion
  than average for age of all potential deficits (symptoms,  
   signs, laboratory abnormalities,  
   disabilities) 
 Rockwood et al. 200525  CSHA Clinical Frailty Scale: a  
   7-point scale ranging from very fit  
   to severely frail, based on clinical  
   judgment
 Rolfson et al. 200649  EFS samples 9 domains: 
   cognition, overall health (self  
   reported and number of hospital  
   admissions in the last year), 
   functional independence, social  
   support, medication use, nutrition,  
   mood, incontinence and a timed  
   up-and-go test
Abellan van Kan et al. 200850 Various existing frailty  The Geriatric Advisory Panel
  definitions (Fried et al., 20012;   proposed the FRAIL Scale that
  Rockwood et al., 199935;   consists of 5 domains: Fatigue, 
  Rolland et al., 200645) Resistance (ability to climb 1 flight 
    of stairs), Ambulation (ability to  
   walk 1 block), Illnesses (greater  
   than 5), Weight Loss (>5%)
 Ravaglia et al. 200851  Frailty score based on 9 variables  
   from different domains that predict  
   mortality: age >80, physical  
   inactivity, male gender, daily use  
   of ≥3 drugs, sensory deficits, calf  
   circumference ≥31 cm, IADL  
   limitations, gait and balance test  
   score <24, pessimism about  
   one’s own health
 Gobbens et al. 201052 Frailty is a dynamic state  TFI: questionnaire
  affecting an individual who  (25 questions) in 2 parts.
  experiences losses in one or  Part A: 10 questions about
  more domains of human  determinants of frailty, and in
  functioning (physical,  part B : 15 questions about
  psychological, social), which is  3 components of frailty
  caused by the influence of a  (physical, psychological and
  range of variables and which  social)
  increases the risk of adverse 
  outcomes
  
Abbreviations: MNA, Mini Nutritional Assessment; ADL, Activities of Daily Living; SPPB, Short Physical Performance 
Battery; IADL, Instrumental Activities of Daily Living; WHO, World Health Organization; BMI, Body Mass Index; SOF, 
Study of Osteoporotic Fractures; IL-6, Interleukin-6; CRP, C-Reactive Protein; MPPT, Modified Physical Performance 
Test; FI-CGA, Frailty Index-Comprehensive Geriatric Assessment; PBA, Personal Biological Age; GFI, Groningen Frailty 
Indicator; CGIC-PF, Clinical Global Impression of Change in Physical Frailty; CSHA, Canadian Study of Health and 
Aging; EFS, Edmonton Frail Scale; FRAIL-scale, Fatigue Resistance Ambulation Illnesses Loss of weight-scale; TFI, Tilburg 
Frailty Indicator 
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Discussion  
First, it can be concluded that despite an exponential growth in the amount of 
articles regarding frailty, there is no consensus about how frailty is defined and how 
frailty should be operationalized. In a recent international consensus meeting these 
concerns were not resolved.50 Second, literature regarding frailty in gerontopsychiatric 
literature is scarce. The available studies are cross-sectional and point to an association 
between frailty and depression; information about causality and/ or confounding 
due to symptom overlap is lacking. 
Points of discussion
Important topics for discussion are whether frailty should be defined according to 
solely biomedical factors (physical phenotype), or whether psychosocial factors 
should also be included in the definition of frailty. Furthermore, it remains unclear 
whether frailty can be regarded as a unidimensional disease concept with unique 
pathophysiology, or whether frailty is an epidemiological construct that consists of a 
combination of criteria that together are more predictive of adverse health outcomes 
than the sum of those criteria (statistical interaction). Finally, it can be discussed 
whether frailty consists of a number of individual components associated with aging, 
that should not be considered in clusters.53
Regarding the second point of discussion, no consensus will be reached on short 
term. Currently, several aging mechanisms exist54 on both a molecular/ genetic 
level (e.g. telomere length), as well as a systemic level (e.g. inflammation, hormonal 
changes). Presumably, all these mechanisms contribute to the occurrence of frailty. 
Considering the many frailty definitions that have a predictive value with regard to 
adverse health outcomes,55 and the various existing aging mechanisms, it seems 
unlikely that a final common pathway will be found. 
For fundamental frailty research within a psychiatric setting we advocate the use of 
the physical phenotype of frailty. First, because this offers the possibility for studying 
frailty in relation to psychiatric disorders without including psychiatric disorders such 
as depression in the (broad) definition of frailty. Second, because underlying mecha-
nisms associated with and moderating psychiatric disorders can be studied. In order 
to enable comparison with previous studies, it is preferred that the physical frailty 
definition by Fried and colleagues is applied.2 It should be noted that unifying the 
operationalization of the components of physical frailty is an important step forward, 
as is the validation of these frailty criteria in various populations. In these validation 
studies, negative health outcomes should be limited to mortality, because mortality is 
least susceptive to cultural and socio-economical differences. 
Disadvantages of the broad frailty phenotype
Based on our reasoning, the question arises whether the broad frailty phenotype only 
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creates confusion. Nevertheless, the popularity of the broad phenotype seems to 
gradually grow8, 56 which is because of its compatibility with clinical practice. The 
broad frailty phenotype forces clinicians to assess factors like social context, cognitive 
functioning and psychiatric disorders.56 Physical and cognitive training programs 
contribute to healthy aging57 and may prevent frailty.36, 58, 59 Furthermore, interventions 
that focus on multiple, reciprocally influencing factors have yielded good results in 
vulnerable older persons.60, 61 Important components of these interventions were physical 
activity and therapy aimed at balance skills and strength, and regular visits by a 
social worker.
Both quantitative and qualitative research into the relations between frailty and 
psychiatric disorders are scarce, merely because lifestyle factors are important etio- 
logical factors in the occurrence of frailty.16 Psychiatric diseases are often accompanied 
by an unhealthy lifestyle62 and systemic aging mechanisms such as elevated inflam-
matory markers.63 Adequate treatment of psychiatric disorders may be a key element 
in preventing frailty. 
Conclusion
Frailty deserves a prominent place in old age psychiatry research. The proliferation of 
operational definitions forces clinicians to carefully substantiate the definition that is 
used to assess frailty. In psychiatric research, a physical frailty definition is preferred in 
order to prevent symptom overlap and confounding with psychiatric disorders. Future 
research will have to show whether older psychiatric patients with frailty will benefit 
from specific treatment strategies, as is increasingly the case in somatic medicine.64 
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Abstract
Objectives- To systematically compare and pool the prevalence of frailty, including 
prefrailty,reported in community-dwelling older people overall and according to sex, 
age and definition of frailty used. 
Design- Systematic review of the literature using the keywords elderly, aged, frailty, 
prevalence and epidemiology.
Setting- Cross-sectional data from community-based cohorts.
Participants- Community-dwelling adults older aged 65 years and older.
Measurements- In the studies that were found, frailty and prefrailty were measured 
according to physical phenotype and broad phenotype, the first defining frailty as a
purely physical condition and the second also including psychosocial aspects.
Results- Reported prevalence in the community varies enormously (range 4.0–59.1%). 
The overall weighted prevalence of frailty was 10.7% (95% confidence interval 
(CI) = 10.5–10.9; 21 studies; 61,500 participants). The weighted prevalence was 
9.9% for physical frailty (95% CI = 9.6–10.2; 15 studies; 44,894 participants) and 
13.6% for the broad phenotype of frailty (95% CI = 13.2–14.0; 8 studies; 24,072 
participants) (chi-square (χ2) = 217.7, degrees of freedom (df)=1, P < .001). 
Prevalence increased with age (χ2 = 6067, df = 1, P < .001) and was higher in 
women (9.6%, 95% CI = 9.2–10.0%) than in men (5.2%, 95% CI = 4.9–5.5%; 
χ2 = 298.9 df = 1, P < .001).
Conclusion- Frailty is common in later life, but differential operationalization of frailty 
status results in widely different prevalence rates between studies. Improving the 
comparability of epidemiological and clinical studies constitutes an important step 
forward. 
Key words: frailty, prevalence, elderly
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Introduction 
Not everyone can achieve successful aging. Decreasing well-being and increasing 
levels of frailty often accompany increasing age.1 Although chronological and bio- 
logical age correlate,2 individuals with the same chronological age may vary widely 
in health and functional status.3 The concept of frailty attempts to explain this hetero-
geneity in older adults and is thus an important concept for clinical practitioners and 
policy-makers. From a clinical perspective, frailty is important because it constitutes 
a condition of greater risk of adverse health outcomes, such as falls, less mobility, 
less independence, hospitalization, disability and death.1 The explanation for these 
increased health risks is sought in a reduction of the reserve capacity of various 
physiological systems. Frailty appears when the reserve capacity has decreased to 
a critically low point, where even small disturbances can lead to a series of compli- 
cations.4 Frailty is important from a societal perspective because it identifies groups of 
people in need of extra medical attention. Frailty is also important when considering 
financial health care planning. 
Although it is generally assumed that the prevalence of frailty increases with age, 
is higher in women than men, and is more prevalent in the presence of chronic 
disease,1, 5, 6 no consensus exists about the prevalence rates of frailty. The definition 
of frailty can at least partly explain discrepancies. Two groups of researchers mainly 
dominate the ongoing discussion about the definition of frailty. One group defines 
frailty according to a physical phenotype and has attracted the most attention of 
researchers.7 In this phenotype, frailty is defined as a purely physical condition and 
therefore consists of solely physical components. For example, the Fried Frailty Index 
(FFI) requires the presence of three or more out of five components: weight loss, 
exhaustion, weakness, slowness, and low physical activity.1 The other group defines 
frailty by a broader definition, including social and psychological aspects.8 For 
example, the Frailty Index (FI) is based on the routinely used Comprehensive Geriatric 
Assessment (CGA) and consists of a count of impairments in various areas such as 
mood, cognition and incontinence.9 In addition to these two operationalizations of 
frailty, many variations on these definitions can be found in the literature.10-12 Most 
definitions also include a prefrailty state1, 13 -a state in between frail and nonfrail- 
acknowledging the dimensional aspect. This latter aspect has further stimulated the 
development of several instruments to measure the frailty status14-17 , which in turn has 
indicated the dynamic nature of frailty over time.18 
The objectives of this literature review were to systematically compare the prevalence 
of frailty with regard to definition, sex and age reported in community-dwelling older 
persons and to pool these rates to overall frailty and prefrailty prevalence.     
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Methods
The process of reviewing was divided into three steps: obtaining, extracting and 
assessing data. First, the literature was systematically searched in the PubMed 
database using the keywords elderly, aged, frailty, prevalence and epidemiology. 
If applicable to the keyword, Medical Subject Heading terms were included and 
then combined with the search. References of the included articles were checked to 
find studies that had not been found with the search string.
Inclusion criteria were community-based study, cross-sectional study design or reporting 
of frailty prevalence at the baseline assessment of longitudinal studies, sufficient 
information regarding the definition of frailty that was used, a minimum of age of 65 
years of participants in the cohorts, and no upper age limit for participants. Studies that 
also enrolled younger subjects were included in the present study, as long as prevalence 
was specifically given for persons aged 65 and over. Studies that did not report frailty 
prevalence but only, for example, mean frailty scores on a measurement instrument were 
excluded.  In the case of multiple studies using the same cohort, the study was chosen that 
provided the most detailed information on the subjects and frailty definition or included 
the largest number of subjects. 
Prevalence was calculated for frailty and prefrailty. If a study compared various 
definitions of frailty and therefore provided multiple different prevalence rates, the 
FFI prevalence was used for the calculation for the overall frailty and prefrailty 
prevalence. If a study did not use the FFI, the lowest prevalence rates were chosen for 
the overall calculations, to be conservative. The variables of interest for the subgroup 
analyses were the definition of frailty (physical frailty versus the broad phenotype of 
frailty), age and sex. 
Two authors (RC and RCOV) independently extracted the data. Results were compared 
and differences were resolved by consensus. 
Statistical Methods
Data analyses were performed using SPSS, version 16.0 (SPSS, Inc., Chicago, IL). 
Prevalence was taken directly from the articles. Weighted average rates were calcu-
lated by weighting the results according to the number of participants in the study. In 
each of the studies in this review, frailty has its own unique variance. These variances 
were included in the calculation of the 95% confidence intervals (CIs). Important 
variables, such as age and sex, were subsequently compared using analyses of 
variance (continuous variables) and chi-square (χ2) statistics (categorical variables).
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Results
The search strategy yielded 507 hits, of which 54 were eligible articles. Of these, 
33 were excluded because they described a double study sample that was already 
included. A total of 21 community-based studies was included. Four studies provided 
results according to age group and 10 studies according to sex (Table 1). One 
additional study was used for the calculation of frailty prevalence according to 
sex but could not be used for the overall frailty prevalence calculation because 
prevalence rates were given only according to sex.19 No new studies were found in 
the references of the articles. 
The prevalence of frailty in community-dwelling older adults varied from 4.0% to 
59.1%. The FFI1 was the most frequently used definition of frailty (n=14). Two 
studies compared two frailty indexes.13, 20 Another study compared three self-report 
screening instruments.21 The studies that reported the highest prevalence rates, used 
self-report questionnaires.21, 22 
The wide range in the results was considerably reduced by arranging the studies 
according to the frailty definition used. In studies that used a frailty definition according 
to the physical phenotype, frailty prevalence ranged from 4.0% to 17.0%. In studies 
that used broad definitions or measurement instruments, prevalence varied from 4.2% 
to 59.1%. 
The proportion of women was calculated across 15 studies including 53,322 
participants. There were slightly more women (51.3%, 95% CI = 50.9–51.7%) 
than men in the studies (χ2 = 1506.7, df = 1, P < .001). Weighted mean age, 
derived from 20 studies with a total of 56,183 participants, was 74.9 (95% CI = 
74.8–74.9). Table 1 shows the details of the studies.
The overall weighted average prevalence of frailty was 10.7% (95% CI = 10.5–
10.9%; 21 studies; 61,500 participants). The overall weighted average prevalence 
of prefrailty was 41.6% (95% CI = 41.2–42.0%; 15 studies; 53.727 participants).
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Subgroup analyses
Definition of frailty
In studies that used physical frailty definitions, the weighted average was 9.9% 
for frailty (95% CI: 9.6-10.2%; 15 studies; 44,894 participants) and 44.2% for 
prefrailty (95% CI: 44.2-44.7%; 13 studies; 41,197 participants). The weighted 
frailty and prefrailty rates were also calculated for studies that applied the broad frailty 
phenotype. The weighted average prevalence of frailty prevalence in this group was 
13.6% (95% CI: 13.2-14.0%; 8 studies; 24,072 participants) and 33.5% had a 
prefrail state (95% CI: 32.9-34.1%; 4 studies; 19,996 participants).The difference 
between weighted rates of frailty according to physical phenotype (9.9%) versus 
broad phenotype (13.6%) was statistically significant (χ²=217.7, df=1, P< .001).
Sex
The 11 studies that described frailty prevalence according to sex enrolled 17,746 
women and 22,596 men. In women, the weighted average prevalence of frailty 
was statistically significantly higher (9.6%, 95% CI = 9.2–10.0%) than in men (5.2%, 
95% CI = 4.9–5.5%; χ2= 298.9, df =1, P< .001).
Prefrailty prevalence was addressed in six studies involving 10,683 female participants 
and 17,160 male participants. Prefrailty was more prevalent in women (39.0%, 
95% CI = 38.1–39.9%) than in men (37.3%, 95% CI = 36.6–38.0%; χ2 = 8,629, 
df = 1, P= .003). Mean age was 75.7 for women and 75.0 for men (t = –33.15, 
df = 19,877, P< .001; 7 studies; 20,236 participants).
Age 
Four studies presented the data according to age group, resulting in increasing 
prevalence rates according to age (χ²=6,067, df= 1, P< .001). For two studies, the 
age groups of 85-89 years and 90 and older had to be combined. Figure 1 shows 
weighted average rates of frailty overall and for each subgroup. 
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Figure 1 Prevalence of Frailty and 95% Confidence Intervals
 
Discussion
Based on 21 cohorts involving 61,500 subjects, on average 10.7% of community- 
dwelling older persons are frail and another 41.6% prefrail. Nevertheless, the reported 
prevalence rates differed substantially, ranging from 4.0% to 59.1%. 
The range of frailty rates found in the included studies was wide, but arranging the 
results according to frailty definition reduced this variety. Studies using a physical 
frailty definition consistently report lower prevalence of frailty than those using a 
broad frailty definition. Most studies reporting on the physical phenotype of frailty 
used the original or slightly adjusted FFI as applied in Cardiovascular Health Study 
CHS, making a comparison of the studies within this group easier. The diversity in 
frailty criteria of broad frailty definitions thus appears to have contributed to the wide 
range of prevalence found in literature. Although the broad phenotype of frailty has 
its roots in Canadian population surveys, it has stimulated researchers around the 
world to develop their own (broad) criteria for frailty. Therefore, the often-proposed FI 
of broad phenotype research groups did not dominate among studies applying the 
broad phenotype.35, 38  
The smaller range of frailty rates in studies that used a physical frailty definition 
implies more consensus between researchers searching for physical frailty and or 
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a more-reliable definition of frailty. These findings argue for the use of a physical 
definition of frailty, because by employing the narrower but more-consistent physical 
definition of frailty, comparability of studies will be improved. In the case of a distinct 
preference for the use of a broad frailty definition, the different aspects within this 
definition should be examined separately (physical, social, psychological). Not only 
does this approach provide more information about who needs special care in specific 
domains, it also enables researchers to examine underlying pathophysiological 
processes of frailty more accurately. 
Another finding is that frailty increases with age. This pattern of increasing frailty 
prevalence has also been confirmed in previous studies that divided the cohort into 
age groups. In the present study, the prevalence for the oldest-old persons were 
15.7% (aged 80-84) and 26.1% (≥85). This contrasts with prevalence of 40% as 
estimated by the American Medical Association,39 which institutionalization of frail 
older persons in these higher age groups could explain, whereas the current results 
are community based. Older persons, especially when frail, account for the highest 
costs in health care in developed countries.40 This makes it absolutely necessary that 
policy-makers explicitly state their target population (age group, sex), when applying 
these rates of frailty.
Women had higher rates of frailty than men. This finding is not unexpected, given 
that women have lower average amounts of lean body mass and muscle strength.1 
The relationship between frailty and sarcopenia has been confirmed in previous 
research.6 
In another study, it was shown that men have a higher likelihood of dying suddenly 
than women, the latter showing a more-steady, progressive decline.41 This decline 
could lead to frailty, providing women with more frailty characteristics. 
Another, possible explanation is the longer life expectancy of women. As a result of 
which the women in the age groups were older than the men. Because frailty increases 
with age, this could contribute to the differences between the sexes. Only one study 
mentioned an age difference between men and women.23 
One of the limitations of this systematic review is that it included slightly more women 
(51.3%) than men, so the overall prevalence of frailty may be overestimated. The 
review showed that age in men and women in the studies may not have differed 
in a clinically significant matter but differed significantly statistically, leading to a 
potential confounder of the findings in studies that did not correct for age differences 
between men and women. Nevertheless, women were not overrepresented when 
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compared with the distribution of older men and women in the community. Because 
not all studies provided information on sex distribution, it was impossible to control 
for this difference. Future researchers should be aware of and, if possible, control for 
differences in age between men and women.
Secondly, the included studies enrolled subjects from different countries. It has been 
reported that frailty prevalence might be higher in Mexican older adults32 and among 
inhabitants of southern European countries.30 If true, this may have led to an overesti-
mation of the overall frailty prevalence, although the inclusion of studies from Europe, 
as well as the United States, Australia and Asia, enhances the generalizability of the 
results. The exclusion of studies from countries with higher prevalence of frailty would 
have decreased the robustness of the findings.
In conclusion, this systematic review finds that approximately one in 10 independently 
living adults aged 65 years and older is frail and confirms sex differences. 
The aim of the concept of frailty is to predict adverse health outcomes. Previous 
research showed that two different frailty definitions (a broad and a physical definition) 
had the same predictive value concerning adverse outcomes, such as falls, hip fracture 
and death,13 although the results of this review suggest that the physical definition of 
frailty leads to a lower estimation of prevalence but is likely more easily comparable 
between studies that use a physical definition of frailty. 
The next step is to recognize frail elderly adults and to prevent adverse outcomes 
with special multidisciplinary treatments. To enable preventive interventions, it should 
be clear which frailty characteristics or underlying processes predict each outcome 
most accurately. Fundamental research therefore not only warrants summary scores or
categorical definitions of frailty, but should also consider the separate components 
and their dimensional aspects. As long as no consensus has been reached about 
the operationalization of frailty, clinicians and policy-makers should be aware of 
these differences and should take these differences into account.7 Consequences of 
these differences are amount, content, and type of collaborative care projects but 
also planning of somatic, mental, or integrated healthcare centers. A physical model of 
frailty should be used in fundamental research and a multidimensional model in studying 
healthcare organization and planning. Improving the comparability of epidemiological 
and clinical studies by consensus regarding these two operationalizations of frailty 
constitutes an important step forward.
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with late-life depression?
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Abstract
Objectives- Frailty, a state of increased risk of negative health outcomes, is increasingly 
recognized as a relevant concept for identifying older persons in need of preventative 
geriatric interventions. Even though broader concepts of frailty include psychological 
characteristics, frailty is largely neglected in mental health care. The aim of the present 
study is to examine the prevalence of physical frailty in depressed older patients and 
its potential overlap with depression criteria. 
Methods- Cross-sectional observational study including 378 older adults with depression 
according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV) criteria and 132 non-depressed adults, all aged ≥60 years. Physical frailty 
was defined as ≥3 out of 5 criteria (handgrip strength, weight loss, poor endurance, 
walking speed, low physical activity).
Results- Prevalence rates of physical frailty were 27.2% and 9.1% among depressed and 
non-depressed participants, respectively, which remained significant after controlling for 
relevant covariates (odds ratio [OR]=2.66 [95% confidence interval [C.I.] =1.36- 
5.24], p=.004). Physical frailty in depression was associated with more severe 
depressive symptoms; this association remained significant in subsequent analyses 
with purely physical proxies for frailty (handgrip strength, walking speed) and different 
severity measures of depressive symptoms.
Conclusion- A quarter of depressed older patients is physically frail, especially the 
most depressed group. This cannot be explained by overlap in criteria and should be 
examined in future studies, primarily on its presumed clinical relevance. 
Keywords: depression, frailty, elderly, Netherlands Study of Depression in Older 
persons (NESDO) 
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Introduction
Frailty is conceptualized as a state of increased risk of adverse health outcomes, 
such as falls, reduced mobility, reduced independence, hospitalization, disability 
and death.1 The explanation of the increased health risks is sought in a reduction 
of the reserve capacity of various physiological systems. Frailty is prevalent when 
the reserve capacity has decreased to a critically low point, where even small 
disturbances can lead to a series of complications. As this theoretical foundation 
is not (yet) supported by a clear underlying pathophysiological process, research 
has led to various operationalizations of frailty and prevalence rates vary widely.1-3 
Among community-dwelling older persons, meta-analysis showed a prevalence rate 
of frailty of 9.9% for physical frailty and 13.6% for the broader operationalization of 
frailty.4 The latter also includes psychological and psychosocial characteristics. 
Irrespective of the exact conceptualization of frailty, prospective studies have unequi-
vocally demonstrated a worsening of prognosis of somatic conditions in the presence 
of frailty.5, 6 Quite recently, the clinical relevance is further substantiated by several 
randomized controlled trials, showing that interventions targeted at frailty components, 
improve health outcomes of frail older persons.7-10 For example: high-intensity progres-
sive resistance training reduced mortality and nursing home admission after hip fracture 
surgery.11 In physically frail older persons, a home-based physical therapy targeted 
at underlying impairments in physical ability, significantly reduced functional decline.12 
Finally, a home-based self-administered exercise program with protein supplementation 
led to significantly less decline in walking ability and instrumental activities of daily 
living.13
Although hardly examined, frailty can be assumed to be of special relevance in older 
persons suffering from psychiatric diseases, especially depressive disorders that are 
also associated with increased mortality rates and negative health outcomes, such as 
somatic diseases and increased risk of suicide.14, 15 However, the disparity between 
body and mind has probably led to the ignorance of physical frailty in psychiatric 
patients. Broader concepts of frailty include several psychiatric symptoms next to 
physical symptoms, thereby not discriminating anymore between them. Empirical 
data indeed show some overlap between frailty and late-life depression,16 but also 
underline that frailty and depression represent distinct syndromes rather than a single 
construct.17 To improve treatment of older depressed persons it is important to further 
study frailty in this specific group.
Objectives
The objective of the present study is to determine the prevalence of physical frailty in 
depressed older and non-depressed older adults, adjusted for potential confounders. 
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For this purpose, frailty should be defined in purely physical terms. Therefore, a definition 
was chosen that did not contain depression as a characteristic of frailty. The definition 
of Fried and colleagues1 is widely used in geriatric research and encompasses a 
physical phenotype of frailty.1, 3, 18, 19 Nevertheless, as included physical symptoms 
such as exhaustion, weight loss and slowness, may also be related to depression, 
we further explored whether the hypothesized association between depression and 
physical frailty can be explained by shared characteristics. 
Methods
Ethics statement
The study was approved by the Ethical Review Board of the VU University Medical 
Center in Amsterdam. Since this was a multi-center study, the ethical review boards of 
the other participating institutes approved of the local feasibility of the study, of which 
the details are described elsewhere.20 Participants received written and oral information 
about the study. They had the opportunity to ask questions and it was checked by the 
research nurses whether the participants understood the consequences of the study. 
All participants were competent to consent to participation. Written informed consent 
was obtained from all participants. 
The present study was embedded within a prospective cohort study: the Netherlands 
Study of Depression in Older persons (NESDO).20 The aims for NESDO are to examine 
the (determinants of the) course and consequences of depressive disorders in older 
persons, and to compare the course and determinants of late-life depression with that 
of early-life depression. 
The NESDO sample consists of 378 depressed participants with a current Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnosis of 
major depressive disorder (95%), minor depression (5.6%) or dysthymia (26.5%), 
of which 26.5% have two depressive disorders. The comparison group consists of 
132 non-depressed participants, aged 60 through 93 years. Persons with a primary 
diagnosis of dementia, a Mini Mental State Examination score (MMSE) under 18 or 
an organic or psychotic disorder were excluded, since the course of these persons 
will be largely determined by the primary disorder. Insufficient mastery of the Dutch 
language is also an exclusion criterion.20 
Of the depressed participants, 86.2% was recruited from mental health institutes 
(both in- and outpatients) and 13.8% from primary care. The non-depressed comparison 
group was recruited from 14 primary care practices and screened for absence of 
depression. 
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All participants underwent a baseline examination at one of the research locations 
or at the homes of the participants. A questionnaire including several of the written 
measurement instruments was sent to the homes of the participants prior to the baseline 
examination and when necessary, the assessment was spread over two appointments. 
Measures
Depression
The Composite International Diagnostic Interview (CIDI), version 2.1; life time version 
was used in order to determine depression classification according to the criteria of 
DSM-IV and the criteria of the International Classification of Diseases-10 (ICD-10).21 
The CIDI has high validity for depressive disorders.22 To determine the research DSM-IV 
diagnosis of current minor depression, questions were added to the CIDI, as in The 
Netherlands Study of Depression and Anxiety (NESDA).23 
Severity of depression was measured by the 30-item self-rating Inventory of Depressive 
Symptomatology (IDS), which has acceptable psychometric properties.24, 25 IDS sum 
score (range 0 – 84) was used as a continuous variable. The clinical interpretation of the 
IDS sum score is as follows: 0–13=normal, 14–25=mild depression, 26–38=moderate 
depression, 39–48=severe depression and 49–84=very severe depression.26 
Principal component analysis and confirmatory factor analysis of the IDS-SR indicated 
a three-factor model of which two factors could be optimized with Rasch analyses to 
function as homogenous measures of depressive symptoms dimensions: the mood/
cognition factor and the anxiety/arousal factor (age range 18-65).27  
 
Frailty
Frailty was assessed according to the criteria of Fried et al.,1 which are weight loss, 
weakness, poor endurance and energy, slowness and low physical activity level. 
A person is classified as frail when ≥3 criteria are present, classified as prefrail when 1 
or 2 criteria are present and classified as robust when none of the criteria are present. 
Unintentional weight loss was defined as a positive response on the CIDI question 
about unwanted weight loss of a minimum of one kilogram a week, during two or 
more consecutive weeks or a body mass index (BMI) of less than 18.5 kg/ m². 
A handgrip dynamometer was used to assess weakness. Participants were asked to 
perform two squeezes with the dynamometer, using their dominant hand. The best 
performance, recorded as strength in kilograms, was used for analysis. Cutoff scores 
were stratified by gender and BMI quartiles according to Fried at al.1 Participants 
unable to perform the test were also considered weak. 
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Poor endurance and energy (exhaustion) were determined by two questions from the 
Center for Epidemiologic Studies-Depression scale (CES-D),28 similar to other studies1, 
18: “I felt that everything I did was an effort” and “I could not get going.” The items 
asked “How often in the last week did you feel this way?” and subjects responded 
on a four-point scale: 0=rarely or never (<1 day), 1=some or a little of the time 
(1–2 days), 2=a moderate amount of the time (3–4 days), 3=most of the time (5–7 
days). Participants answering 2 or 3 to either of these two items were categorized 
as positive for this item.
Slowness was measured by a six-meter walking test. For men ≤173 centimeters (cm) 
tall the cutoff time was 9 seconds, for men >173 cm the cutoff time was 8 seconds. 
The cutoff time on this criterion for women with a height of ≤159 cm was 9 seconds, 
for women >159 cm the cutoff time was 8 seconds (extrapolated from the data of 
Fried and colleagues).1 
Low physical activity level was defined as no daily activities such as walking and 
gardening, or sports activity less than once weekly. The last-seven-days short form 
of the self-administered version of the International physical Activities Questionnaire 
(IPAQ),29 consisting of seven items, was used to collect the physical activity data. 
Psychometric properties of the short and long version of the IPAQ are acceptable.29
In addition to the syndromal definition of frailty based on the Fried criteria, we also 
included two unidimensional proxies for frailty based on previous research into physical 
frailty, i.e. muscle weakness30 and gait velocity.31 Muscle weakness was defined as 
the handgrip strength, as described above. Gait velocity was based on the six-meter 
walking test, as described above. 
Covariates
Demographic data were collected during the interview (age, gender, living circumstances 
and educational level). 
Somatic comorbidity was assessed using a self-report questionnaire about the presence 
of somatic diseases (lung disease, cardiovascular disease, diabetes, arthritis, rheuma-
tism, cancer, ulcer, intestinal disorder, liver disease, epilepsy, allergy, thyroid gland 
disease and (head) injury), as originally developed by Statistics Netherlands (Centraal 
Bureau voor de Statistiek, www.cbs.nl). This questionnaire has high accuracy for 
chronic somatic disease as previously reported.32
Global cognitive functioning was assessed by the MMSE.33 MMSE score (range 
0-30) will be measured as a continuous variable, with higher scores indicating better 
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cognitive functioning. Interrater reliability and test-retest reliability are good.34, 35 
Statistical analyses
Demographics and clinical characteristics of the participants with and without 
depression were examined using independent samples t-tests for normally distributed, 
continuous variables, nonparametric Mann Whitney U tests for skewed continuous 
variables, and χ² tests for categorical variables. The association between physical 
frailty and depression diagnoses (yes/no) as the dependent variable was sub- 
sequently assessed by multivariate logistic regression analysis corrected for age, gender, 
educational level, living circumstances, number of comorbid somatic diseases and 
MMSE score.
Multicollinearity was tested by calculating the bivariate correlation coefficient of all 
pairs of independent variables. These tests showed no multicollinearity problems.
The second objective was evaluated within the depressed subgroup only. Multiple 
logistic regression analyses were used to investigate the association between severity 
of depression (independent variable) and physical frailty (dependent variable). First, 
the variable was tested univariately. Subsequently, the regression analyses were 
corrected for the following potential confounders: age, gender, educational level, 
living circumstances, number of comorbid somatic diseases and MMSE score (model 1). 
To examine whether overlap in criteria may explain some of the associations, analyses 
were repeated with different definitions of frailty and depressive symptoms. Frailty 
was operationalized with two unidimensional proxies for frailty, namely weakness30 
and slowness,31 as these definitions do not overlap with symptoms of depression. 
Severity of depression was included in the model in different ways. First by calculating 
the IDS sum score excluding all items that overlap with physical frailty (i.e. items 11-14 
[appetite and weight change], item 20 [energy level], item 23 [feeling slowed 
down] and item 28 [physical energy]). Secondly, by the two IDS subscale scores as 
identified by Wardenaar and colleagues.27 
All p values were two-tailed, and the level of statistical significance was set at p< .05. 
Statistical analyses were carried out using Statistical Package for the Social Sciences 
(SPSS), version 16.0.
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Results
Comparison depressed patients and non-depressed comparison group
The mean age [standard deviation (SD)] of the 510 participants was 70.6 [7.3] 
years, and 64.9% was female. Table 1 presents the characteristics of both the depressed 
and non-depressed group. 
Table 1 Demographics, Clinical Characteristics and Frailty 
  Depressed Group Comparison Group
Characteristic (N=378)  (N=132) P Valuea
Age, mean (SD)  70.7 (7.4) 70.1 (7.2) .371
Age, range 60 – 90 60 – 93 
Gender, % female 66.1 61.4 .322
Living alone, % 54.0 34.8 <.001
Education, % low education  79.1 60.6 <.001
MMSE score, mean (SD) 27.6 (2.5) 28.3 (1.6) <.001
Chronic diseases, mean (SD), no 1.54 (1.21) 1.14 (0.99) .001
Frailty, % 27.2 9.1 <.001
• Weight loss, % 35.4 3.8 <.001
• Weakness, % 25.1 19.7 .205
• Exhaustion, % 45.8 3.8 <.001
• Slowness, % 26.5 18.9 .084
• Low activity level, % 42.3 34.8 .132
Number of frailty criteria:   <.001
• % 0 15.6 48.1 
• % 1 30.8 32.8 
• % 2 26.3 9.9 
• % 3 18.8 7.6 
• % 4 6.6 1.5 
• % 5 1.6 0.0
 
Abbreviation: MMSE, Mini Mental State Examination. 
a Comparison using analyses of variance (continuous variables), χ² statistics (categorical variables) and U 
tests (continuous, skewed variables).
Four participants had missing data on one physical frailty criterion (weakness). However, 
frailty status could be computed based on the four remaining criteria. In order to be 
classified as frail, three or more out of five criteria had to be present. Two of the 
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participants with missing data were considered frail (because of 3 out of 4 positive 
criteria) and two participants were classified nonfrail (because of 0 or 1 positive 
criteria, respectively). 
The prevalence of physical frailty was significantly higher in the depressed group 
compared to the non-depressed comparison group (27.2% versus 9.1%; χ²=18.5, 
df=1, p< .001). Logistic regression analysis, adjusted for age, gender, and all baseline 
characteristics that differed between both groups (number of somatic diseases, educa-
tional level, MMSE score and living status), showed an increased odds ratio (OR) of 
frailty for depression (OR=2.66, 95% confidence interval [CI] =1.36-5.24, p=.004).
Comparison of frail and nonfrail depressed older persons
Compared to nonfrail depressed older persons (n=275), frail depressed elderly 
(n=103) were significantly older, had fewer years of education, lower cognitive 
functioning, more comorbid somatic diseases, and were more severely depressed 
(Table 2). Including all characteristics in a multivariate logistic regression model with 
physical frailty (yes/no) as the dependent variable, age (OR=1.10, 95% CI=1.06-
1.14, p<.001) and severity of depression (OR=1.07, 95% CI=1.05-1.10, p<.001) 
were significantly associated with physical frailty in the depressed group. 
 
Table 2 Characteristics of Frail and Nonfrail Depressed Participants
 
  Depressed Participants (N=378)
 Frail Group Nonfrail Group
Characteristic (N=103) (N=275) P Valuea
 
Age, mean (SD), y  73.8 (8.0) 69.6 (6.9) <.001
Female gender 68.9 65.1 .482
Living alone 57.3 52.7 .429
Education, mean (SD), y  9.7 (3.2) 10.7 (3.5) .008
Cognition (MMSE score), mean (SD) 27.1 (2.5) 27.8 (2.5) .008
Chronic diseases, mean (SD), no 2.1 (1.5) 1.5 (1.1) .001
IDS score, mean (SD) 37.2 (12.4) 27.5 (12.3) <.001
Abbreviations: MMSE, Mini Mental State Examination; IDS, Inventory of Depressive Symptomatology.
a Comparison using analyses of variance (continuous variables), χ² statistics (categorical variables) and U 
tests (continuous, skewed variables).
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The proportion of women was equal in both the frail and the nonfrail group (χ²= 
0.49, df=1, p=.482) (Figure 1). Frailty did increase with age in the depressed 
group (χ²=25, df=5, p<.001) (Figure 2). Frailty prevalence between health care 
setting did not differ significantly (χ²=2, df=2, p=.407) (Figure 3). 
Figure 1 Frailty Prevalence in the Depressed Subgroup
Figure 2 Frailty Prevalence in Depressed Elderly According to Age Groups
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Figure 3 Health Care Setting and Frailty Prevalence in Depressed Elderly
Deconstructing frailty
In order to disentangle the relationship between physical frailty and depression, 
the analyses were repeated with two unidimensional proxies for frailty: weakness 
(operationalized as grip strength) and slowness (operationalized as gait velocity). 
As both variables had a skewed distribution that could not be transformed to a normal 
distribution and outliers were considered informative (a very low grip strength certainly 
points to frailty and should not be excluded), analyses were performed on dichoto-
mized scores of cutoff points of both dependent variables. These analyses yielded 
similar results compared to the analyses using the Fried Frailty Index as indicator for 
frailty (Table 3).
Deconstructing depression
Since the severity of depressive symptoms was significantly higher among frail depres-
sed elderly compared to their nonfrail counterparts, finally all analyses were repeated 
using the adapted IDS sum score (without overlapping frailty items) as well as the 
total scores on two IDS subscales. As shown in Table 4, all measures of depressive 
symptoms were significantly associated with frailty in depressed patients, irrespective 
of the used definition of frailty. 
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Table 3 A
ssociation Betw
een Severity of D
epression (ID
S) and Frailty, W
eakness and Slow
ness in D
epressed Persons A
ged 60 Years 
and O
lder
N
=373 
Frailty 
 
W
eakness 
 
Slow
ness 
Severity of depression 
O
R (95%
 C
I) 
P Value 
O
R (95%
 C
I) 
P Value 
O
R (95%
 C
I) 
P Value
U
nadjusted 
1.07 (1.05, 1.09) 
<.001 
1.02 (1.01, 1.04) 
.001 
1.03 (1.02, 1.05) 
<.001
A
djusted
1 
1.07 (1.05, 1.10) 
<.001 
1.02 (1.00, 1.04) 
.025 
1.03 (1.01, 1.04)  
.005
A
bbreviation: ID
S, Inventory of D
epressive Sym
ptom
atology.
¹ A
djusted for age, gender, living circum
stances, level of education, num
ber of som
atic com
orbidities and M
ini M
ental State Exam
ination (M
M
SE) score.
Table 4 ID
S A
dapted Sum
 Score w
ithout O
verlapping Frailty Item
s and Tw
o ID
S Subscales Yielded by Factor A
nalysis
27: A
ssociation w
ith 
Frailty, W
eakness and Slow
ness (A
djusted for A
ge, G
ender, Living C
ircum
stances, Level of Education, N
um
ber of Som
atic C
om
orbidities 
and M
M
SE Score)
N
=373 
Frailty 
 
W
eakness 
 
Slow
ness 
 
O
R (95%
 C
I) 
P Value 
O
R (95%
 C
I) 
P Value 
O
R (95%
 C
I) 
P Value 
ID
S adapted sum
 score 
1.08 (1.06, 1.11) 
<.001 
1.04 (1.01, 1.06) 
.005 
1.05 (1.02, 1.08) 
<.001
ID
S subscales 
 
 
 
 
 
   1. M
ood/
cognition 
1.13 (1.08, 1.19) 
<.001 
1.05 (1.01, 1.10) 
.022 
1.08 (1.03, 1.13) 
.002
   2. A
nxiety/
arousal 
1.21 (1.13, 1.29) 
<.001 
1.07 (1.01, 1.14) 
.028 
1.13 (1.06, 1.21) 
<.001
A
bbreviations: ID
S, Inventory of D
epressive Sym
ptom
atology; M
M
SE, M
ini M
ental State Exam
ination.
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Discussion
With an overall prevalence of 27.0%, the prevalence of physical frailty was signifi-
cantly higher among depressed compared to non-depressed older persons. Higher 
age and severity of depression were independently associated with physical frailty 
in depressed older adults. 
This raises the question whether depressed frail persons might have inflated depressi-
ve symptom scores (due to the shared characteristics of both syndromes). Therefore, 
the construct of depression was decomposed (using the IDS sum score without items 
that might overlap with physical frailty, as well as using IDS subscale scores) and 
different measures of frailty were used (weakness and slowness). These analyses, 
however, still revealed a significant association between all measures of depressive 
symptom severity and all measures of frailty. It is thus unlikely that the higher severity 
of depressive symptoms in frail compared to nonfrail depressed older persons can be 
explained by shared characteristics. 
A review on the relationship of depression and frailty in later life suggests that depres-
sion and frailty might be bi-directionally related.36 Included studies, however, neither 
measured depression according to state-of-the-art diagnostic criteria nor considered 
the use of antidepressants.36 Another recent study found that depressive symptoms 
as well as antidepressant drug use were indeed associated with frailty after three 
years of follow-up.37 Indirect evidence points to several explanations for the asso-
ciation between physical frailty and the severity of depressive symptoms in late-life 
depression. First, it may be hypothesized that severely depressed patients are more 
prone to developing frailty by both lifestyle factors associated with depression (inac-
tivity and non-compliance of medication in case of somatic comorbidity), as well as 
physiological disturbances associated with depression (for example hypo- and hyper-
cortisolemia affecting the endothelium or autonomic nervous system disturbances38). 
Secondly, frailty may result in a more severe depressed state due to its association 
with chronic somatic diseases and functional limitations. At population level, depres-
sion is more strongly associated with consequences of chronic disease than with the 
disease.39 We a priori chose to include only somatic comorbidity as a confounder, 
because of the risk of overcorrecting. Nevertheless, additional adjustment for functional 
limitations (as assessed with the WHO-Disability Assessment Schedule40), yielded 
similar results to the analyses with somatic comorbidity only (data available on 
request). A third explanation may be common underlying processes, related to both 
frailty and depression. Low-grade inflammation, for example, is generally considered 
one of the underlying mechanisms of both frailty41 and late-life depression.42, 43 
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Implications
Irrespective of the mechanisms by which frailty and late-life depression are related, 
late-life depression with comorbid frailty is challenging in clinical practice. First, an 
older person with frailty can easily be misclassified as suffering from a depressive 
disorder during a period of (physiological) low mood. Such a person may inappro-
priately receive antidepressant drugs and may be withhold appropriate strategies 
to prevent negative health outcomes, associated with frailty. Secondly, although not 
examined yet, it is possible that treatment of depression among frail older persons 
benefits from adapted treatment strategies. In somatic conditions it has already 
been shown that the optimal treatment needs to be different for frail and for nonfrail 
persons.44 Nursing health promotion, proactively provided to frail older adults, increases 
quality of life and reduces depressive symptoms of frail older persons, while not 
increasing the overall healthcare costs.45 The benefits of integrated, multidisciplinary 
geriatric care have been determined in several studies.46-48 Frailty highlights the need 
to individualize and integrate guidelines for treatment, and to prevent adverse outcomes 
by choosing health care interventions fit for such frail elderly.49 By differentiating 
between frail and nonfrail elderly, it will be easier to treat frail older adults with 
the appropriate, multidisciplinary interventions. Such treatment opportunities seem 
especially important in late-life depression with comorbid frailty, as lifestyle is supposed 
to be the greatest contributor to the onset of frailty50 and late-life depression negatively 
affects lifestyle behavior.51, 52
Methodological considerations
Some strengths and limitations of this study should be mentioned. A major strength 
of this study is the use of two proxies for physical frailty (weakness and slowness) in 
addition to a multi-component measure of frailty.1 Furthermore, where other studies 
use questionnaires as a substitute for depression diagnosis, this study used a formal 
diagnosis of depression according to DSM-IV criteria. Decomposing of the severity 
of depressive symptoms makes it unlikely that the higher severity of depression can 
be explained by overlapping concepts. Finally, since participants were recruited from 
primary care as well as in- and outpatient secondary care clinics, our sample covers 
the whole spectrum of depressive disorders, varying from mildly depressed, independent 
living older adults to severely depressed inpatients. This enhances the generalizability 
of the results, specifically the second aim of the study. Interestingly, frailty prevalence 
did not differ across the different echelons of our health care system. 
A limitation of the study was the small size of the 85+ group. Therefore, specific 
conclusions about this generally frail subgroup cannot be drawn. Furthermore, the 
comparison group was recruited among non-depressed general practice visitors, who 
can be assumed to have more illnesses and medical complaints than community- 
dwelling elderly. The difference between depressed and non-depressed persons in 
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our study should thus be considered conservative. On the other hand, the found 
prevalence rates of frailty in our comparison group resembled those found in a recent 
meta-analysis on the prevalence of frailty in community-dwelling elderly4 suggesting 
no or only limited selection bias.
Finally, this study provides the opportunity of adequate control of potential confounders, 
but it cannot be ruled out that the association between physical frailty and depression 
is confounded by unknown variables. Moreover, the cross-sectional nature of our 
study precludes causal interpretation of the association demonstrated. 
Future perspective 
The high prevalence of physical frailty among depressed elderly persons and potential 
benefits of targeting frailty argues for the need of screening of this particularly vulnerable 
group of persons. As frail depressed older patients were more severely depressed 
than nonfrail depressed patients, it may be required that especially the frail subgroup 
should be treated in secondary mental health care in which integrative geriatric care 
is more likely to be available. Future research should examine underlying mechanisms 
and consequences of frailty in late-life depression, as well as effectiveness of screening 
for frailty. Multidisciplinary interventions focused on lifestyle and behavioral activation 
to reduce the negative impact of frailty within this particularly vulnerable group of 
patients, should also be examined. 
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Abstract
Background- Depression and physical frailty in older persons are both associated 
with somatic diseases, but are hardly examined in concert. 
Objectives- To examine whether depression and physical frailty act independently 
and/or synergistically in their association with somatic diseases.
Design- Baseline data of an ongoing observational cohort study including depressed 
cases and non-depressed comparison subjects. 
Settings- Netherlands Study of Depression in Older persons (NESDO). 
Participants- 378 depressed older persons confirmed by the Composite International 
Diagnostic Interview (CIDI), version 2.1, and 132 non-depressed comparison subjects. 
Methods- Multiple linear regression analyses adjusted for socio-demographic and 
lifestyle characteristics were conducted with the number of somatic diseases as the 
dependent variable and depression and physical frailty as independent variables. 
Physical frailty was defined as ≥3 of the following characteristics, slowness, low 
physical activity, weight loss, exhaustion, and weakness. 
Results- Depression and physical frailty did not interact in explaining variance in 
the number of somatic diseases (p=.57). Physical frailty, however, partly mediated 
the association between depression and somatic diseases, as the strength of this 
association decreased by over 10% when frailty was added to the model (B=0.47, 
p=.003, versus B=0.41, p=.01). The mediation effect was primarily driven by 
the frailty criterion exhaustion. Of the remaining frailty components, only slowness 
was associated with the number of somatic diseases; but this association was fully 
independent of depression.
Conclusions- Our results suggest that depression and physical frailty have common 
pathways towards somatic diseases, as well as unique pathways. As no high-risk 
group was identified (no significant interaction), mental health nurses should regularly 
monitor for physical frailty within their caseload of depressed patients. 
Keywords: depression, frailty, aged, somatic diseases, Netherlands Study of Depression 
in Older persons (NESDO)
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Introduction
Depression not only deteriorates the symptom burden of chronic somatic diseases, 
but also places persons at higher risk of new-onset somatic diseases like cardiovas-
cular diseases, diabetes, overweight, and even cancer.1 The wide range of somatic 
consequences of depression, as well as an increasing strength of these associations 
in later life, suggest common underlying mechanisms associated with accelerated 
aging.2, 3 Several explanations for the relationship between depression and somatic 
comorbidity can be put forward, such as an unhealthy lifestyle, non-compliance to 
treatment in case of existing somatic diseases, as well as physiological dysregulations 
like overactivity of the hypothalamic-pituitary-adrenal axis, autonomic nervous system 
dysregulation, and immune activation.1, 4 Interestingly, many of these explanations are 
also thought to be the basis of frailty. Frailty is a condition of increased risk of adverse 
health outcomes.5 This risk is presumed to be caused by a reduction of the reserve 
capacity of various physiological systems, due to declines in molecular, cellular and 
physiological systems of the aged body.6 Negative consequences of depression, 
such as somatic comorbidity, may thus occur as a result of the development of frailty. 
Depression, frailty and somatic morbidity are highly prevalent in later life, and their 
mutual relationship is complex. Meta-analytic studies have estimated that 10.7% 
in community dwelling elderly aged 65 and over meet the criteria for frailty7 and 
between 1.8% and 9.3% for major depressive disorder.8, 9 Empirical data have 
shown that although frailty and depression share overlapping characteristics, both 
represent distinct syndromes.10 Similar to the bidirectional association between 
depression and somatic diseases, a recent review also pointed to a potential bidirec-
tional association between depression and frailty.11 Interpretation remains difficult as 
all studies in this review relied on depression severity scales (prone to confounding 
by frailty) instead of formal diagnostic criteria.
Up until today, no research has been conducted into the triangle depression – frailty 
– somatic morbidity. In order to prevent somatic morbidity, knowledge of the interplay 
between depression and physical frailty is crucial. In outpatient mental health care, 
specialized nurses generally care for the most vulnerable patients among which those 
with chronic depression, frailty, physical disabilities and unhealthy lifestyle. Mental 
health care nurses who care for depressed elderly are very capable of detecting 
frailty and monitoring the development of frailty.12, 13 Moreover, effective frailty inter-
ventions to date are usually based on nursing skills, such as assistance in daily living 
and improving exercise frequency.14 
In this study, we first aimed to confirm that somatic diseases are more prevalent among 
depressed patients, compared to non-depressed controls. Secondly, assuming several 
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physiological pathways potentially underlie both frailty and depression, we hypothesize 
that frailty is an explanatory factor (in statistical terms a mediator) of the association 
between depression and somatic disease. Furthermore, we will also explore a mode-
rating effect of frailty that might be explained by a reinforcing effect of two underlying 
pathways when depression and physical frailty occur simultaneously. In order to 
avoid contamination between frailty and depression, frailty will be defined as physical 
frailty, as done by the frequently used Fried Frailty Index (FFI) of Fried et al.5 
Methods
Study participants came from NESDO (the Netherlands Study of Depression in Older 
persons). This cohort study consists of 378 depressed patients with a current DSM-IV 
diagnosis of major depressive disorder (95%), minor depression (5.6%) or dysthymia 
(26.5%), of which 26.5% have two depressive disorders, and 132 non-depressed 
participants, aged 60 through 93 years.15 
Recruitment of depressed participants took place in five regions in the Netherlands. 
Participants were recruited from mental health institutes (both in- and outpatients) and 
from primary care, in order to include persons with late-life depression in various 
developmental and severity stages.15 The non-depressed comparison group was 
recruited from primary care practices. 
Persons with a clinical diagnosis of dementia, a Mini Mental State Examination score 
(MMSE) under 18 or an organic or psychotic disorder were excluded, since the course 
of depression in these persons will be largely determined by the primary disorder. 
Insufficient mastery of the Dutch language was also an exclusion criterion. 
All participants received written and oral information about the study and were competent 
to consent to participation. Written informed consent was obtained from the participants. 
The ethical review boards of the participating institutes approved of this study. 
All participants underwent a baseline examination at one of the participating clinics 
or at the homes of the participants. This examination included an interview with 
internationally accepted, frequently used measures, among which measures of demo-
graphic variables, depression, somatic comorbidity and physical tests such as gait 
speed. Trained research professionals, mainly consisting of mental health care nurses 
and psychologists, conducted all interviews and physical examinations. Details of 
NESDO are described elsewhere.15 
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Measures
Depression
The Composite International Diagnostic Interview (CIDI), version 2.1 was used in 
order to determine the presence of depression.16 The CIDI is a structured interview 
that diagnoses psychiatric disorders in adults according to the criteria of Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) and the criteria of 
the International Classification of Diseases-10 (ICD-10). The CIDI has high validity for 
depressive and anxiety disorders.17, 18 To determine the research DSM-IV diagnosis 
of current minor depression, questions were added to the CIDI, as in Netherlands 
Study of Depression and Anxiety (NESDA).19  Severity of depression was measured by 
the well-validated 30-item self-rating Inventory of Depressive Symptomatology (IDS).20 
Somatic comorbidity
Somatic comorbidity was assessed by Statistics Netherlands (Centraal Bureau voor 
de Statistiek, www.CBS.nl) questionnaire: a self-report questionnaire about the 
presence of chronic diseases. In order to enhance its reliability, the questionnaire 
was conducted by the interviewers. Compared to general practitioner information, 
the accuracy of self-reports of these diseases was shown to be adequate and 
independent of cognitive impairment.21 We used the number of reported diseases 
(not necessarily under treatment) as a continuous variable. This variable included the 
following diseases or disease categories: lung disease (asthma, chronic bronchitis, 
pulmonary emphysema), cardiovascular disease (cardiac events, heart failure, heart 
infarction, cardiac arrhythmia, coronary heart disease, angina pectoris, vascular 
abnormalities), stroke, diabetes, arthritis/rheumatism (osteoarthritis, rheumatism), 
gastro intestinal disease (ulcer, irritable bowel syndrome, Crohn’s disease, colitis 
ulcerosa, constipation), cancer, epilepsy and thyroid disease. Presence of separate 
diseases/categories was dichotomized (by present yes/ no). 
Frailty
Physical frailty was operationalized by the criteria of Fried et al.5 Conform these 
criteria physical frailty is present if three out of the following five criteria are met: 1) 
slowness, 2) low physical activity, 3) weight loss, 4) exhaustion, and 5) weakness. 
In this study, we included frailty as a dichotomized variable and as a dimensional 
variable based on the number of criteria present (range 0 – 5). 
Slowness was measured by a six meter walking test. For men ≤173 centimetres (cm) 
tall the cutoff time was 9 seconds, for men >173 cm the cutoff time was 8 seconds. 
The cutoff time for this criterion for women with a height of ≤159 cm was 9 seconds, 
for women >159 cm the cutoff time was 8 seconds (extrapolated from the data of 
Fried and colleagues).5 
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Low physical activity level was defined as no daily activities such as walking and 
gardening, or the performance of sports less than once weekly. The last-seven-days 
self-administered version of the International Physical Activities Questionnaire (IPAQ),22 
consisting of eight items, was used to collect the physical activity data. 
The presence of unintentional weight loss or low body mass index was used for 
the weight loss criterion. The CIDI question about unwanted weight loss was used 
to determine the loss of a minimum of one kilogram a week, during two or more 
consecutive weeks. BMI was defined as weight in kilograms divided by height in 
meters squared. With a BMI of <18,5 kg/ m² weight loss was also considered to 
be present.
Exhaustion (poor endurance and energy) was determined by two questions from the 
Center for Epidemiologic Studies-Depression scale (CES-D),23 similar to other studies5, 
24-27: “I felt that everything I did was an effort” and “I could not get going.” The items 
asked “How often in the last week did you feel this way?” and subjects responded 
on a four-point scale: 1=rarely or never (<1 day), 2=some or a little of the time (1–2 
days), 3=a moderate amount of the time (3–4 days), 4=most of the time (5–7 days). 
Participants answering 3 or 4 to either of these two items were categorized as positive 
on this criterion.
A handgrip dynamometer was used to assess muscle weakness. Participants were 
asked to perform two squeezes with the dynamometer, using the dominant hand. The 
best performance, recorded as strength in kilograms, was used for analysis. Cutoff 
scores were stratified by gender and BMI quartiles according to Fried et al.5 Partici-
pants unable to perform the test were also considered weak. 
A total of four participants (3 depressed, 1 non-depressed) had missing data on one 
frailty criterion (weakness criterion) and were excluded from analyses with frailty as 
a dimensional characteristic. Nonetheless, the dichotomised frailty status could be 
classified based on the available criteria.28 
Covariates
Potential confounders were selected a priori, based on their relationship with depression 
or frailty as well as with somatic diseases in general29 and included socio-demo-
graphic variables,9, 30 and lifestyle characteristics.31
Demographics data were collected during the interview (age, gender, partner status 
and educational level). 
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Lifestyle variables included smoking status, use of alcohol, physical exercise and BMI. 
Smoking status was divided into two categories: non-smoker and current smoker. The 
Alcohol Use Disorder Identification Test (AUDIT) is designed to detect hazardous and 
harmful alcohol consumption.32 AUDIT score was divided into three categories, no 
alcohol use, moderate alcohol use and problematic alcohol use. These categories 
were based on the first two questions assessing the frequency drinking and the number 
of units taken on a typical drinking day. Physical exercise was measured with the 
IPAQ,22 by calculating energy expenditure based on sports and daily activities in 
MET minutes/week. METs are multiples of the resting metabolic rate and a MET-minute 
is computed by multiplying the MET score of an activity by the minutes performed. 
Missing values in the IPAQ questionnaire were imputed by mean scores of age-sex 
stratified samples (n=90). 
Statistical analysis
Demographics and clinical characteristics of the participants with and without 
depression were compared using independent samples t-tests for normally distributed, 
continuous variables, nonparametric Mann Whitney U tests for skewed continuous 
variables, and χ² tests for categorical variables. 
Multiple linear regression analyses were conducted to examine associations of the 
number of somatic diseases (dependent variable) with depression (independent 
variable) adjusted for socio-demographic variables (age, gender, educational level, 
partner status, income) and lifestyle factors (smoking status, alcohol use, BMI, and 
physical exercise). First, we checked whether the associations between depression 
and somatic comorbidity were dependent on frailty by including interaction terms 
between frailty and depression in the fully adjusted models. We tested both, frailty 
as a dichotomous characteristic (present yes/no) and as a dimensional variable 
based on the number of criteria present. A significant interaction term between 
depression and frailty (yes/no) implies that the association between depression and 
somatic diseases is different in patients with and without frailty. In case of a significant 
interaction term with the number of frailty criteria present, the association between 
depression and frailty differs among the different levels of frailty. Subsequently, it was 
tested whether frailty was an explanatory factor in the association between depression 
and somatic diseases by assessing whether B decreased with 10% or more when 
adding frailty to the fully adjusted model. 
Subsequently, we performed in-depth analyses to examine whether identified effects 
were driven by individual frailty criteria as well as whether frailty effects could also be 
identified in explaining the presence of individual somatic diseases. First, we analyzed 
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components of frailty in a linear regression analysis with the number of somatic 
diseases as the dependent variable and depression as the independent variable, 
in the fully adjusted model. Next, we assessed whether depression was associated 
with individual diseases (disease present yes/no) with logistic regression analysis 
with disease category as the dependent variable and depression as the independent 
variable. Only diseases that differed (in the unadjusted analysis) between depressed 
and non-depressed participants were analyzed. Frailty (both dichotomized and 
continuous frailty) was evaluated as an explanatory factor of the association between 
depression and type of somatic disease. 
All p-values were tested two-tailed and p values ≤.05 were considered statistically 
significant. Data were analysed using Statistical Package of the Social Sciences 
(SPSS), version 20.0. 
Results
The mean age [standard deviation (SD)] of the 510 participants was 70.6 [7.3] 
years, and 64.9% was female. Table 1 presents the characteristics of both the 
depressed and non-depressed group. The two groups differed significantly with respect 
to educational level, partner status, prevalence of frailty, smoking status, depression 
severity, physical activity and somatic disease burden. Depressed persons suffered 
from more somatic diseases than the non-depressed persons. Regarding the type of 
disease, the two groups differed with respect to lung disease, stroke and gastrointestinal 
disease. 
Associations between depression, frailty and somatic diseases 
Multiple regression analyses adjusted for socio-demographic and lifestyle characteristics 
showed that the number of somatic diseases (dependent variable) was associated 
with depression (B (SE)=0.47 (0.16); p=.003) as well as with frailty (presence 
of frailty: B (SE)=0.64 (0.17); p<.001; frailty dimensional: B (SE)=0.27 (0.06), 
p<.001). Moreover, multiple logistic regression analyses adjusted for socio-demo-
graphic and lifestyle characteristics also revealed that depression (dependent variable) 
was significantly associated with frailty (presence of frailty: OR=2.9 [95% CI: 1.3–
6.7], p=.012; frailty dimensional: OR=2.2 [95% CI: 1.6–2.9]. p<.001). 
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Table 1 Sample Characteristics And Differences Between Amount and Type of Somatic 
Diseases
  Depressed Group Comparison Group
Characteristic (N=378)  (N=132) P Valuea
Age, mean (SD), y 70.7 (7.4) 70.1 (7.2) .371
Female gender, % 66.1 61.4 .322
Married or with partner, %  52.4 75.0 < .001
Education, mean (SD), years  10.4 (3.4) 12.5 (3.5) < .001
Frailty, % 27.0 9.1 < .001
Smoking, %   < .001
   Non smoker 29.9 31.8
   Former smoker 42.9 59.8
   Smoker (<20) 19.3 6.8
   Heavy smoker (≥20)   7.1 1.5
Alcohol use, %   < .001
  No alcohol use 39.7 12.9
  Moderate alcohol use 50.5 63.6
  Problematic alcohol use 8.7 20.5 
IDS score, mean (SD) 30.1 (13.0) 7.8 (6.4) < .001
BMI, mean (SD) 27.0 (4.6) 26.3 (4.1) .138
Physical exercise: MET 2391 (2460) 3324 (2909) < .001
minutes/week, mean (SD)
Walking speed, s/6m 7.7 6.9 .025
Handgrip strength, kg 27.2 30.2 .007
Chronic diseases, mean (SD) 2.1 (1.5) 1.5 (1.1) .001
Type of disease, %
   Lung 15.3 7.6 .023
   Cardiovascular    29.9 24.2 .215
   Stroke 11.4 2.3 .002
   Diabetes 12.7 18.2 .119
   Arthritis/rheumatism 52.4 47.7 .343
   Cancer 19.6 18.9 .863
   Gastro-intestinal 14.0 6.8 .029
   Epilepsy 1.3 0.0 .184
   Thyroid    10.3 6.1 .143
  
Abbreviations: IDS, Inventory of Depressive Symptomatology; BMI, Body Mass Index.
a Comparison using analyses of variance (continuous variables), χ² statistics (categorical variables) and U 
tests (continuous, skewed variables).
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Frailty as a moderating factor
Whether the association between depression and number of somatic diseases 
was dependent on frailty status, was examined by adding the interaction term of 
depression by frailty to the fully adjusted linear regression models. Depression neither 
interacted with the presence of frailty (yes/no) (p=.57), nor with the number of frailty 
components present (p=.25). 
Frailty as an explanatory factor
In order to examine whether frailty was an explanatory factor of the association between 
depression and somatic diseases, frailty was added to the different (fully adjusted) 
regression models that regarded the association between depression and somatic 
diseases (Table 2, models 2a through 2g). Adding the presence of physical frailty 
(yes/no) to the linear regression model reduced the association between depression 
and somatic diseases by 14.7%, indicating that frailty explained a substantial part 
of the association between depression and somatic diseases. Nonetheless, the 
association between depression and somatic diseases remained significant, indicating 
an association between depression and somatic diseases independent of frailty. 
Comparable effects were found when frailty was added as a continuous variable. 
In-depth analyses
Only the frailty criteria “exhaustion” and “slowness” were associated with the number 
of somatic diseases. In the depressed group 45.8% reported exhaustion and 26.5% 
was slow, compared to 3.8% and 18.9% respectively in the non-depressed group. 
Of these two criteria, exhaustion mediated the association between depression and 
somatic diseases, whereas the effect of slowness was fully independent of the presence 
of depression (Table 2).
With regard to individual categories of somatic diseases, only lung disease, stroke 
and gastro intestinal disease were univariately associated with the presence of 
depression (Table 1). After adjustment for potential confounders, however, only stroke 
remained significantly associated with depression in our study (Table 3). Subsequently, 
we tested whether this association was mediated by frailty. However, the presence 
of frailty (yes/no) was not identified as an explanatory factor in the relation between 
depression and stroke (Table 3). Nonetheless, when frailty was entered as a continuous 
variable, it was an explanatory factor of the association between depression and 
stroke (Table 3). 
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Table 2 Depression and Frailty as Determinants of the Total Number of Somatic 
Diseases a
N=510 B(SE) Beta P Value ΔB
Model 1b:    
- Depression 0.484 (0.161) .15 .003 
Model 2ac:    
- Depression 0.413 (0.159) .13 .010 - 14.7%
- Frailty (yes/no) 0.590 (0.166) .17 .001 
Model 2bc:    
- Depression 0.333 (0.163) .10 .041 - 31.2%
- Number of frailty components  0.243 (0.061) .21 .001 
Model 2cc:    
- Depression 0.473 (0.165) .14 .004 - 2.3%
- Frailty: Weight loss criterion -0.003 (0.150)  < -.01 .983 
Model 2dc:    
- Depression 0.485 (0.161) .15 .003 + 0.2%
- Frailty: Handgrip strength criterion 0.191 (0.158) .06 .225 
Model 2ec:    
- Depression 0.254 (0.167) .08 .129 - 47.5%
- Frailty: Exhaustion/ 0.552 (0.140) .18 .001
- poor energy criterion 
Model 2fc:    
- Depression 0.467 (0.158) .14 .003 - 3.5%
- Frailty: Slowness criterion 0.632 (0.161) .19 .001 
Model 2gc:    
- Depression 0.474 (0.160) .14 .003 - 2.1%
- Frailty: Low activity level criterion 0.105 (0.149) .04 .481 
  
a Multiple linear regression analyses with number of somatic diseases as the dependent variable, adjusted 
for age, sex, years of education, partner status, average income, smoking status, alcohol consumption, 
physical activity and body mass index. 
b Model 1: Association between depression and the number of somatic diseases.
c Model 2: Independent effect of depression and frailty (different definitions) added simultaneously in one 
linear regression analyses with the number of somatic diseases as the dependent variable.
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Table 3 Depression and Frailty as Determinants of Individual Somatic Disease 
Categoriesa
N=510 OR (95% C.I.) B P Value ΔB
Lung disease    
Model 1b:    
- Depression 0.50 (0.21, 1.22) -0.687 .130 
Stroke    
Model 1b:    
- Depression 0.29 (0.08, 1.00) -1.255 .049 
Model 2c:    
- Depression 0.34 (0.10, 1.23) -1.068 .100 - 14.9%
- Number of frailty components  1.30 (0.97, 1.76) 0.264 .083 
Gastro-intestinal disease    
Model 1b:    
- Depression 0.45 (0.19, 1.05) -0.802 .065
 
a Multiple logistic regression analyses with type of somatic disease as the dependent variable, adjusted 
for socio-demographic and lifestyle characteristics.
b Model 1: Adjusted association of depression (independent variable) and type of somatic disease 
c Model 2: Independent effect of depression and frailty when added simultaneously in one logistic regres-
sion analyses with the type of somatic disease as the dependent variable. 
Discussion
As expected, somatic diseases were more prevalent among depressed patients than in 
the non-depressed comparison group.33, 34 Confirming our hypothesis, an accumulation 
of frailty characteristics, such as the frailty criteria of Fried et al.5 indeed partly 
explained the relation between depression and the number of somatic diseases. 
Since depression and frailty remained associated with the number and presence 
of somatic diseases, independently of each other, our results imply that depression 
and frailty have common relations with somatic diseases as well as unique relations. 
As frailty did not moderate the relation between depression and somatic diseases 
(interaction), the presence of frailty does not aggravate the negative health effects 
already associated with the depression itself. 
Frailty as explanatory factor
Although physical frailty defined by the criteria of Fried et al.5 partly explained the 
association between depression and somatic diseases, this effect was primarily driven 
by the criterion “exhaustion”. This is not surprising, as the operationalization of the 
criterion is based on two items of a depression severity scale, i.e. the CES-D. This 
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overlap between operationalization of frailty and depression probably explains its 
mediating effects (in clinical terms). Even attempts to define frailty in pure biomedical 
terms thus still overlap with depression, stressing the need to measure both mental illness 
and frailty simultaneously when trying to evaluate long-term negative health outcomes. 
This approach can help us disentangle unique effects of depression and frailty.
The fact that of the other four frailty criteria, only slowness (or gait speed) was associated 
with the number of somatic diseases is an interesting finding. This association was 
completely independent from the presence of depression, implying that gait speed 
does have underlying pathophysiological mechanisms leading to somatic diseases 
or vice versa, which are different from mechanisms associated with depression. Gait 
speed as well as handgrip strength are the only two performance-based frailty criteria, 
and both have also been used as simplified measures of frailty in other studies.35, 36 
Our results suggest that when studied in concert with depression, gait speed may 
be preferred to disentangle the relationship between frailty, depression and somatic 
diseases. Interestingly, gait speed can be quantified as done in our study, but mental 
health nurses can also easily observe gait speed. These observations and especially 
changes in gait speed, may trigger nurses for further assessment and treatment.
 
The discussion about how frailty should be operationalized is ongoing.7 When interested 
in pathophysiological mechanisms that are involved in both depression and physical 
frailty, the FFI can be used, but a simple measure of “vital exhaustion” may be even 
better. The pathophysiological mechanisms underlying vital exhaustion probably 
explain the shared impact of depression and frailty with respect to the negative health 
outcomes. This is in line with findings from a recent review, where it was stated that 
atypical depression, that is characterized by exhaustion, is more related to biological 
dysregulations than the melancholic subtype of depression.1 Both the depression 
and the biological dysregulations may lead to somatic health decline.1 The shared 
pathway may lead to the hypothesis that shared mechanisms may fully account for 
the negative health effects of depression. Nonetheless, this seems unlikely, as depression 
also remained independently associated with the number of somatic diseases and 
it has been shown before that the relation between depression and frailty is not fully 
explained by overlap between these two syndromes.28 
Clinical relevance
Depression is a highly prevalent condition among elderly and recurrence or relapse 
are not uncommon.37 Since frailty is a potentially reversible factor,29 of which the 
negative health impact can be reduced by specific interventions, assessment of frailty 
in depression is relevant for clinical practice. The other way around, somatic 
comorbidity is often accompanied by depression and in those cases associated 
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with increased levels of disability.38 Nurses are particularly likely to be caring for 
persons with chronic somatic diseases39 and their work also requires knowledge 
of depression and frailty as well as their reciprocal relations with somatic diseases. 
Better recognition of frailty in older patients suffering from depression and/or chronic 
somatic conditions by nurses is also important, as nurse-led health promotion to frail 
older persons enhances quality of life, while not increasing the overall health care 
costs.12, 14 This implies the need for a constant state of alertness towards the severity 
of frailty in depressed patients by nurses treating depressed elderly. Regarding this, 
it is noteworthy that simple screening tools for daily practice are available to confirm 
the presence of frailty.40 
Strengths and weaknesses
Some strengths and limitations of this study have to be mentioned in order to allow 
proper interpretation of the results. Whereas other studies use questionnaires as a 
substitute for depression diagnosis, this study used a formal diagnosis of depression 
according to DSM-IV criteria. This is an important strength of our study as formal 
criteria of depression are less prone to confounding by symptoms or signs of somatic 
diseases and frailty compared to (self-report) questionnaires assessing depressive 
symptoms. Furthermore, our findings also point to the importance of physical frailty 
within a psychiatric sample. Since participants were recruited from primary care as 
well as in- and outpatient secondary care clinics, this sample covers a large spectrum 
of depressive disorders. The fact that we did not find strong results for one or two 
specific chronic diseases, adds to our hypothesis of general underlying pathways 
relating depression and frailty towards different somatic comorbidity. Nonetheless, 
we must acknowledge that due to low prevalence rates of some of the individual 
diseases, statistical power is probably too low for more definitive conclusions. Another 
limitation might be that somatic diseases were assessed by a self-report measure 
which may have led to bias, however previously the reliability of this questionnaire 
has shown to be adequate.21 
Finally, as with any cross-sectional design it is not appropriate to draw causal 
conclusions. The relation between depression, frailty and somatic comorbidity is a 
complicated one, with reciprocal associations between all entities, and possibly other 
factors influencing these associations. Therefore, the relation between depression, 
frailty and somatic comorbidity should be further examined in prospective designs. 
Final conclusion
This study confirms the relation between depression and somatic comorbidity. Frailty 
partly explains this relationship, but depression also remains an independent determinant 
of the somatic condition. As the prevalence of frailty is almost three times higher 
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among depressed older persons compared to non-depressed older persons,28 our 
findings argue for integral assessment of frailty in depressed older persons and 
mental health nurses should regularly monitor for physical frailty within their caseload 
of depressed patients. Analogue to the impact of frailty on the course of somatic 
diseases ,41, 42 the presence of frailty in depression probably also complicates the 
course and treatment of late-life depression. This, however, should be subject to 
further study, as well as future projects examining whether the effects of (nurse-led) 
interventions to prevent or reduce frailty in depressed older adults indeed improves 
both depression outcome and the negative health effects of depression. 
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Abstract
Objectives- To determine whether physical frailty is associated with low-grade inflam-
mation in older adults with depression, because late-life depression is associated with 
frailty and low-grade inflammation. 
Design- Baseline data of a cohort study.
Setting- Primary care and specialized mental health care.
Participants- Individuals aged 60 and older with depression according to Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition, criteria (N=366).
Measurements- The physical frailty phenotype, defined as three out of five criteria 
(weight loss, weakness, exhaustion, slowness, and low physical activity level), and 
three inflammatory markers ( C-reactive protein (CRP), interleukin-6 (IL-6) and neutrophil 
gelatinase-associated lipocalin (NGAL) were assessed. 
Results- The physical frailty phenotype was not associated with inflammatory markers 
in linear regression models adjusted for sociodemographic charateristics, lifestyle 
characteristics and somatic morbidity. Of the individual criteria, handgrip strength 
was associated with CRP (β=-0.21, p=.002) and with IL-6 (β=-0.25, p<.001), and 
gait speed was associated with NGAL (β=0.15, p=.02). Principal component analysis 
identified two dimensions within the physical frailty phenotype: performance-based 
physical frailty (encompassing gait speed, handgrip strength and low physical 
activity) and vitality-based physical frailty (encompassing weight loss and exhaustion). 
Only performance-based physical frailty was associated with higher levels of 
inflammatory markers (CRP: β=0.14, p=.03; IL-6: β=0.13, p=.060; NGAL: 
β=0.14, p=.03).
Conclusion- The physical frailty phenotype is not a unidimensional construct in 
individuals with depression. Only performance-based physical frailty is associated 
with low-grade inflammation in late-life depression, which might point to a specific 
depressive subtype.
Keywords: frailty, depressive disorder, inflammation, C-reactive protein, interleukin-6, 
lipocalin-2, NGAL.
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Introduction
Frailty is a medical syndrome describing persons at greater risk of adverse health 
outcomes when exposed to a stressor.1 Frailty is considered an important syndrome 
for geriatric health care, because frail persons are high users of community resources, 
hospitalization, and nursing homes. Therefore, early intervention may improve quality 
of life and reduce costs of care.1 The mean prevalence rate of physical frailty is estimated 
9.9% in community-dwelling persons aged 65 and older (range 4.0–17.0%).2 
Although the criteria for physical frailty and depression partly overlap, both represent 
unique, but reciprocally related constructs.3 Two models of physical frailty are 
dominant.4,5 The deficit model of Rockwood consists of adding together an individual’s 
number of impairments and conditions to create a Frailty Index.4 The physical frailty 
phenotype of Fried, as included in the current study, consists of a constellation of 
three out of five possible criteria (weight loss, exhaustion, weakness, slowness, and 
reduced physical activity).5 It was recently shown that 27% of older persons with 
depression met the criteria for the physical frailty phenotype.6 The physical frailty 
phenotype is assumed to mark an underlying physiological state of multisystem and 
energy dysregulation.7 Depressive disorder is increasingly recognized as a disorder of 
accelerated aging,8 sharing at least some underlying pathophysiological mechanisms 
with physical frailty.9 
It has been proposed that immunosenescence is one of the mechanisms underlying frailty. 
Aging of the immune system results in a condition of chronic low-level inflammation, also 
called “inflamm-aging”,10 characterized by high levels of the inflammatory cytokine 
interleukin-6 (IL-6) and the non-specific acute phase reactant C-reactive protein 
(CRP).11 Frailty and depression have been associated with higher serum CRP and IL-6 
levels.12 High circulating levels of neutrophil gelatinase-associated lipocalin (NGAL), 
an acute phase protein, have recently been found in aging-related disorders such 
as mild cognitive impairment, Alzheimer’s disease and late-life depression.13,14 The 
association between inflammation and frailty has been reported consistently, in contrast 
to the association between inflammation and late-life depression.12,15 Low-grade 
inflammation in late-life depression might thus depend on the level of frailty. 
The present study examined whether the physical frailty phenotype is associated 
with low-grade inflammation in older adults with depression. It was hypothesized 
that inflammatory markers would be found to be associated with the physical frailty 
phenotype and that the frailty criteria that do not overlap with the depression criteria 
(muscle strength and gait speed) would be found to determine this association.
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Methods
Study population
The present study was embedded within the Netherlands Study of Depression in 
Older persons (NESDO).16 The NESDO sample consists of 378 subjects aged 
60 years and older with a current diagnosis of 6-month major depressive disorder 
(95%), minor depression (5.6%) or dysthymia (26.5%). Diagnoses were established 
according to the criteria of Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition (DSM-IV) using the Composite International Diagnostic Interview version 
2.1.17 Three hundred twenty-six of the participants (86.2%) were recruited from mental 
health institutes (in- and outpatients) and 52 (13.8%) from primary care. 
Exclusion criteria were a diagnosis of dementia, a Mini Mental State Examination 
(MMSE) score less than 18, an organic or psychotic disorder, and finally insufficient 
mastery of the Dutch language.16
All participants underwent a baseline examination at one of the five research locations 
(University Medical Center Groningen, Free University Medical Center Amsterdam, 
Leiden University Medical Center, Radboud university medical center, Mental Health 
Care Center GGNet) or at the home. The ethical review boards of all participating 
study centers approved of the study protocol, and all participants provided written 
informed consent.16 
Physical frailty phenotype
The physical frailty phenotype was assessed according to the criteria of Fried et al.5 
A person is classified as frail when at least three out of the following five criteria are 
present:6 
• Unintentional weight loss: unwanted weight loss of 1 kg/wk or more during two 
 or more consecutive weeks or a body mass index (BMI) of less than 18.5 kg/m². 
• Weakness: based on the maximum handgrip strength of the dominant hand 
 assessed using a handgrip dynamometer. The best out of two trials was stratified 
 according to sex and BMI quartile according to Fried et al.5 Participants unable 
 to perform the test were also considered weak.  
• Exhaustion: determined according to two questions from the Center for Epidemiologic 
 Studies Depression scale,18 as in previous studies:5 “I felt that everything I did 
 was an effort” and “I could not get going.” Participants answering “3 or more 
 days a week” to either of these two items were categorized as positive.
• Slowness: measured using the 6-m walking test, using sex- and body height-stratified 
 cutoffs as extrapolated from Fried et al.5 (9 seconds for men ≤173 cm and 
 women ≤159 cm tall; 8 seconds for men >173 cm and women >159 cm).5
• Low physical activity level: no daily activities such as walking and gardening 
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 and sports activity less than once weekly, as assessed according to short form of 
 the International physical Activities Questionnaire (IPAQ).19
Inflammatory markers
Fasting blood samples were obtained and kept at −80°C for subsequent analyses. 
Plasma CRP, IL-6 and NGAL levels were assessed. Plasma levels of high-sensitivity CRP 
were measured in duplicate using a immunoturbidimetric assay (Tina-quant CRPHS; 
Roche Diagnostics, Mannheim, Germany). Intra- and interassay coefficients of variation 
were both 2%. Plasma IL-6 levels were measured in duplicate using a high-sensitivity 
enzyme-linked immunosorbent assay (ELISA) kit (PeliKine Compact ELISA; Sanquin, 
Amsterdam, the Netherlands). Intra- and interassay coefficients of variation were 8% 
and 12%, respectively. 
Finally, the plasma NGAL levels (ng/ml) were measured in duplicate using an ELISA kit 
(R&D Systems, Minneapolis, MN).14 The intra- and interassay coefficients of variation 
were 2% and 5%, respectively. 
Covariates
Demographic data were collected on age, sex, and years of education, as well as 
lifestyle and disease-related characteristics that are potentially associated with either 
inflammatory markers or physical frailty. 
Lifestyle characteristics included smoking (yes/no), alcohol intake (no drinking/moderate 
drinking/problematic drinking (5 – 10 units on a typical drinking day regardless of the 
frequency of drinking or 3 or 4 units on a typical drinking day at least 4 days a 
week)), physical activity (measured using the IPAQ in metabolic equivalent minutes 
(ratio of energy expenditure during activity to rest times the number of minutes performing 
the activity per week), and BMI. 
Disease-related covariates included global cognitive functioning (MMSE, range 
0-30), somatic comorbidity, depression severity, and medication use. The total number 
of self-reported chronic diseases as determined by well-validated algorithms20 (lung 
disease, cardiovascular disease, diabetes mellitus, osteoarthritis or rheumatic disease, 
cancer, ulcer, intestinal problems, liver disease, epilepsy, and thyroid gland disease) 
was included. Severity of depression was measured using the 30-item self-rating 
Inventory of Depressive Symptomatology (IDS).21 Finally, antidepressant drug use as 
well as antiinflammatory drugs (amino salicylic acid and similar agents, antiallergic 
agents, systemically applied corticosteroids, antiinflammatory and antirheumatic 
products, other analgesics and antipyretics, statins) drug use was controlled for.
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Data analysis
Multiple linear regression analyses were conducted to examine the association 
between the different measures of physical frailty (independent variable) and each 
inflammatory marker (dependent variable) separately adjusted for all covariates 
described above. Because CRP and IL-6 values were positively skewed, ln-transformed 
values were used in all analyses. 
The different measures of physical frailty included the presence of the physical frailty 
phenotype (yes/no), the number of the individual frailty criteria met (sum score), and 
five criteria (yes/no) individually. Associations with gait speed and handgrip strength 
(as two continuous proxies for frailty) were subsequently examined. 
Finally, a non-linear principal components analysis (PCA) was conducted on the five 
binary criteria of the Fried Frailty Index (FFI). The purpose of PCA is data reduction. In 
PCA, relations between variables (in this case, the five FFI criteria) are analyzed, and 
underlying common factors are defined. So, factors are broadly formulated features 
that cover more than one variable.22 PCA was chosen over factor analysis as PCA 
results in continuous latent factors (rotated axes) with purely binary variables (unrotated 
axes). Factor scores were calculated on the basis of unstandardized item factor 
loadings, the five criteria of the FFI in this case, and transformed into standardized 
z scores (using the Anderson-Rubin method) to increase their interpretability.23 
Results
Sample
Of the 378 older persons with depression, three were excluded because they 
had missing values for one of the frailty criteria. Another nine were excluded due 
to missing data on all inflammatory markers because they refused or failed blood 
withdrawal. The mean age of the remaining 366 patients was 70.8 ± 7.4, and 
242 (66.1%) were female. Table 1 presents the characteristics the study population 
for frail (n=97, 26.5%) and nonfrail participants separately.
IL-6 levels were available for all patients, whereas CRP levels were missing for four and 
NGAL levels for one because of invalid laboratory results. CRP level was significantly 
associated with IL-6 (r=0.24, p<.001) and NGAL level (r=0.20, p<.001), whereas 
Il-6 and NGAL levels were not associated (r=0.04, p=.46). The severity of depressive 
symptoms (IDS sum score) were not associated with any of the inflammatory markers 
(CRP: Pearson correlation coefficient (r)=0.01, p=.83; IL-6: r<0.01, p=.94; NGAL: 
r=0.04, p=.50).
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Table 1 Characteristics of the Study Population According to Frailty Status
Characteristic Frail (N=97) Nonfrail (N=269) P Value
Sociodemographic   
Age, mean ± SD 74.0 ± 8.0 69.4 ± 6.7 <.001b
Female, n (%) 68 (70.1) 174 (64.7) .33c
Education, years, mean ± SD 10.0 (3.2) 10.8 (3.5) .01b
Somatic and cognitive functioning   
Mini Mental State Examiniation score,  27.3 ± 2.3 28.0 ± 1.7 .003b
mean ± SD 
Number of somatic diseases, mean ± SD 2.6 ± 1.7 1.9 ± 1.4 <.001b
Use of medication, n (%)a   
Antidepressant 76 (78.4) 189 (70.3) .13c
SSRI 29 (29.9) 70(26.0) .47c
TCA 33 (34.0) 56 (20.8) .71c
Other 33 (34.0) 72 (26.8) .16c
Antiinflammatory 12 (12.4) 32 (11.9) .90c
Statin 27 (27.8) 59 (21.9) .24c
Lifestyle characteristics   
Current smoker, n (%) 22 (22.7) 73 (27.1) .44c
Alcohol use, n (%)   .08c
 No 44 (45.4) 100 (37.2) 
 Moderate 45 (46.4) 138 (51.3) 
 Severe 4 (4.1) 29 (10.8) 
Physical activity (metabolic equivalent 1,099.9 ± 1,497 2,884.8 ± 2,519.9 <.001b
minutes), mean ± SD
Body Mass Index, kg/m2, mean ± SD 26.8 ±4.8 26.1 ± 4.1 .14b
Depression   
Inventory of Depressive Symptoms sum 36.3 ± 12.0 27.4 ± 12.0 <.001b
score, mean ± SD
Late-onset depression, n (%) 33 (34.0) 79 (29.4) .40c
Frailty   
Fried Frailty Index, mean ± SD 3.4 ± 0.6 1.1 ± 0.8 <.001b
Handgrip Strength, kg, mean ± SD 19.9 ± 8.8 30.6 ± 10.8 <.001b
Gait speed, seconds, median (IQR) 9.0 (7.0) 6.4 (2.0) <.001d
Inflammatory markers   
C-reactive protein, mg/L, median (IQR) 2.20 (5.05) 1.87 (4.76) .26d
Interleukin-6 ,pg/L, median (IQR) 0.56 (10.80) 0.46 (5.64) .17d
Neutrophil gelatinase-associated  68.4 ± 26.5 59.9 ± 21.3 .01b
lipocalin, ng/ml, mean ± SD
a Medications were defined according to the Anatomical Therapeutic Chemical classification system: selective 
serotonin reuptake inhibitor (SSRI) (N06AB), serotonin-norepinephrine reuptake inhibitor (N06AX16, 
N06AX21), tricyclic antidepressant (TCA)( N06AA) tetracyclic antidepressant (N06AX03, N06AX05, 
N06AX11), antiinflammatory drug (including amino salicylic acid and similar agents) (A07EC), antiallergic 
agents (A07EB), systemically applied corticosteroids (H02A), antiinflammatory and antirheumatic products 
(M01) and other analgesics and antipyretics (N02B), and statins (C10AA, C10B).
P-values were calculated using bt-tests, cchi-square tests, or dMann-Whitney-U tests.
SD= standard deviation; IQR= interquartile range.
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Table 2 Associations Between C-Reactive Protein (CRP), Interleukin-6 (IL)-6, and Neutrophil 
Gelatinase-Associated Lipocalin (NGAL) and the Physical Frailty Phenotype 
 CRP IL-6 NGAL
Frailty Characteristics  β (P Value) 
Unadjusted    
Frailty (0=no, 1=yes) 0.06 (.26) 0.05 (.36) 0.13 (.01)
Frailty sum score (range 0-5) 0.10 (.05) 0.08 (.13) 0.20 (<.001)
Individual frailty criteria (dichotomous)     
Weight loss -0.03 (.53) -0.02 (.71) -0.03 (.56)
Weakness 0.15 (.004) 0.12 (.02) 0.10 (.06)
Exhaustion, poor energy 0.02 (.77) -0.02 (.78) 0.11 (.04)
Slowness 0.15 (.005) 0.11 (.04) 0.26 (<.001)
Low activity level <0.01 (.95) 0.03 (.64) 0.12 (.03)
Performance-based criteria (dimensional)     
Handgrip strength -0.13 (.01) -0.15 (.004) -0.08 (.14)
Gait speed 0.13 (.01) 0.12 (.03) 0.24 (<.001)
Fully adjusteda     
Frailty (0=no, 1=yes) 0.04 (.56) 0.04 (.47) 0.02 (.73)
Frailty sum score (range 0-5) 0.10 (.13) 0.08 (.21) 0.10 (.12)
Individual frailty criteria (dichotomous)    
Weight loss <0.01 (.99) -0.03 (.64) -0.07 (.20)
Weakness 0.12 (.03) 0.09 (.10) 0.03 (.61)
Exhaustion, poor energy -0.01 (.91) <-0.01 (.95) 0.07 (.23)
Slowness 0.11 (.08) 0.08 (.22) 0.17 (.006)
Low activity level <-0.01 (.95) 0.06 (.39) 0.06 (.38)
Performance-based criteria (dimensional)     
Handgrip strength -0.21 (.002) -0.25 (<.001) -0.04 (.57)
Gait speed 0.09 (.18) 0.11 (.12) 0.15 (.02)
a Adjusted for age, sex, years of education, severity of depressive symptoms (Inventory of Depressive 
Symptomatology sum score), cognitive functioning (Mini Mental State Examination score), number of chronic 
diseases, antiinflammatory drug use (including statins), antidepressants (selective serotonine reuptake 
inhibitors, tricyclic antidepressants, other), alcohol use (none, moderate, severe), smoking (yes/no), body 
mass index, physical activity (metabolic equivalent minutes).
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Association between inflammatory markers and the physical frailty phenotype
Bivariate and multivariate associations between inflammatory markers and the physical 
frailty phenotype are shown in Table 2. In the fully adjusted models, only handgrip 
strength and gait speed were significantly associated with inflammatory markers 
(handgrip strength with CRP and IL-6, gait speed with NGAL).
Principal component analysis of physical frailty criteria
The scree plot of eigenvalues and the number of complex items revealed a two-factor 
solution as the optimal solution (KMO-measure of sampling adequacy: .575; Bartlett’s 
test of sphericity: chi-square=50.1, degrees of freedom=10, p<.001). Handgrip 
strength, gait speed and low activity level loaded on Factor 1 (explained variance: 
28.7%, factor loadings 0.75, 0.65, 0.55, respectively); this dimension was called 
‘performance-based physical frailty’. Weight loss and exhaustion loaded on Factor 2; 
this dimension was labeled ‘vitality-based physical frailty’ (explained variance: 20.2%, 
factor loadings 0.84 and 0.54, respectively). 
The frailty dimensions did not correlate with each other (r=-0.08, p=.13). Associations 
between each dimension of physical frailty and the three inflammatory markers are 
shown in Table 3. 
Table 3 Associations Between C-Reactive Protein (CRP), Interleukin-6 (IL)-6 and 
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Dimensions of the Physical 
Frailty Phenotype 
 CRP IL-6 NGAL
Physical Frailty  β (P Value)
Unadjusted    
Performance-based  0.14 (.01) 0.11 (.06) 0.16 (.003)
Vitality-based  -0.03 (.56) -0.01 (.89) -0.09 (0.7)
Fully adjusteda    
Performance-based  0.14 (.03) 0.13 (.06) 0.14 (.03)
Vitality-based  0.01 (.93) -0.02 (.69) -0.10 (.07)
a Adjusted for age, sex, years of education, severity of depressive symptoms (Inventory of Depressive 
Symptomatology sum score), cognitive functioning (Mini Mental State Examiniation score), number of chronic 
diseases, antiinflammatory drug use (including statins), alcohol use (none, moderate, severe), smoking 
(yes/no), body mass index, physical activity (metabolic equivalent minutes).
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Discussion
Main findings
The physical frailty phenotype was not associated with high levels of inflammatory 
markers in older adults with depression participating in the NESDO study. Nonetheless, 
performance-based measures such as handgrip strength and gait speed were asso-
ciated with markers of low-grade inflammation. The criteria of the FFI represent two 
dimensions of physical frailty in a population with depression. Only one dimension, 
including the criteria based on the handgrip strength and gait speed, was associated with 
inflammation independent of somatic illnesses, medication use or lifestyle characteristics.
Physical frailty phenotype in late-life depression
This first dimension, based on the criteria for weakness, slowness and low activity 
level, was called “performance-based physical frailty”. Weight loss and exhaustion 
represented a second dimension, called “vitality-based physical frailty”. 
Measures of handgrip strength and gait speed are often used as indicators of 
sarcopenia,24 which is considered to be an important mechanism underlying physical 
frailty.25 The physical frailty criteria of exhaustion and of low physical activity may 
also be indicators of sarcopenia, but their relationship with sarcopenia is not straight-
forward. The physical frailty criterion of exhaustion may simply reflect a symptom of 
depression in the current sample for two reasons. First, this criterion is derived from 
a self-report instrument assessing depression severity18 and overlaps with the DSM-IV 
criteria for major depressive disorder. Second, exhaustion has many different causes 
in old age, of which sarcopenia is only one, among others such as anemia, endocrine 
disorders, sleep disorders, pain and polypharmacy. 
The frailty component of low physical activity can be cause and consequence of 
depression or sarcopenia. Because low physical activity loads on the same dimension 
as handgrip strength and gait speed, it seems to reflect sarcopenia the current study 
population.
Finally, unintended weight loss may reflect sarcopenia but again, in the current study 
population probably, may be more likely a symptom of depression. Therefore, the 
dimension of vitality-based physical frailty has face validity for being a marker of 
depression severity instead of a true (second) dimension of physical frailty. Nonethe-
less, this hypothesis needs further validation.
Inflammation and frailty in late-life depression
Although the physical frailty phenotype was not associated with any of the three 
inflammatory markers, IL-6 and CRP were significantly associated with handgrip 
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strength and NGAL with gait speed. These findings suggest differential patterns 
between specific inflammatory markers and specific frailty criteria. Nonetheless, all 
three inflammatory markers were associated with the performance-based physical frailty 
dimension. Low-grade inflammation may thus be a general mechanism underlying 
performance-based physical frailty. 
The association between NGAL and vitality-based physical frailty is also of interest. 
In the NESDO study, only NGAL levels were higher in participants with depression 
than in those without.26 NGAL seems to be an inflammatory marker associated not 
only with frailty in depression, but also specifically with depression.
Associations between high IL-6 and CRP levels and depression have not been 
found consistently.27,28 It might be that low-grade inflammation in depression is conditional 
on the level of frailty in the population under study, but this needs further investigation.
Methodological considerations
Strengths of the current study are the large number of older persons with depression 
and the comprehensive assessment of depression characteristics and confounding 
factors. However, some limitations should also be acknowledged. First, the cross- 
sectional study design precludes causal interpretations. It is generally assumed that 
depressive symptoms and frailty are reciprocally associated.3 Low-grade inflammation 
might be involved in both directions. Frailty-associated inflammatory processes may 
drive the pathway from frailty to depression by activating the hypothalamo-pituitary- 
adrenocortical axis.12,29 Conversely, low physical activity and low protein intake due 
to a depressive disorder may result in sarcopenia, which in itself is associated with 
inflammation30 and may culminate in the physical frailty phenotype. Longitudinal studies 
with repeated measurement of physical frailty, depression and inflammatory markers 
should be conducted to evaluate the sequence of events. Second, although negative 
cognitions (e.g. self-report symptoms of physical functioning) do not negatively bias 
performance-based measures of fhysical frailty, poorer performance due to lack of 
motivation during testing cannot be fully excluded, although research assistants were 
specifically trained to enhance motivation and performance as much as possible.
 
Conclusion
The operationalization of the physical frailty phenotype should be adapted in an 
older population with depression, with a more prominent role for criteria associated 
with low-grade inflammation that does not overlap with the criteria of depressive 
disorder. An interesting question that merits further investigation is to examine whether 
late-life depression with physical frailty represents a specific depressive subtype.
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Part III: 
Does physical frailty affect 
the incidence and course 
of late-life depression?
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Abstract
Background- Late-life depression and physical frailty are supposed to be reciprocally 
associated, however longitudinal studies are lacking.
Objectives- This study examines whether physical frailty predicts a higher incidence 
of depression, as well as a less favorable course of depression. 
Methods- A population-based cohort study of 888 people aged 65 years and over 
with follow-up measures at 3, 6 and 9 years. Cox proportional hazards models 
adjusted for age, sex, education, smoking, alcohol usage and global cognitive 
functioning were applied to calculate the incidence of depressed mood in those 
non-depressed at baseline (n=699) and remission in those with depressed mood at 
baseline (n=189). Depressed mood onset or remission was defined as crossing the 
cutoff score of 20 points on the Center for Epidemiological Studies-Depression Scale 
(CES-D) combined with a relevant change in CES-D score. Physical frailty was based 
on the presence of ≥3 out of 5 components (i.e. weight loss, weakness, slowness, 
exhaustion and low physical activity level). 
Results- A total of 214 out of 699 (30.6%) non-depressed persons developed depressed 
mood during follow-up. Physical frailty predicted the onset of depressed mood with 
a hazard rate of 1.26 (95% confidence interval: 1.09-1.45, p=.002). Of the 189 
persons with depressed mood at baseline, 96 (50.8%) experienced remission during 
follow-up. Remission was less likely in the presence of a higher level of physical frailty 
(hazard rate =0.72, 95% confidence interval: 0.58–0.91, p=.005).
Conclusions- Because physical frailty predicts both the onset and course of late-life 
depressed mood, physical frailty should receive more attention in mental health care 
planning for older persons as well as its interference with treatment. Future studies into 
the pathophysiological mechanisms may guide the development of new treatment 
opportunities for these vulnerable patients.
Keywords: depression, frailty, older persons, InCHIANTI
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Introduction
Late-life depression places a great burden on patients and society,1 partly due to its 
often chronic course and high relapse rates.2-5 Not only depressive disorder, but also 
clinically relevant depressive symptoms have high impact on well-being, disability and 
utilization of health care services.1 Late-life depression is a complex mood disorder 
with various etiological pathways and high comorbidity rates with cognitive decline 
and physical diseases.6-9 These high comorbidity rates suggest involvement of general 
aging mechanisms. In an earlier study, we showed that 27% of depressed older 
patients can be classified as physically frail.10 Recently, a consensus conference 
concluded that physical frailty is an important medical syndrome with multiple causes 
and contributors that is characterized by diminished strength, endurance and reduced 
physiologic function that increases an individual’s vulnerability for developing increased 
dependency and/or death.11 Promising ideas were the optimism about the possibility 
to prevent and treat frailty and, thus, the need to take frailty into account in geriatric 
medicine. 
Despite shared underlying pathophysiological mechanisms of depression and frailty,12 
the concept of frailty has received little attention in mental health care for older persons. 
This can partly be explained by overlapping criteria of frailty and psychiatric diseases, 
which is most apparent for broader frailty concepts (including both physical and 
psychosocial components, such as depressive symptoms). The physical frailty 
phenotype for example remained significantly associated with late-life depression 
when overlapping criteria were omitted.13 Accordingly, latent class analyses have 
shown that physical frailty and depression identify distinct, but overlapping subpopu-
lations.14 For research into the relations between depression and frailty, the physical 
frailty phenotype by Fried et al.,15 defined as the presence of ≥3 out of the following 
5 criteria: weight loss, weakness, slowness, exhaustion and low physical activity 
level, is particularly useful, as depressive symptomatology is not part of this frailty 
definition. This is in line with the conclusions from the earlier mentioned consensus 
conference.11
If frailty indeed can be distinguished from late-life depression, it may be expected 
that physical frailty will be predictive for the onset of depression (as an adverse 
health effect). Additionally, it may be expected that frailty in depression is associated 
with negative health effects independent of the adverse effects of late-life depression 
itself, such as a more persistent course. Such data will contribute to the relevance 
of physical frailty in late-life mental health, and may ultimately lead to different 
interventions for frail and nonfrail persons, as previously have been suggested in 
general medicine. 16, 17 To date, the impact of physical frailty on incident depression 
has been examined twice using a prospective study design. Both studies identified 
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physical frailty as an independent predictor of incident depression.18, 19 Generalization 
to a Western society, however, may be limited as both studies were conducted in 
an Asian population. Moreover, one of them had a duration of follow-up limited to 
15 months.19 
The objectives of the present study are, therefore, to investigate whether in a Western 
society, physical frailty also predicts a higher incidence of depressed mood in non- 
depressed community-dwelling older persons and, whether physical frailty decreases 
the chance on remission of depressed mood in persons with depressed mood at 
baseline.
 
Methods
Data are from the InCHIANTI (Invecchiare in Chianti, aging in the Chianti area) Study, 
a prospective, population-based cohort study. Details of the study are described 
elsewhere.20 Briefly, the baseline data collection started in 1998 and was completed 
in 2000. It included an interview at the homes of the participants and a medical 
examination at the study clinic. The medical examination was conducted within 21 
days after the home interview. Follow-up assessments took place at 3, 6 and 9 years 
after baseline. After explaining the study procedures to the participants, they were 
asked to sign informed consent. The ethics committee of the Italian National Institute 
of Research and Care on Ageing approved of the study protocol. 
The InCHIANTI study included 1155 persons aged 65 years and older. Because of 
missing data on depressed mood at baseline (N=76) or lack of follow-up data with 
respect to depressive symptoms (N=191), the present study included 888 participants. 
Persons with missing data were significantly older (82.3 (standard deviation [SD] 
7.6) versus 73.4 (6.3) years, p<.001), less educated (4.2 (3.2) versus 5.6 (3.3) 
years, p<.001), had more somatic diseases (1.18 versus 0.89, p=.002), and were 
more likely to be frail (20.2% versus 6.8%, p<.001). The two groups did not differ 
with respect to gender and depressed mood status at baseline. 
Depressed mood
Depressive symptoms were assessed at baseline, 3 years, 6 years and 9 years of 
follow-up, using the Center for Epidemiological Studies-Depression Scale (CES-D). 
The CES-D is a self-report 20-item measurement scale for depressive symptoms 
experienced during the previous week.21 It has been shown to be a valid and reliable 
instrument for identifying depressed mood in community-dwelling older persons.22
The sum score ranges from 0 through 60, whereas a score of 20 was the best indicator 
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of clinically relevant depressive symptoms within the InCHIANTI sample.23, 24 Crossing 
the cutoff of 20 points combined with a relevant change on the CES-D was considered 
the primary outcome variable (i.e. onset of depressed mood in case of no depressed 
mood at baseline and remitted depressed mood in case of depressed mood at 
baseline). A relevant change was defined as a decrease or an increase of at least 
4 points (one-half a standard deviation) on the CES-D between 2 measurements. This 
criterion of a minimum change of 4 points was chosen to avoid random fluctuations 
or clinically irrelevant changes of symptoms leading to a respondent being identified 
as either incident depressed or remitted from depressed mood. 
Frailty
Frailty was defined according to the widely used criteria of Fried and colleagues.15 
In this definition frailty is operationalized as the presence of ≥3 out of the following 
5 criteria: weight loss, weakness, slowness, exhaustion and low physical activity 
level. In the analyses, however, frailty was used as a continuous variable based on 
the number of criteria met (range 0 – 5). Each criterion was operationalized using 
previously published methods.25, 26
• Weight loss was defined as the unintentional weight loss of >4.5 kilogram in the 
 past year.
• Handgrip strength was used to assess weakness. If handgrip strength corresponded 
 to the lowest quintile for stratified gender and body mass index groups, weakness 
 was considered present.
• Slowness was measured by a 4-m walking test, and was considered to be present 
 when walking speed corresponded to the lowest quintile of stratified gender and 
 height groups. 
• Exhaustion was evaluated by a CES-D question (“How often in the last week did 
 you feel that everything you did was an effort?”). If the participants answered 
 “often” or “most of the time”, exhaustion was considered present. 
• Low physical activity was assessed during the home interview. It was defined as 
 sedentary state or performing light intensity activity (i.e. walking) less than 1 hour 
 a week. 
Covariates
The following covariates were included in the analyses: socio-demographic varia-
bles, lifestyle variables and cognitive functioning. Socio-demographic variables in-
cluded age, gender and years of education. Lifestyle variables included smoking 
(non-smoker/ former smoker/ current smoker) and alcohol use (<3 or ≥3 drinks a day). 
Cognitive functioning was measured by the Mini Mental State Examination (MMSE).27
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The number of somatic diseases was established using standardized criteria that 
combined information from self-report history, medical records and a clinical 
examination (including heart failure, coronary heart disease, stroke, chronic obstructive 
lung disease, hypertension, diabetes, cancer, Parkinson’s disease and hip arthritis). 
Statistical analyses
All analyses will be presented for persons with depressed mood (CESD score ≥20) 
and non-depressed (CESD score <20) persons at baseline. Demographics and clinical 
characteristics of the participants with and without frailty (yes/no) were compared 
using independent samples t-tests for normally distributed, continuous variables, 
nonparametric Mann Whitney U tests for skewed continuous variables, and χ² tests 
for categorical variables. All predictors and covariates (primary variables) that were 
included in the models were checked for normality and collinearity.
Missing data of determinants and covariates was handled by multiple imputations 
using the fully conditional specification method with IBM SPSS statistics (SPSS Inc, 
Chicago, IL), whereas the outcomes (depressed mood status) were not. Appendix 1 
and 2 show the variables in the imputation model and their role in the model (predictor, 
imputed variable or both). 
In the non-depressed group 43 datasets were created because 43% of the cases had 
missing data on at least 1 variable. In the depressed mood group 58 datasets were 
created.28 Analyses on the imputed dataset were considered the primary analyses. 
Nonetheless, results of the original data (complete cases) were also shown.28, 29 
Cox proportional hazards models adjusted for age, gender, education, smoking status, 
alcohol use, number of somatic diseases and MMSE score were used to examine 
whether frailty predicts incidence of depressed mood during follow-up (either at 3, 6 
or 9 years of follow-up, CES-D scores of ≥20 combined with a relevant change) 24 
among those originally not depressed at enrollment. The proportionality of hazards 
assumption was checked for the primary variables by log minus log plots. 
Only subjects with data from at least one follow-up measure were included in the 
analysis. First, the number of frailty components (range 0 -5) was used as a continuous 
predictor variable. Subsequently, the impact of the individual frailty components was 
examined by including each component in a separate model. 
Among persons with depressed mood at baseline, a similar strategy was applied. 
We used Cox proportional hazards models to examine whether frailty status at baseline 
predicted remission of depressed mood during follow-up. 
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Interactions with gender were tested because the prevalence rates for both frailty and 
depression are higher in women than in men. Finally, because the exhaustion criteri-
on from the physical frailty definition is derived from a depression scale (CES-D), we 
performed a sensitivity analysis by excluding the exhaustion criterion from the frailty 
definition. The sum score was re-calculated on the remaining 4 frailty components. 
With this measure of frailty, the analyses were repeated. All statistical procedures were 
performed using IBM SPSS version 20. Final outcomes were considered statistically 
significant if P values were ≤.05. 
Results
The mean age [SD] of total study population (n=888) was 73.4 [6.3] years and 
56.3% was female. At baseline, 21.3% had depressed mood and 6.8% were frail. 
Table 1 presents the characteristics of both the depressed mood and the non-depressed 
group by frailty status. 
Persons with baseline depressed mood were significantly older, were more often female, 
were less frequently a smoker, drank less alcohol, had lower cognitive functioning, 
were more likely to be frail and were more likely to have depressed mood at follow-up. 
Incidence of depressed mood
Incidence of depressed mood was assessed in persons who were not depressed 
at baseline (n=699). Of these persons 92.4% (n=646) had CES-D data available 
at 3 years of follow-up, 81.4% (n=569) at 6 years follow-up and 64.2% (n=449) 
at 9 years follow-up. Of the persons not depressed at baseline, 30.6% (n=214) 
developed depressed mood during the 9-year follow-up. The risk of becoming 
depressed was increased for persons with frailty, compared to the nonfrail persons 
in the unadjusted analyses. When the analyses were corrected for age, gender, 
educational level, smoking status, alcohol use, number of somatic diseases and 
MMSE score, this increased risk remained present (hazard rate (HR)=1.26 [95% CI: 
1.09–1.45], p=.002). Subsequently, frailty components were analyzed separately. 
Only low physical activity level significantly increased the risk of incident depressed 
mood (Table 2).
Remission in depressed mood group
Remission of depressed mood was assessed in persons who had depressed mood 
at baseline (n=189). Follow-up data were available for 93.7% (n=177) at 3 years 
follow-up, for 73.0% (n=138) at 6 years follow-up and for 49.7% (n=94) at 9 years 
follow-up. Of the persons with initially depressed mood, 50.8% (n=96) experienced 
remission during follow-up. 
122
 
Fr
ai
lty
 p
re
di
ct
s 
de
pr
es
se
d 
m
oo
d 
C
ha
pt
er
 7
With regard to remission during follow-up, Cox regression analysis showed that 
frailty strongly predicts lower remission during follow-up (Table 3). This increased 
likelihood of remission remained present, also in the fully adjusted model (HR=0.72 
[95% CI: 0.58–0.91], p=.005). When frailty was decomposed into compo-
nents, only absence of low physical activity level predicted remission of depressed 
mood in the fully adjusted model (Table 3). No significant interactions between 
frailty*gender were found (non-depressed mood group: p=.919, depressed mood 
group: p=.621). 
Sensitivity Analysis
The analyses were repeated after excluding the exhaustion criterion from the frailty 
definition. Frailty without exhaustion remained significantly associated with incident 
Table 1 Sample Characteristics (complete cases)
 Participants (n=888), %
 Depressed Mood at Baseline No Depressed Mood at Baseline
 (n=189), 21.3 (n=699), 78.7
 Frail Nonfrail  Frail Nonfrail
Characteristic (n=31), 16.4 (n=158), 83.6 P Valuea (n=29), 4.1 (n=670), 95.9 P Valuea
Sociodemographics      
Age, mean (SD), y  79.9 (6.2) 74.6 (6.4) <.001 77.0 (7.1) 72.6 (6.0) <.001
Female gender, % 77.4 77.8 .958 48.3 50.6 .807
Education, mean (SD), y  4.3 (2.7) 5.4 (3.4) .072 5.4 (3.1) 5.7 (3.3) .622
Health indicators      
Smoking, %   .560   .120
  Never smoked 77.4 72.8  37.9 54.3
  Former smoker 9.7 17.1  34.5 30.4
  Current smoker 12.9 10.1  27.6 15.2
Alcohol use, ≥3 drinks 3.2 12.0 .145 13.8 22.8 .253
a day, %
MMSE score, mean (SD) 23.3 (2.9) 25.3 (2.8) <.001 24.4 (3.4) 25.9 (2.7) .023
Somatic diseases,  1.4 (1.1) 0.9 (1.0) .007 1.7 (1.2) 0.8 (0.9) <.001
mean no (SD)
Frailty indicators      
Weight loss, % 25.8 3.8 <.001 27.6 3.1 <.001
Weakness, % 58.1 11.4 <.001 75.9 13.0 <.001
Slowness, % 80.6 16.4 <.001 86.2 10.9 <.001
Exhaustion, % 83.9 46.8 <.001 65.5 7.5 <.001
Low physical activity  80.6 24.1 <.001 72.4 8.2 <.001
level, %
Amount of frailty 3.3 (0.5) 1 (0.7) <.001 3.3 (0.5) 0.4 (0.7) <.001
criteria present, mean (SD)
Abbreviations: MMSE, Mini Mental State Examination
a Comparison using analyses of variance (continuous variables), χ² statistics (categorical variables) and 
U tests (continuous, skewed variables).
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depressed mood and remission in the fully adjusted model (incidence: HR=1.31 
[95%CI: 1.10–1.56], p=.003, remission: HR=0.70 [0.53–0.92], p=.010). 
Table 2 Cox Proportional Hazards Model for Incidence of Depressed Mood in the 
Group Not Depressed at Baselinea
N=699 Imputed Data  Complete Cases 
Frailty (N=29)b: HR (95% CI) P Value HR (95% CI) P Value
Unadjusted 1.41 (1.24, 1.60) <.001 1.43 (1.23, 1.60) <.001
Fully adjusted 1.26 (1.09, 1.45) .002 1.25 (1.08, 1.46) .003
Components of frailtyc:    
Weight loss (N=29) 1.49 (0.80, 2.76) .205 1.48 (0.79, 2.75)  .218
Weakness (N=115) 1.21 (0.85, 1.73) .279 1.20 (0.84, 1.71) .329
Slowness (N=106) 1.39 (0.95, 2.03) .087 1.36 (0.92, 2.02) .123
Exhaustion (N=69) 1.40 (0.95, 2.08) .090 1.40 (0.95, 2.08) .090
Low physical activity 1.68 (1.17, 2.42) .005 1.68 (1.17, 2.42) .005
level (N=76)
aNumber of events: 214, number of person years: 4668 (45.8 events/ 1000 person years).
bFrailty was used as a continuous variable.
cFrailty components were analyzed separately and adjusted for age, gender, level of education, smoking 
status, alcohol use, number of somatic diseases and Mini Mental State Examination score.
Table 3 Cox Proportional Hazards Model for Remission in the Group Depressed 
Mood at Baselinea 
N=189 Imputed Data  Complete Cases 
Frailty (N=31)b: HR (95% CI) P Value HR (95% CI) P Value
Unadjusted 0.73 (0.60, 0.90) .003 0.73 (0.59, 0.90) .004
Fully adjusted 0.72 (0.58, 0.91) .005 0.74 (0.58, 0.93)  .010
Components of frailtyc:    
Weight loss (N=15) 1.17 (0.54, 2.50) .688 1.22 (0.58, 2.57) .600
Weakness (N=41) 0.66 (0.35, 1.24) .195 0.65 (0.34, 1.24) .190
Slowness (N=53) 0.55 (0.30, 1.01) .052 0.55 (0.30, 1.02) .057
Exhaustion (N=100) 0.75 (0.49, 1.13) .169 0.75 (0.49, 1.13) .169
Low physical activity 0.55 (0.33, 0.94) .028 0.55 (0.33, 0.94) .0.28
level (N=63)
aNumber of events: 96, number of person years: 999 (96.1 events/ 1000 person years). 
bFrailty was used as a continuous variable.
¹Frailty components were analyzed separately and adjusted for age, gender, level of education, smoking 
status, alcohol use, number of somatic diseases and Mini Mental State Examination score
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Discussion
Main findings
This study describes the longitudinal association between physical frailty and de-
pressed mood; focusing on incidence as well as remission of depressed mood. It 
is confirmed that the severity of frailty negatively interferes with both the onset and 
remission of late-life depressed mood independent of age, sex, level of education, 
lifestyle, somatic diseases and global cognitive functioning. 
Comparison with literature
Our findings are fully in line with a recent systematic review on the relationship between 
frailty and depression.30 The authors concluded that frailty, its components and functional 
impairments are risk factors for depression.30 In most of the included cohort studies, 
however, frailty was defined by Activities of Daily Living indices. None of these 
cohort studies used a definition of frailty according to the physical phenotype. This 
is important, as physical frailty should reflect the biological age of a person and 
should be distinguished from disabilities and multimorbidity.11 Not included in this 
review are two recent studies on the longitudinal association between physical frailty 
and depression.18, 19 Both studies find that physical frailty predicts the incidence of 
depressive symptoms in an Asian population. In 1 study, the persistence of depressive 
symptoms is also investigated, and frailty is identified as an independent predictor of 
persistence of depressive symptoms.18 Our findings not only confirm these findings for 
a Western population, but also extend to these findings by determining the contribution 
of frailty to remission in a group that has depressed mood at baseline. Furthermore, the 
risk of depression in the case of frailty is also confirmed for a relatively long follow-up 
period (9 years). 
With regard to components of frailty; weight loss, slowness, exhaustion and low 
physical activity seem to contribute to the impact of frailty on the onset of depressed 
mood, whereas the impact of weakness seems to be less strong. Nonetheless, only 
low physical activity significantly increased the risk of depressed mood onset in the 
fully adjusted models. The association between low physical activity and incident 
depression is in line with previous studies.31
Among older persons suffering from depressed mood, frailty was associated with 
a lower chance on remission during follow-up. The impact of frailty on remission 
of depressed mood seems to be driven by slowness and low physical activity level 
whereas an impact of weight loss was reverse. Previous research showed the same 
(non-significant) inverse association of weight loss with depressed mood.18 Nonethe-
less, again only (absence of) low physical activity level was an independent predic-
tor of remission in the fully adjusted models. 
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So, what do the findings among depressed and non-depressed persons tell us about 
the concept of frailty? The physical frailty phenotype according to the criteria of Fried 
et al.15 is a widely used and well-validated concept.11 In our study, the construct of 
frailty is consistently associated with depressed mood. Results with respect to the 
individual frailty components also seem consistent. With respect to the prediction of 
depressed mood, all components pointed towards the same direction. Regarding 
remission of depressed mood, the association with weight loss is opposite to the 
direction of the association of the other frailty components. When the unidimensionality 
of physical frailty is examined with respect to its association with late-life depression, 
zooming in on frailty components may help revealing the validity of the concept of 
frailty. Future studies therefore, should pay more attention to the relationship between 
adverse outcomes and the individual components of frailty. 
In recent research it was found that overlap between depression and frailty was highest 
for the somatic and severely depressed subgroups; almost three quarters of the severely 
depressed older persons was also frail.32 The co-occurrence of frailty and depressed 
mood is confirmed in the present study. The frailty prevalence of 6.8% in the present 
study, however, is lower than the prevalence rate we found before in a meta-analysis of 
frailty prevalence among community dwelling older persons (10.7%).10 This difference 
can almost completely be explained by the higher prevalence of frailty (20.2%) 
among the persons that were excluded due to missing data. Nonetheless, another 
less weighty explanation for this finding may be the lower age of the InCHIANTI 
participants, compared to the mean age of the participants in the meta-analysis, as 
the prevalence of frailty increases with age. 
What underlies this compound between physical frailty and depression? Shared 
mechanisms include low-grade inflammation, nutritional deficits among which vitamin 
D deficiency, lack of exercise and sarcopenia, and/or age-related hormonal changes, 
which all have been associated with frailty as well as depression.31, 33-40 These 
pathophysiological mechanisms add to the multi-facetted pathways to both frailty 
and depression. Moreover, when depression and frailty are simultaneously present, 
disentangling causes and consequences of either one from another becomes 
challenging. For instance, a factor like lack of exercise can be part of the path 
towards frailty and depression, as well as a result of one or both of these syndromes. 
All factors may even occur in a complicated vicious circle. Nonetheless, the longitudinal 
association between frailty and depression is clearly present in this study. Therefore, 
treatment of frailty deserves a more prominent role in late-life depression, as it may 
prevent depression or shorten the duration of depression. Older persons that are not 
only depressed, but also frail confer specific complex care needs.41, 42 
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Strengths and limitations
Our study has some important strengths. The association between frailty and 
depressed mood was examined within a prospective design, with data of 9 years of 
follow-up. A large, community-based sample was used, providing the opportunity to 
investigate onset, as well as persistence of depressed mood. Frailty was included as 
a continuous variable, reflecting the dimensional nature of physical frailty.43 Relations 
were further disentangled by examining components of frailty separately. 
Because the dropout of study participants during follow-up is selective when studying 
older persons (in our case the most frail participants dropped out during follow-up, 
data not shown), the strength of the association between frailty and depressed mood 
may decrease at the end of the follow-up time (9 years). Cox regression analysis 
takes this into account by censoring the data at time of dropout. 
Nonetheless, the findings have to be interpreted in light of the study limitations also. 
In our sample, persons with missing data on baseline depressive symptoms or all 
follow-up data on depressive symptoms were excluded prior to the analyses. The 
persons with missing data were older, less educated, more frail and had more somatic 
diseases, as compared to persons with no missing data. This implies that the most 
frail and unhealthy persons were not included in the analyses, and therefore the 
findings may be biased towards an underestimation of the association between 
frailty and depressed mood.
Depressive symptoms were assessed with the CES-D; a self-report questionnaire. 
With a score of ≥20 combined with a relevant change in symptoms (≥4 CES-D 
points), a person was considered to have depressed mood. Although a CES-D 
score of 20 points or more reflects clinically relevant depressive symptoms,22, 44 it 
is not necessarily a psychiatric diagnosis of major depressive disorder.22 Our re-
sults should therefore be confirmed by future studies assessing depressive disorder 
according to DSM-5 or International Classification of Diseases-10th revision criteria. 
Finally, the history of depression was unknown and some of the persons in the 
non-depressed group may have suffered from depressed mood in the past.
Clinical implications
This study confirms that frailty predicts incidence of depressed mood and not being 
frail predicts remission. In long-term care, both frailty and depression are highly 
prevalent,45, 46 and these findings may change the perspective on the treatment of 
late-life depression and frailty. Our results imply that interventions proven to improve 
the frailty status, such as exercise, nutritional intervention and vitamin D suppletion,11 
might be relevant for old age psychiatry and for prevention of frailty. Future research 
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should guide interventions for persons suffering from frailty and depression, especially 
the influence of treating frailty and the consequences for depression. 
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Appendices
Appendix 1:
Missing data patterns in persons with depressed mood at baseline
Variable N (%) Cases With Role
N=189 Missing Values 
Age 0 (0) Predictor 
Gender 0 (0) Predictor 
Education 0 (0) Predictor 
Smoking status 0 (0) Predictor 
Alcohol use 0 (0) Predictor 
MMSE score 0 (0) Predictor 
Somatic diseases 0 (0) Predictor
Weight loss 8 (4.2) Predictor and imputed
Grip strength 22 (11.6) predictor and imputed
Walking speed 27 (14.3) Predictor and imputed
Exhaustion 0 (0) Predictor 
Low activity level 0 (0) Predictor  
CES-D follow-up 1 12 (6.3) Predictor 
CES-D follow-up 2 51 (27.0) Predictor 
CES-D follow-up 3 95 (50.3) Predictor 
CES-D baseline 0 (0) Predictor 
When patterns of missing data were analyzed, it showed that data was missing 
by a random pattern and therefore the Fully Conditional Specification Method was 
used. We created 58 datasets, as 58% of the cases had at least 1 missing value.29 
In total, 7.1% of the data were missing. The imputation included the variables that 
were used in the final model. 
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Appendix 2:
Missing data pattern in the group non depressed at baseline
Variable N (%) Cases With Role
N=699 Missing Values 
 
Age 0 (0) Predictor 
Gender 0 (0) Predictor 
Education 0 (0) Predictor 
Smoking status 0 (0) Predictor 
Alcohol use 0 (0) Predictor 
MMSE score 0 (0) Predictor 
Somatic diseases 0 (0) Predictor
Weight loss 5 (0.7) Predictor and imputed
Grip strength 35 (5.0) predictor and imputed
Walking speed 48 (6.9) predictor and imputed
Exhaustion 0 (0) Predictor 
Low activity level 0 (0) Predictor 
CES-D follow-up 1 53 (7.6) Predictor 
CES-D follow-up 2 130 (18.6) Predictor 
CES-D follow-up 3 250 (35.8) Predictor 
CES-D baseline 0 (0) Predictor 
When patterns of missing data were analyzed, it showed that data was missing by a 
random pattern and therefore the Fully Conditional Specification Method was used. 
We used the Fully Conditional Specification Method and created 43 datasets, as 
43% of the cases had at least 1 missing value. 29 In total, 4.7% of the data were 
missing. The imputation included the variables that were used in the final model. 
130
 
Re
fe
re
nc
es
 
C
ha
pt
er
 7
References
[1] Beekman AT, Penninx BW, Deeg DJ, et al. The impact of depression on the well-being, 
disability and use of services in older adults: a longitudinal perspective. Acta Psychiatr Scand. 
2002;105: 20-27.
[2] Stek ML, van Exel E, van Tilburg W, et al. The prognosis of depression in old age: 
outcome six to eight years after clinical treatment. Aging Ment Health. 2002;6: 282-285.
[3] Mueller TI, Kohn R, Leventhal N, et al. The course of depression in elderly patients. 
Am J Geriatr Psychiatry. 2004;12: 22-29.
[4] Mitchell AJ, Subramaniam H. Prognosis of depression in old age compared to middle 
age: a systematic review of comparative studies. Am J Psychiatry. 2005;162: 1588-1601.
[5] Licht-Strunk E, van der Windt DA, van Marwijk HW, et al. The prognosis of depression 
in older patients in general practice and the community. A systematic review. Fam Pract. 2007;24: 
168-180.
[6] Beekman AT, de Beurs E, van Balkom AJ, et al. Anxiety and depression in later life: 
Co-occurrence and communality of risk factors. Am J Psychiatry. 2000;157: 89-95.
[7] Lenze EJ, Rogers JC, Martire LM, et al. The association of late-life depression and 
anxiety with physical disability: a review of the literature and prospectus for future research. 
Am J Geriatr Psychiatry. 2001;9: 113-135.
[8] Steffens DC, McQuoid DR, Potter GG. Outcomes of older cognitively impaired individuals 
with current and past depression in the NCODE study. J Geriatr Psychiatry Neurol. 2009;22: 
52-61.
[9] Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public 
Health. 2013;34: 119-138.
[10] Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in 
community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012;60: 1487-1492.
[11] Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med 
Dir Assoc. 2013;14: 392-397.
[12] Révész D, Verhoeven JE, Milaneschi Y, et al. Dysregulated physiological stress systems 
and accelerated cellular aging. Neurobiol Aging. 2013.
[13] Collard RM, Comijs HC, Naarding P, Oude Voshaar RC. Physical frailty: vulnerability 
of patients suffering from late-life depression. Aging Ment Health. 2014;18: 570-578.
[14] Mezuk B, Lohman M, Dumenci L, Lapane KL. Are Depression and Frailty Overlapping 
Syndromes in Mid- and Late-life? A Latent variable analysis. Am J Geriatr Psychiatry. 2012.
[15] Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. 
J Gerontol A Biol Sci Med Sci. 2001;56: M146-156.
[16] Afilalo J, Karunananthan S, Eisenberg MJ, et al. Role of frailty in patients with cardio-
vascular disease. Am J Cardiol. 2009;103: 1616-1621.
[17] Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: understanding 
frailty and the geriatric assessment. CA Cancer J Clin. 2010;60: 120-132.
[18] Feng L, Nyunt MS, Yap KB, Ng TP. Frailty predicts new and persistent depressive 
131
C
hapter 7 
References
symptoms among community-dwelling older adults: findings from Singapore longitudinal aging 
study. J Am Med Dir Assoc. 2014;15: 76.e77-76.e12.
[19] Makizako H, Shimada H, Doi T, et al. Physical frailty predicts incident depressive 
symptoms in elderly people: prospective findings from the Obu Study of Health Promotion for 
the Elderly. J Am Med Dir Assoc. 2014.
[20] Ferrucci L, Bandinelli S, Benvenuti E, et al. Subsystems contributing to the decline in 
ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI 
study. J Am Geriatr Soc. 2000;48: 1618-1625.
[21] Radloff L. The CES-D scale: a self-report depression scale for research in the general 
population. Appl Psychol Meas. 1977;1: 385-401.
[22] Beekman AT, Deeg DJ, Van Limbeek J, et al. Criterion validity of the Center for Epide-
miologic Studies Depression scale (CES-D): results from a community-based sample of older 
subjects in The Netherlands. Psychol Med. 1997;27: 231-235.
[23] Vogelzangs N, Suthers K, Ferrucci L, et al. Hypercortisolemic depression is associated 
with the metabolic syndrome in late-life. Psychoneuroendocrinology. 2007;32: 151-159.
[24] Penninx BW, Guralnik JM, Ferrucci L, et al. Depressive symptoms and physical decline 
in community-dwelling older persons. JAMA. 1998;279: 1720-1726.
[25] Ble A, Cherubini A, Volpato S, et al. Lower plasma vitamin E levels are associated with 
the frailty syndrome: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2006;61: 278-283.
[26] Cesari M, Leeuwenburgh C, Lauretani F, et al. Frailty syndrome and skeletal muscle: 
results from the Invecchiare in Chianti study. Am J Clin Nutr. 2006;83: 1142-1148.
[27] Folstein M, Folstein S, McHugh P. “Mini-mental state”. A practical method for grading 
the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12: 189-198.
[28] Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemio-
logical and clinical research: potential and pitfalls. BMJ. 2009;338: b2393.
[29] White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues 
and guidance for practice. Stat Med. 2011;30: 377-399.
[30] Mezuk B, Edwards L, Lohman M, et al. Depression and frailty in later life: a synthetic 
review. Int J Geriatr Psychiatry. 2011.
[31] Wassink-Vossen S, Collard RM, Oude Voshaar RC, et al Physical (in)activity and 
depression in older people. J Affect Disord. 2014;161: 65-72.
[32] Lohman M, Dumenci L, Mezuk B. Sex differences in the construct overlap of frailty and 
depression: evidence from the health and retirement study. J Am Geriatr Soc. 2014;62: 500-505.
[33] Cesari M, Penninx B, Pahor M, et al. Inflammatory markers and physical performance 
in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59: 242-248.
[34] Leng SX, Xue QL, Tian J, et al. Inflammation and frailty in older women. J Am Geriatr 
Soc. 2007;55: 864-871.
[35] Penninx BW, Milaneschi Y, Lamers F, Vogelzangs N. Understanding the somatic 
consequences of depression: biological mechanisms and the role of depression symptom 
profile. BMC Med. 2013;11: 129.
132
 
Re
fe
re
nc
es
 
C
ha
pt
er
 7
[36] Cesari M, Landi F, Vellas B, et al. Sarcopenia and physical frailty: two sides of the 
same coin. Front Aging Neurosci. 2014;6: 192.
[37] Kim NH, Kim HS, Eun CR, et al. Depression is associated with sarcopenia, not central 
obesity, in elderly korean men. J Am Geriatr Soc. 2011;59: 2062-2068.
[38] Shardell M, Hicks GE, Miller RR, et al. Association of low vitamin D levels with the 
frailty syndrome in men and women. J Gerontol A Biol Sci Med Sci. 2009;64: 69-75.
[39] Milaneschi Y, Hoogendijk W, Lips P, et al. The association between low vitamin D and 
depressive disorders. Mol Psychiatry. 2014;19: 444-451.
[40] Savela SL, Koistinen P, Stenholm S, et al. Leisure-time physical activity in midlife is 
related to old age frailty. J Gerontol A Biol Sci Med Sci. 2013;68: 1433-1438.
[41] Han H, Kim M, Lee HB, et al. Correlates of depression in the Korean American elderly: 
Focusing on personal resources of social support. J Cult Gerontol. 2007;22: 115-127.
[42] Wild B, Heider D, Maatouk I, et al. Significance and costs of complex biopsychosocial 
health care needs in elderly people: results of a population-based study. Psychosom Med. 
2014;76: 497-502.
[43] Collard RM, Arts M, Comijs HC, et al. The role of frailty in the association between 
depression and somatic comorbidity: results from baseline data of an ongoing prospective 
cohort study. Int J Nurs Stud. 2014.
[44] Fava GA. Assessing depressive symptoms across cultures: Italian validation of the 
CES-D self-rating scale. J Clin Psychol. 1983;39: 249-251.
[45] de la Rica-Escuin M, Gonzalez-Vaca J, Varela-Perez R, et al. Frailty and mortality or 
incident disability in institutionalized older adults: the FINAL study. Maturitas. 2014;78: 329-334.
[46] Bruce ML, McAvay GJ, Raue PJ, et al. Major depression in elderly home health care 
patients. Am J Psychiatry. 2002;159: 1367-1374.
133
C
hapter 8 
Frailty and the course of depression 
Chapter 8
Frailty as a predictor of the course 
of late-life depression: 
findings from the Netherlands 
Study of Depression 
in Older persons  
Submitted
Rose M. Collard, Matheus H.L. Arts, Aart H. Schene, Paul Naarding, 
Richard C. Oude Voshaar and Hannie C. Comijs
134
 
Fr
ai
lty
 a
nd
 th
e 
co
ur
se
 o
f d
ep
re
ss
io
n 
C
ha
pt
er
 8
Abstract
Background- Understanding the associations between frailty and depression may 
help to improve treatment outcome of late-life depression. The aim of this study is to 
test whether frailty predicts non-remission of late-life depression. 
Methods- A cohort study (N=285) of depressed older persons aged ≥60 years with 
two years follow-up. Depression was classified according to the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria. Severity of 
depression was assessed with the Inventory of Depressive Symptomatology (IDS). 
Frailty was defined as physical frailty (weakness, slowness, weight loss, exhaustion, 
low physical activity). 
Results- Frailty predicted non-remission of depression with an odds ratio of 1.21 [95% 
CI=0.99-1.49] (p=.064) for each additional component of physical frailty. A higher 
level of frailty was associated with a higher severity of depressive symptoms over 
the two years. Linear mixed models showed that motivational and somatic symptom 
severity improved significantly more over time in frail patients (p<.001 and p=.003), 
although the overall level of motivational and somatic symptoms remained higher 
over time. 
Limitations- Due to the naturalistic aspect of the cohort no differentiation could be 
made between the type of treatment offered to patients. Despite a large sample size, 
power seems to be limited to draw firm conclusions. 
Conclusions- Although the faster decline of motivational and somatic symptoms of 
depression in patients suffering from a higher severity of physical frailty suggests some 
overlap between frailty and depression, physical frailty still negatively impacts the course 
of late-life depression. This may point to the potential importance of incorporating multi- 
facetted interventions in the treatment of late-life depression. Further understanding of 
the mediating mechanisms underlying the association between frailty and depression 
may further guide the development of these interventions.
Keywords: depression, frailty, older persons, Netherlands Study of Depression in 
Older persons (NESDO)  
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Introduction
Depressive disorder is a highly prevalent condition among older persons1 and constitutes 
an important worldwide health issue due to its often chronic course.2, 3 To optimize 
treatment of late-life depression, understanding the processes involved in the course 
of this mental illness is essential. An important step would be to identify risk factors 
that predict an unfavorable course of depression; frailty may be such a risk factor.4, 5 
Frailty is a condition of increased risk of adverse health outcomes.6 In a recent 
consensus meeting it has been concluded that physical frailty is an important medical 
syndrome with multiple causes and contributors.7 Physical frailty is defined as the 
presence of three or more of the following five characteristics: weight loss, weakness, 
slowness, exhaustion and low activity level.6 The dimensional nature of frailty is 
acknowledged by including a prodromal frailty state in this definition; prefrailty, which 
is defined as the presence of only one or two of the characteristics. When no frailty 
characteristics are present an older person is classified as robust.6 Meta-analytic 
research has shown that approximately one out of ten persons over 65 years can 
be classified as physically frail.8 Recently, we showed that more than a quarter of 
clinically depressed older persons fulfill criteria for physical frailty.9 
The association between physical frailty and depressive symptoms in the population 
is assumed to be bidirectional.9, 10 This leads to the question whether frailty and 
late-life depression are causal factors for each other, or whether they simply share 
similar underlying mechanisms that may also influence the presentation of one another. 
Suggestions for the latter hypothesis involve both psychosocial factors and stress- 
related pathophysiological dysregulations.4 Latent class analyses on the individual 
components of physical frailty and depression suggests that the most appropriate 
model for understanding depression and frailty is one of comorbidity.11 To date, 
three longitudinal studies in the general population have identified physical frailty as 
an independent predictor of the increase and protracted course of depressive 
symptoms.4, 5, 12 Because these studies focused on depressive symptoms instead 
of a depressive disorder according to Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition (DSM-IV) criteria results may be confounded by overlap 
between self-report depressive symptoms and signs of frailty. Moreover, these 
community-based findings cannot be extrapolated to a psychiatric population. The 
next step would be to assess frailty and the course of depression in a clinically 
depressed sample. 
In the present study the effect of physical frailty on the course of late-life depression 
is examined. More specifically, we first examined whether physical frailty predicts 
non-remission of depressive disorder at two years follow-up, and second, whether 
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physical frailty predicts the course of depressive symptoms over time. Additionally, 
we zoomed in on depressive symptoms subscales. Hypothesizing a negative effect of 
physical frailty on depression outcome, we expect lower remission rates at follow-up 
and a more adverse course of depressive symptoms over time. Furthermore, we 
expect less improvement on the mood subscale compared to the motivation and 
somatic subscales with a higher level of frailty, indicating a true effect on depression 
that cannot be explained by symptom overlap. 
Methods
Study participants came from the Netherlands Study of Depression in Older persons 
(NESDO),13 an ongoing cohort study aimed at examining the long-term course and 
consequences of depressive and anxiety disorders in older persons (aged ≥ 60 
years). The NESDO study has included 378 depressed subjects (age range: 60 
through 93 years) from mental health institutes (both in- and outpatients) and from 
primary care who suffered from a current DSM-IV diagnosis of major depressive 
disorder (95%), dysthymia (26.5%), or minor depression (5.6%), of which 26.5% 
have two types of depressive disorders. Persons with a primary diagnosis of 
dementia, a Mini Mental State Examination score (MMSE) under 18 or an organic 
or psychotic disorder were excluded, since the course of these persons will be largely 
determined by the primary disorder. Insufficient mastery of the Dutch language was 
another exclusion criterion. All participants were competent to consent to participation 
and all gave written informed consent. The ethical review boards of the participating 
institutes approved of this study. 
Data collection included an examination at one of the participating clinics or at the 
homes of the participants, including a structured diagnostic interview, physical tests 
(such as blood pressure and gait speed), and paper and pencil questionnaires. These 
assessments were conducted at baseline (n=510) as well as at two year follow-up 
(overall attrition rate of 21.4%). The course of late-life depression was followed up 
every six months by means of a postal assessment, including questionnaires on the 
severity of depressive symptoms and physical health in the past six months.
The present study was performed on all participants from the depressed group. 
Because of missing data on follow-up measures (n=93), this study consisted of 285 
participants.14 Persons that were lost to follow-up had lower cognitive functioning 
(MMSE score 27.2 versus 27.9, p=.014) and more frailty characteristics (2.2 versus 
1.7, p=.002). No baseline differences with regard to age, gender, educational level, 
severity of depression and number of diseases were found between persons that 
participated in follow-up and persons that did not participate in follow-up. 
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Measures
Depression
The Composite International Diagnostic Interview (CIDI), version 2.1 was used in 
order to determine the presence of depression at baseline, as well as at two years 
follow-up.15 The CIDI is a structured interview that assesses psychiatric disorders in 
adults according to the criteria of DSM-IV. The CIDI has good validity and reliability for 
depressive and anxiety disorders.16, 17 To determine the research DSM-IV diagnosis 
of current minor depression, questions were added to the CIDI, as in the Netherlands 
Study of  Depression and Anxiety (NESDA).18 Diagnosis of depression after two years 
consisted of major depression and dysthymia in the past six months, and minor 
depression in the past month. Severity of depression was measured by the well- 
validated 30-item self-rating IDS,19 which in older persons has three subscales; a mood, 
motivation and somatic subscale.20 In the IDS, items are scored on a four point scale, 
with each item equally weighted and summed up to a total score. A higher total score 
indicates more severe depression. 
Frailty
Physical frailty was operationalized by the following five criteria of Fried et al.6; 1) 
slowness, 2) low physical activity, 3) weight loss, 4) exhaustion, and 5) weakness. 
As a dimensional measure we used the number of criteria present (range 0 – 5). 
Subsequently, components of frailty were analyzed. For clinical interpretation, a frailty 
score of 0 is considered robust; a score of 1 or 2 is considered prefrail whereas a 
score of 3 or more is considered physically frail.
• Slowness was measured by a 6-m walking test. For men ≤173 centimetres 
 (cm) tall the cutoff time was 9 seconds, for men >173 cm the cutoff time was 8 
 seconds. The cutoff time for this criterion for women with a height of ≤159 cm 
 was 9 seconds, for women >159 cm the cutoff time was 8 seconds (extrapolated 
 from the data of Fried and colleagues).6 
• Low physical activity level was defined as no daily activities such as walking and 
 gardening, or the performance of sports less than once weekly. The self-administered 
 version of the International Physical Activities Questionnaire (IPAQ),21 was used to 
 collect physical activity data over the last seven days. 
• The presence of unintentional weight loss or low body mass index was used for 
 the weight loss criterion. The CIDI question about unwanted weight loss was used 
 to determine the loss of a minimum of one kilogram a week, during two or more 
 consecutive weeks. Body Mass Index (BMI) was defined as weight in kilograms 
 divided by height in meters squared. With a BMI of <18.5 kg/ m² weight loss 
 was also considered to be present.
• Exhaustion (poor endurance and energy) was determined by two questions from 
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 the IDS,19 about energy level and leaden paralysis/physical energy. Participants 
 answering positive on either of these two questions were categorized as exhausted.
• A handgrip dynamometer was used to assess muscle weakness. Participants were 
 asked to perform two squeezes with the dynamometer, using the dominant hand. 
 The best performance, recorded as strength in kilograms, was used for analysis. 
 Cutoff scores were stratified by gender and BMI quartiles according to Fried 
 et al.6 Participants unable to perform the test were also considered weak. 
Covariates
Demographic data were collected during the baseline assessment (age, gender, 
and educational level). Global cognitive functioning was assessed by the MMSE.22 
MMSE score (range 0-30) was used as a continuous variable, with higher scores 
indicating better cognitive functioning. Interrater reliability and test-retest reliability of 
the MMSE are good.23, 24 Health indicators included smoking status, use of alcohol 
and the number of somatic diseases present. Smoking status was divided into two 
categories: non-smoker and current smoker. The Alcohol Use Disorder Identification 
Test (AUDIT) is designed to detect hazardous and harmful alcohol consumption.25 AUDIT 
score was used as a continuous score. Somatic comorbidity was assessed using 
a self-report questionnaire about the presence of somatic diseases (lung disease, 
cardiovascular disease, diabetes, arthritis, rheumatism, cancer, ulcer, intestinal 
disorder, liver disease, epilepsy, allergy, thyroid gland disease and (head) injury), as 
originally developed by Statistics Netherlands (Centraal Bureau voor de Statistiek, 
www.cbs.nl). This questionnaire has high accuracy for chronic somatic disease as 
previously reported.26
Statistical analyses
Baseline demographics and clinical characteristics of the depressed participants 
were compared using independent samples t-tests for normally distributed, continuous 
variables, nonparametric Mann Whitney U tests for skewed continuous variables, 
and χ² tests for categorical variables. Logistic regression analyses were used to 
assess whether frailty score at baseline (predictor) was associated with depression 
during follow-up (dependent variable). Analyses were performed unadjusted, and 
subsequently adjusted for socio-demographics (age, gender, education) and health 
indicators (MMSE score, smoking status, alcohol use and number of somatic diseases). 
Multi-collinearity of variables included in the final model was tested with correlation 
matrices. All correlations between variables were <0.60, therefore none of the variables 
were excluded from the final model. Finally, fully adjusted linear mixed models were 
used to examine the association between frailty (predictor) and IDS total score during 
5 time points (dependent variable). The three IDS subscales were also analyzed.20 
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Frailty and all covariates were entered as fixed factors. Subjects were treated as 
random factors. The interaction term frailty by time was added to the final model 
to assess whether the course of depression differed according to the level of frailty. 
When estimated mean scores of depression severity and depressive subscales were 
calculated, frailty was used as a nominal variable with three categories (robust, 
prefrail and frail) for graphical purposes. In all other analyses frailty was used as 
a continuous variable. All p-values were tested two-tailed and p values ≤.05 were 
considered statistically significant. Data were analysed using Statistical Package of 
the Social Sciences (SPSS), version 20.0. 
Results
The mean age of the participants was 70.7 (Standard deviation (SD) =7.4) years 
and 66.1% was female. One participant had more than two missing items on the 
frailty count and was therefore considered missing. Baseline characteristics of the 
participants are shown in Table 1. Participants with frailty were older, less educated, 
had lower cognitive functioning, used less alcohol, and were more severely 
depressed than participants without frailty at baseline. After two years, 40.4% of the 
participants had a depressive disorder in the past six months, 25.3% had dysthymia 
in the past six months and 3.9% had a minor depression in the past month. Of the 
participants with depression at baseline, 21.1% had two types of depression (major 
depression and dysthymia) during follow-up.
Depression diagnosis after two years
Persons depressed and frail at baseline suffered from depression after two years more 
often than their non-frail counterparts in the unadjusted model. This association lost 
significance in the fully adjusted model (odds ratio (OR)=1.21 [95% CI: 0.99-1.49], 
p=.064, Table 2). Nonetheless, the OR was borderline significant in this final model. 
Removing somatic comorbidity from the model resulted in a significant association 
(OR=1.25 [95%CI: 1.02-1.53], p=.028). With regard to the five frailty components, 
only exhaustion and low physical activity level at baseline were significantly associated 
with depression diagnosis after two years. 
Chronicity of depressive symptoms
The presence of frailty at baseline predicted chronicity of depressive symptoms, 
also after adjusting for socio-demographics and health indicators simultaneously. An 
interaction effect with time was also found, implying that the course of depressive 
symptoms differed according to frailty status at baseline (Figure 1). Figure 1 presents the 
course of depressive symptoms graphically for robust (score 0), prefrail (score 1 or 2) 
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and frail (score ≥3) depressed older persons. It shows that robust persons have 
rather consistent depressive symptom levels over time, in contrast to prefrail and frail 
depressed persons who show persistent elevated levels of depressive symptoms despite 
higher symptom reduction over two years. 
When subscales of the IDS were analyzed (mood, motivation and somatic subscale), 
frailty was associated with higher severity on all three subscales (Table 3). Mood 
symptoms of depression reduced equally over the two years follow-up for all categories 
of frailty in depressed older persons (Figure 2). Frailty predicted more decline of 
motivational and somatic symptoms of depression (Figures 3 and 4). In all subscales, 
frail depressed older persons had increased depressive subscale symptom levels over 
two years follow-up.   
Table 1 Sample Characteristics (N=285)
 Frailty at baseline No frailty at baseline
Characteristics (N=76, 26.7%) (N=209, 73.3%) P Valuea
Age, mean (SD), y  73.5 (8.3)  69.6 (6.9)  <.001
Female gender, % 72.4  63.2  .148
Education, mean (SD), years  9.9 (3.0)  10.8 (3.6)  .046
MMSE score, mean (SD) 27.4 (2.1)  28.1 (1.6)  .014
Smoker, % 20  35.9  .268
Alcohol use, mean AUDIT score (SD) 1.8 (2.7)  2.9 (3.7)  .010
No of diseases, mean (SD) 1.8 (1.4)  1.4 (1.10)  .030
IDS score, mean (SD) 37.2 (12.5)  27.0 (11.8)  <.001
Frailty components:   
- Weight loss, % 57.9  26.3  <.001
- Weakness, % 65.8  6.3  <.001
- Slowness, % 57.3  12.6  <.001
- Exhaustion, % 90.7  41.5  <.001
Low physical activity level, % 74.7  24.1  <.001
Abbreviations: IDS, Inventory of Depressive Symptomatology; MMSE, Mini Mental State Examination; 
WHODAS, WHO-Disability Assessment Schedule
a Comparison using analyses of variance (continuous variables), χ² statistics (categorical variables) and U 
tests (continuous, skewed variables).
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Table 2 Logistic Regression Analysis of the Association Between Frailty and Depression 
Diagnosis After Two Years of Follow-up
N= 285 
Frailty: OR (95% CI) P Value
Unadjusted 1.23 (1.02, 1.49) .028
Adjusted1 1.21 (0.99, 1.49) .064
Frailty components1:
Weight loss 0.72 (0.43, 1.19) .200
Weakness 1.05 (0.58, 1.90) .886
Slowness 1.55 (0.82, 2.92) .175
Exhaustion 1.90 (1.15, 3.12) .012
Low physical activity level 1.81 (1.09, 3.02)  .021
¹ Adjusted for age, gender, level of education, Mini Mental State Examination score, smoking status, alcohol 
use and somatic diseases.
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Table 3 Linear M
ixed M
odel Analysis of the Longitudinal Association Betw
een Frailty and Depressive Sym
ptom
s, and Depressive Sym
ptom
s 
Subscales
N
=285 
D
epressive Sym
ptom
s 
M
ood Subscale 
M
otivation Subscale 
Som
atic Subscale
Frailty 
β (SE) 
P Value 
β (SE) 
P Value 
β (SE) 
P Value 
β (SE) 
P Value
U
nadjusted 
3.51 (0.48) 
<.001 
1.10 (0.19) 
<.001 
0.61 (0.11) 
<.001 
1.09 (0.16) 
<.001
M
odel 1 
3.24 (0.50) 
<.001 
1.09 (0.20) 
<.001 
0.61 (0.11) 
<.001 
0.93 (0.16) 
<.001
¹A
djusted for age, gender, level of education, M
ini M
ental State Exam
ination score, sm
oking status, alcohol use and som
atic diseases.
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Figure 1 Course of Depressive Symptoms (Estimated Means) Over Two Years for 
Robust (Score 0), Prefrail (Score 1 or 2) and Frail (Score≥3) Depressed Older Persons 
(N=285)1, 2
 
Abbreviation: IDS, Inventory of Depressive Symptomatology 
1 Based on linear mixed model analyses adjusted for age, gender, level of education, Mini Mental State 
Examination score, smoking status, alcohol use and somatic diseases.
2 Interaction effect frailty*time: p=.001.
Figure 2 Course of Depressed Mood Symptoms (Estimated Means) Over Two Years 
for Robust (Score 0), Prefrail (Score 1 or 2) and Frail (Score≥3) Depressed Older 
Persons (N=285)1, 2
Abbreviation: IDS, Inventory of Depressive Symptomatology
1 Based on linear mixed model analyses adjusted for age, gender, level of education, Mini Mental State 
Examination score, smoking status, alcohol use and somatic diseases.
2 Interaction effect frailty*time: p=.198.
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Figure 3 Course of Motivational Symptoms (Estimated Means) Over Two Years for 
Robust (Score 0), Prefrail (Score 1 or 2) and Frail (Score ≥3) Depressed Older 
Persons (N=285)(N=285)1, 2 
 
Abbreviation: IDS, Inventory of Depressive Symptomatology 
1 Based on linear mixed model analyses adjusted for age, gender, level of education, Mini Mental State 
Examination  score, smoking status, alcohol use and somatic diseases.
2 Interaction effect frailty*time: p<.001.
Figure 4 Course of Somatic Symptoms (Estimated Means) Over Two Years for Robust 
(Score 0), Prefrail (Score 1 or 2) and Frail (Score ≥3) Depressed Older Persons 
(N=285)1, 2 
 
Abbreviation: IDS, Inventory of Depressive Symptomatology 
1 Based on linear mixed model analyses adjusted for age, gender, level of education, Mini Mental State 
Examination  score, smoking status, alcohol use and somatic diseases.
2 Interaction effect frailty*time: p=.003.
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Discussion
Main findings
The present study, to our knowledge, is the first to examine the longitudinal association 
between physical frailty and depressive disorder in a sample of clinically depressed 
older persons. Our results confirm that late-life depression is a highly persisting disorder 
with half of the patients not achieving remission at two years follow-up. A higher 
level of physical frailty predicted non-remission of depression at two year follow-up, 
although the fully adjusted model did not reach statistical significance (p=.064). 
This may, however, be explained by overcorrection by somatic co-morbidity, which is 
associated with physical frailty as well. With respect to frailty components, both exhaus-
tion and low physical activity level predicted non-remission of depression at two years. 
Physical frailty was also associated with a higher level of depressive symptoms over 
time. In contrast to our hypothesis, a higher level of frailty predicted more decline 
in depression severity over time. This finding was driven by the motivational and 
somatic symptoms of depression, which may point to some overlap between both 
syndromes, as has been remarked before.11, 27 
Comparison with literature
Our results are in line with findings from a recent literature review on the relation 
between frailty and depression, that finds that in all prospective studies, frailty is a 
predictor of (persistence of) depressive symptoms.10 However, included studies mainly 
defined frailty as activities of daily living (ADL) indices or used a simplified proxy 
for frailty, such as gait speed. Results from that same review suggest a bidirectional 
relation between frailty and depression, which might imply a vicious frailty-depression 
circle. Even more recently, three longitudinal studies, not included in this review, 
showed that physical frailty was an independent predictor of depressive symptoms 
in community-dwelling older adults.4, 5, 12 However, one study included middle aged 
and older adults (aged ≥55 years)4, and the second had a relatively short follow-up 
period (15 months).12 Our study extends these findings to a clinically depressed 
population, emphasizing the importance of physical frailty for geriatric psychiatry. 
Physical frailty was associated with higher depressive symptom severity over the 
two years follow-up. Interestingly, motivational and somatic symptoms of depression 
decline faster with increasing frailty, an effect not found with respect to the mood 
symptoms of depression. These findings may point to an aggravation of frailty-related 
motivational and somatic depressive symptoms at baseline as measured by the IDS. 
However, despite the faster decline of motivational and somatic symptoms over time, 
depressed patients with physical frailty still suffered from a higher depressive symptom 
severity at two year follow-up. 
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In clinical practice, remaining symptoms will often be regarded as residual depressive 
symptoms that need further (intensifying of) psychiatric treatment. However, our results 
suggest that these symptoms might also be accounted to frailty. If true, these symptoms 
simply warn for more aggressive depression treatment, as physical frailty is a high-risk 
state for adverse effects. These results imply that assessment of physical frailty at the 
start of and during the treatment of the depression may guide treatment choices. 
Persons suffering from this type of frail-depression may be eligible for specialized 
care, targeting both frailty and depression. 
Interventions on reducing frailty could be promising, because previous research 
shows that frailty is a reversible condition28 that can be treated with assistance in 
daily living, vitamin D suppletion, and improving exercise frequency.29-33 Furthermore, 
polypharmacy is recognized as a major contributor to the pathogenesis of frailty, and 
evaluation of inappropriate medication use seems beneficial for frailty status, as well 
as health care costs.7 Growing evidence suggests the effectiveness of these interventions 
not only for frailty, but also for the treatment of depression.34, 35 Since late-life depression 
and frailty frequently co-occur, these interventions may be particularly beneficial for 
the frail-depressed subgroup. 
Diagnosis of depression is often complicated by the presence of somatic comorbidity, 
pain and frailty.11, 35, 36 Underlying mechanisms of the association between frailty 
and depression may include inflammatory processes, sarcopenia, and lifestyle factors 
such as smoking and lack of exercise, because these have all been associated with 
both frailty and depression.35, 37-40 Since the analyses in this study were corrected 
for smoking and somatic comorbidity, a possible explanation for the chronic course 
of depression in the case of co-existing frailty could lie in the hampering effect of 
frailty-induced inflammation and sarcopenia on the recovery from late-life depression. 
Previous studies have shown the negative effect of inflammation and sarcopenia on 
the course of depression.35, 39 
Strengths
This study has some important strengths. We prospectively examined whether frailty 
predicts a chronic course of depression. Furthermore, we included a sample of older 
persons with a DSM-IV confirmed depression diagnosis, contrary to previous 
studies that used questionnaires as an indicator of depression status.4, 5, 11, 12 In addition 
to the formal depression diagnosis, this study used a well-validated measure of severity 
of depressive symptoms (IDS) that included symptom profiles of depression, in order 
to perform in-depth analysis of the associations that were found between frailty and 
depression diagnosis after two years. 
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Limitations
A limitation of this study is the naturalistic aspect of the cohort, in which no differentiation 
was made between the types of treatment that depressed older persons received. 
It is not certain whether persons had the same treatment and if the treatment persons 
received was the most appropriate treatment. Futhermore, the lower frailty scores of 
participants in the analytical sample as compared to those who dropped out, suggest 
that the most frail participants were not followed up. This may bias our results towards 
an underestimation of the association between frailty and depression at two years 
of follow-up, and provides an explanation for the fact that we found only a trend 
towards significance regarding this association in the fully adjusted analysis. The 
most important limitation, however, may be that we still cannot disentangle symptoms 
of frailty and symptoms depression definitively as both constructs have been measured 
at the same time. 
 
Clinical implications
In closing, our results clearly show that depression with comorbid frailty is less likely to 
resolve. Taking previous studies into account, it seems that frailty and depression are 
intertwined and that frailty contributes to a chronic, more severely depressed subtype. 
Frailty and depression might thus stimulate each other’s occurrence, but once both are 
present, multiple interactive processes may arise, worsening the depression as well 
as the frailty status more and more.10, 11, 41 
This indicates that frailty may be an important element in the treatment of depression 
in older persons and that multi-facetted interventions are needed for this particularly 
vulnerable subgroup of depressed older persons.
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The main aim of this thesis was to study the concept of frailty in relation to late-life 
depression, the association between depression and somatic diseases, and the 
explanatory role of frailty in this association. Inflammation is examined as a potential 
mechanism, underlying these complex associations.
The thesis consists of three parts. In part I we focused on the concept and epidemiology 
of frailty by conducting systematic reviews and calculating pooled prevalence rates. 
In part II we described the cross-sectional association between frailty and depression in 
a sample of clinically depressed persons from the Netherlands Study of Depression in 
Older persons (NESDO).1 We also tested whether the association between depression 
and somatic diseases was mediated by frailty and evaluated the association between 
physical frailty and inflammation. In part III we focused on longitudinal associations 
between frailty and depression in a community-dwelling sample of older persons 
(Invecchiare nel CHIANTI; aging in the Chianti area: InCHIANTI)2 and in NESDO. 
In this chapter findings from the preceding chapters will be summarized and discussed 
within the context of current scientific knowledge. Next, some notes will be given on 
methodological issues, clinical implications and recommendations for future research. 
Finally, we will discuss the case report from the Introduction (Chapter 1) in the light 
of the findings from this thesis. 
Summary of the findings
The concept of frailty
The ongoing scientific discussion about the definition of frailty limits the use of the 
concept in clinical practice. This discussion is mainly dominated by two groups 
of researchers. One group defines frailty as a purely physical condition, whereas 
the other group proposes a broader definition of frailty also including psychosocial 
components. Despite this lack of consensus about the definition, there is no reason 
why frailty is of less importance for older patients with mental disorders compared 
to older persons with somatic diseases. Frailty may thus enable the early detection 
of a particularly vulnerable group of older psychiatric patients, at risk of (somatic) 
complications. An issue for implementation of frailty in old age psychiatry however, 
is the overlap between psychiatric disorders and frailty, especially the broad frailty 
definitions. 
In Chapter 2 we contributed to this discussion by giving an overview of existing frailty 
definitions. In addition, we described the relation between frailty and psychiatric 
disorders. In total, 35 operationalizations of frailty were found by means of a systematic 
literature review. These consisted of single measurements as a proxy for frailty (n=4), 
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syndrome diagnoses (n=18), subdivided in single (n=5) and multiple syndrome 
diagnoses (n=13), and dimensional operationalizations for which measurement 
instruments were used (n=13).
Only six studies reported on the relation between frailty and psychiatric disorders. 
These studies revealed an association between frailty and psychopathology, in parti-
cular depression. Whether depression and frailty share the same pathophysiological 
mechanisms or whether depression leads to frailty or vice versa remained unknown, 
although many authors implicitly assumed a reciprocal relationship. 
We conclude that there is agreement that frailty should be considered as a condition of 
vulnerability for adverse health outcomes, but controversy remains about how frailty 
should be exactly defined and operationalized. An important characteristic of broad 
frailty definitions is its applicability to clinical practice, where most older persons 
do not present themselves with problems in only one (physical) domain. For general 
practitioners for instance, it may be very helpful to evaluate vulnerability of older 
persons by a broad definition. This broader approach forces clinicians to consider 
not only physical risk factors, but also factors like social support, cognitive functioning 
and psychopathology as contributing factors to the general condition of an older 
person. However, it is important to realize that by including many domains, two frail 
persons may experience very different problems. Moreover, in old age psychiatry it 
is of little value for a clinician when all patients meet the criteria of frailty, based on 
their psychiatric disorder. 
The lack of articles about the relationship between frailty and psychiatric disorders, 
and especially depression, shows that frailty has not received a lot of attention within 
the field of old age psychiatry. A necessary step would be to clearly define and 
substantiate the choice for the frailty definition that is used. A recent breakthrough in 
the discussion about the definition of frailty is a consensus paper by an international 
group of frailty experts. Here it was concluded that physical frailty is an important 
medical syndrome with multiple causes and contributors.3 It was also agreed that 
a number of validated and well-defined models of frailty exist and that the basic 
criteria of these models should be used to diagnose frailty. For frailty research within 
a psychiatric setting, a physical frailty definition seems most useful, because broad 
frailty definitions include psychiatric symptoms or diseases as a component of frailty. 
Based on these findings, we chose to operationalize frailty according to a purely 
physical definition when studying associations between frailty and depression in the 
following chapters.
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Prevalence of frailty in the community and in a depressed sample of older persons
Chapter 3 and 4 report on the prevalence of frailty. Although it is generally assumed 
that the prevalence of frailty increases with age, is higher among women compared to 
men and more prevalent in the presence of chronic disease,4-6 no consensus exists 
about the prevalence rates of frailty. In Chapter 3 we systematically compared these 
prevalence rates with regard to definition, gender and age groups in community-dwelling 
older persons aged 65 and over. Subsequently, these prevalence rates were pooled 
and weighted in order to calculate overall frailty prevalence. The overall weighted 
prevalence of frailty based on 21 studies, including 61,500 subjects, was 10.7%.
In studies that used a physical frailty definition, frailty prevalence in persons aged 
≥65 years ranged from 4.0% to 17.0%, with a pooled prevalence of 9.9%.7, 8 In 
studies that used broad definitions or measurement instruments, the prevalence rates 
varied from 4.2% to 59.1%, with a pooled prevalence rate of 13.6%.9, 10 Furthermore, 
we confirmed that frailty prevalence increased with age and was higher in women 
than in men. These results imply that frailty is common in later life, however differential 
operationalization of frailty status results in widely different prevalence rates between 
studies. The smaller range of frailty prevalence rates among studies that used a physical 
frailty definition, suggests more consensus between researchers studying physical 
frailty, and probably a less heterogeneous concept.
Future studies should focus on clarifying which frailty characteristics predict particular 
negative health outcomes most accurately. Therefore, frailty should not only be measured 
as a summary score or categorical measure that is either present or absent, but its 
separate components and potentially multidimensional aspects should also be taken 
into account.
After determining the prevalence of frailty in community-dwelling older persons, we 
zoomed in on a group of depressed older persons in Chapter 4. In a cohort of older 
persons with depression according to DSM-IV criteria11 (NESDO) we assessed the 
prevalence of physical frailty. We found that the prevalence was significantly higher in 
the depressed group compared to the non-depressed comparison group (27.2% versus 
9.1%) with an odds ratio (OR) of 2.7 (95% confidence interval [CI] 1.6-5.2) when 
adjusted for age, sex, level of education, somatic comorbidity and cognitive functioning. 
Frail-depressed older persons were more severely depressed than non-frail-depressed 
older persons. 
Subsequently, we explored whether the hypothesized association between depression 
and frailty could be explained by shared characteristics, such as exhaustion and 
weight loss. We repeated the analyses with two uni-dimensional proxies of frailty 
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(weakness and slowness), and this yielded similar results compared to the formal 
physical frailty definition we used. 
Finally, we performed the analyses with the sum score of an adapted version of the 
Inventory of Depressive Symptoms (IDS; without overlapping frailty items), and two 
subscales of the IDS (mood/ cognition subscale and anxiety/ arousal subscale).12 
These analyses showed that frailty was significantly associated with all measures of 
depressive symptoms in depressed patients, and it is therefore unlikely that the higher 
severity of depressive symptoms in frail-depressed older persons can be explained by 
overlapping criteria between frailty and depression. 
Depressed patients therefore, should not be excluded a priori in (community) studies 
of frailty, as has been done in the hallmark study of Fried et al.4 In 2001, Fried 
and colleagues4 validated physical frailty in the Cardiovascular Health Study as a 
constellation of elements of which the presence of a critical subset of these components 
indicates the presence of frailty. The elements were chosen for their predictive value 
towards adverse health outcomes. Adding together these elements would increase 
the predictive value even more than just the sum of these elements. Negative health 
outcomes were defined as major geriatric outcomes and operationalized as: falls, 
disability, hospitalizations and death. Remarkable in the light of findings presented 
in this thesis, is that participants that used antidepressants were excluded from the 
study, as the authors were concerned that a depressed participant could potentially 
present with frailty as a consequence of a single disease (in this case depression). We 
showed that within a sample of depressed older persons three quarters are not frail. 
So, although frailty prevalence is undoubtedly higher in depressed older persons 
than in community-dwelling older persons, the presence of depression does not make 
a person meet the criteria of physical frailty. In this light, the importance of studying 
associations between frailty and depression is emphasized. Previous research 
already showed that frailty prevalence is higher in patients suffering from chronic 
somatic disease than in community-dwelling older persons,13, 14 and now we showed 
that this applies to depressed patients as well. 
Furthermore, recent empirical data confirm that frailty and late-life depression are 
overlapping,15 but distinct syndromes rather than a single construct.16 Based on these 
findings from literature and the findings from this thesis, it is recommended that when 
studying frailty or depression in association with adverse health outcomes, both constructs 
should be treated as determinants of one another in the analyses.
Late-life depression, somatic comorbidity, inflammation and frailty
Depression and frailty are well-established risk factors for somatic diseases,4, 17 but 
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they have hardly been examined in concert. Both frailty and depression may share 
underlying mechanisms or pathways towards somatic diseases, including inflam- 
mation.17, 18 In order to prevent somatic morbidity, knowledge of the interplay between 
depression and physical frailty is crucial. We therefore conducted the study that is 
described in Chapter 5. Based on existing literature19, 20 we hypothesized that somatic 
diseases are more prevalent among depressed patients than among healthy controls. 
Second, we examined whether physical frailty is an explanatory factor of the 
association between depression and somatic diseases. Finally, we explored the 
moderating effect of frailty in the association between depression and somatic 
diseases. This study was conducted within a cohort of older persons with depression 
according to DSM-IV criteria11 (NESDO).
The study showed that depressed patients suffered from more somatic diseases than 
the non-depressed comparison group. We also zoomed in on types of diseases 
(lung disease, stroke and gastro-intestinal disease; retrieved from univariate analyses 
of nine separate diseases), and showed that depression was only associated with 
stroke, in the fully adjusted model. Furthermore, depression and frailty remained 
associated with the number of somatic diseases, independent of each other and frailty 
partly explained the association that was found between depression and somatic 
diseases. This implies that depression and frailty not only have shared relations with 
somatic diseases but also unique relations. No high-risk group could be identified, 
as frailty did not moderate the relation between depression and somatic diseases. 
In geriatric medicine there is a growing consensus that frailty and multimorbidity are 
distinct clinical entities that are causally interrelated.21 The relations between depression 
and somatic diseases are complex, and analogue to the impact of frailty on the 
course of somatic diseases,22, 23 the presence of frailty probably also complicates the 
course and treatment of late-life depression.
 After examining the role of frailty in the association between depression and somatic 
diseases, we wanted to learn more about the possible mechanisms underlying frailty 
and depression. Both depression and frailty are associated with low-grade inflam- 
mation.17, 18, 24, 25 Hence, in Chapter 6 we examined whether low-grade inflammation 
in late-life depression is conditional on the level of frailty. We first assessed the asso-
ciations between inflammatory markers and physical frailty in a sample of depressed 
older persons (NESDO). Next, we examined which frailty components contribute 
to the association between frailty and inflammation. We found that physical frailty 
was not associated with increased levels of inflammatory markers in depressed older 
persons. When studying the individual components of frailty, we found that weakness 
(handgrip strength) and slowness (walking speed) were associated with markers of 
low-grade inflammation. 
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Principal component analysis showed that the frailty components that do not overlap 
with the criteria of depression represent one dimension of the construct of frailty 
(performance-based dimension: consisting of weakness, slowness and low activity 
level). Only this dimension is associated with low-grade inflammation. The other 
dimension consisted of the frailty items weight loss and exhaustion and was labelled 
the vitality-based dimension. These findings imply that physical frailty is not a uni- 
dimensional construct within a depressed population.
Our findings suggest differential patterns between specific inflammatory markers and 
specific frailty components. However, all inflammatory markers were associated with 
the performance-based physical frailty dimension. Low-grade inflammation may thus 
be a general underlying mechanism of the shared variance by the three individual 
frailty components compiling performance-based physical frailty. 
Does frailty predict the incidence and course of depression?
To better understand the findings from the cross-sectional data we need a cause and 
consequence approach. Hitherto, the impact of physical frailty on depression has 
been examined only twice using a prospective study design. Both studies identified 
physical frailty as an independent predictor of incident depressive symptoms according 
to a depression scale.26, 27 Although a cutoff of a depression severity scale cannot 
be extrapolated to a depressive disorder,28 it is still of interest as clinically relevant 
depressive symptoms have high impact on well-being, disability and utilization of health 
care services.29 Generalization to a Western society, however, may be limited because 
both studies were conducted in an Asian population. Moreover, one of these studies 
had a follow-up duration of only 15 months.27 Therefore, we conducted two longitudinal 
studies, one within a sample of community-dwelling older persons and focusing on 
clinically relevant depressive symptoms (InCHIANTI; Chapter 7), and one within a sample 
of older persons with depression according to DSM-IV criteria11 (NESDO; Chapter 8). 
In the first study, we assessed whether physical frailty predicts a higher incidence 
of depressed mood in non-depressed community-dwelling older persons. We also 
assessed whether physical frailty decreases the chance on remission of depressed 
mood in persons with depressed mood at baseline. We found that physical frailty 
predicts onset and non-remission of depressed mood. When frailty was decomposed 
into components, only low physical activity level increased the risk of incident depressed 
mood and non-remission of depressed mood. 
These findings are in line with findings from the two longitudinal studies described 
earlier.26, 27 Both studies also found a longitudinal association between frailty and 
depressive symptoms. Separate frailty components were also analyzed in the study 
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by Feng et al.26 and it was concluded that exhaustion, weakness, slowness and low 
physical activity level were predictive of onset and persistence of depressive symptoms. 
Our study confirms these findings in a Western society, but also extends these 
findings by determining the contribution of frailty to remission of depressed mood. 
In addition, the risk of depression in the case of frailty is also confirmed for a relatively 
long follow-up period (nine years).
Our study differed from the study by Feng and colleagues26 in the level of cor-
rection for possible confounders of the association between frailty and depressi-
ve symptoms, since we did not correct for activities of daily living (ADL) and 
instrumental activities of daily living (IADL) dependency in our analyses. Our multi- 
collinearity tests showed high correlations between frailty, ADL and IADL dependency 
(all >0.6) and therefore we decided not to include these potential confounders in 
our model. However, to confirm that our results are independent of functional status 
we repeated the analyses with correction for ADL, IADL and WHO level of disability 
status for this chapter. The analyses showed that frailty remained an independent 
predictor of depressed mood and lack of frailty predicted remission of depressed 
mood, even after correction for various measures of functional status (all P values 
<.026). 
A recent literature review on the relation between frailty and depression also showed 
that frailty, its components and functional impairments are risk factors for depression.30 
However, none of the studies in this review used a formal definition of frailty. Instead, 
ADL indices were used as a measure of frailty. 
In Chapter 7, physical frailty consistently predicted depressed mood. Results with 
respect to individual frailty components also seem quite consistent. This may be an 
indicator of unequivocal validity of physical frailty as a uni-dimensional concept in 
the general population with respect to its association with late-life depressed mood. 
Whether physical frailty predicts the course of not only depressive symptoms, but 
also of depressive disorder, was examined in Chapter 8. Additionally, we focused 
on depressive symptoms subscales representing symptom clusters. Recent research 
by Hegeman and colleagues with the NESDO data revealed three IDS subscales; 
a mood subscale, a somatic subscale, and a motivational subscale.31 We showed 
that physical frailty was associated with depression diagnosis after two years (statistically 
significant in the unadjusted model and a trend towards significance in the fully adjusted 
model). With respect to frailty components, both exhaustion and low physical activity 
level were associated with a depression diagnosis two years later. Furthermore, we 
confirmed that a higher level of physical frailty was associated with a higher severity of 
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depressive symptoms (IDS) over time. Despite a higher decline in depression symptom 
severity over time, depression with comorbid frailty is less likely to resolve. 
The analyses of the depressive symptoms subscales showed that motivational and 
somatic symptoms of depression improve faster with increasing frailty, an effect 
not found with respect to the mood symptoms of depression. However, despite this 
improvement, the motivational and somatic symptoms of depression remained inflated 
over the two years, as frailty scores increased. This finding has clinical relevance, 
since these remaining symptoms will often be regarded as residual depressive symptoms 
that need further psychiatric treatment. However, these symptoms might also be 
accounted to frailty and in that case, frail older persons might be classified as still 
being depressed while their depression has already improved. This may place them 
at risk for psychiatric overtreatment (and associated side-effects). 
These findings support conclusions that were drawn from earlier studies about overlap 
between physical frailty and depression,16, 33 since the somatic and motivational 
subscales show overlap with frailty components. This is also in line with findings from 
a recent study that finds that the severity of depression may be overestimated in the 
presence of somatic comorbidity, but only with respect to somatic and motivational 
symptoms.34
Overall conclusions
All in all, the physical frailty phenotype4 appears to be a relevant operationalization 
of frailty for research in old age psychiatry. In community-dwelling older persons, one 
out of every ten persons is frail and frailty predicts the incidence of depressed mood, 
as well as chronicity of depressed mood. In older persons that suffer from depression 
according to DSM-IV criteria,11 over a quarter is also physically frail. Furthermore, 
in these clinically depressed older persons frailty partly explains the associations 
between depression and somatic diseases, and inflammatory makers are associated 
with the performance-based components of frailty. Finally, physical frailty predicts an 
adverse course of depression over two years.
These results are indicative of intertwined relations between frailty and late-life 
depression, and may suggest the existence of a specific subtype of late-life depression, 
which might be labeled as a frail-depression. Although this depressive subtype is 
associated with non-remission, the implications of this thesis are positive as well. 
As both depression and frailty are essentially treatable conditions, the comorbidity 
between both conditions argues for the development of multimodal treatment strategies 
focusing on both mental and physical health. Future studies in this particular group 
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of depressed older persons should teach us whether the prognosis of frail-depression 
can indeed be improved. 
Methodological considerations
Strengths and limitations of the individual studies have already been discussed in the 
previous chapters. Below, some overarching considerations will be discussed. 
Study type
The middle part of this thesis was based on cross-sectional findings; the baseline 
NESDO data. No causal relations can be drawn from these studies, as it cannot be 
determined which of the factors occurred first. In addition, the comparison group of 
NESDO was recruited among non-depressed general practitioner visitors, who can 
be assumed to have more illnesses and medical complaints than community-dwelling 
elderly. Therefore, the differences we found between the depressed group and the 
comparison group are probably conservative and may represent an underestimation 
of the actual associations addressed in Chapter 4 and 5. 
In Chapter 7 and 8 we used longitudinal data of respectively the InCHIANTI study 
and NESDO, in order to draw cause and consequence conclusions. InCHIANTI 
consists of a large community-dwelling sample with a long follow-up period (nine years) 
with selective dropout during follow-up; persons that dropped out were more often frail 
than persons who stayed in the study, biasing the results towards an underestimation of 
the associations that were found between frailty and depressed mood. 
A limitation of the longitudinal NESDO data is the naturalistic aspect of the study, 
with no detailed information about the type of treatment and whether the treatment 
that depressed persons underwent was the most appropriate treatment available. 
 
Frailty definition
As shown in Chapter 2, many definitions of frailty are available. We concluded that for 
research in a psychiatric population, a physical definition of frailty is most applicable. 
Although this definition showed some overlap with depression symptoms, the broad 
definitions show even more overlap with depression, by including depressed mood 
as a component of the frailty definition. 
In all chapters we addressed the potential overlap between frailty and depression 
and attempted to control for this overlap by repeating the analyses with an adapted 
IDS sum score (overlapping items were removed) and using proxies of frailty. 
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Frailty was used as a dichotomous variable (present yes/no) in Chapter 4. In Chapter 
5 we also assessed frailty as a continuous variable and examined separate compo-
nents of frailty. We kept this approach throughout the subsequent chapters, as it 
turned out that dimensional frailty was more informative that a dichotomized frailty 
measure. 
Depressive symptoms versus depressive disorder
Depressive symptoms are generally considered on a continuum with depressive 
disorder, and they also have a high impact on quality of life.29 When possible we 
examined both depressive disorder according to DSM-IV criteria11 and depressive 
symptoms in addition to each other. Only the InCHIANTI data did not provide the 
opportunity for that, since no information about depression diagnosis was available 
(Chapter 7). In 2013 DSM-5 came out as a successor of DSM-IV. With regard to 
diagnosing depression no significant alterations have been made, implying that the 
findings from this thesis hold true in the light of the DSM-5. 
Confounding
Both NESDO and InCHIANTI provide the opportunity for adequate control of potential 
confounders. However, it cannot be ruled out that the associations that were studied 
were confounded by some unknown variables. 
 
Implications for clinical practice and recommendations for future studies 
An important step is to translate the findings from this thesis to clinical practice. Frailty 
is relatively unknown and unrecognized in daily clinical practice of old age psychiatry. 
However, this thesis will hopefully add to the growing sense of importance of frailty, 
in order to provide the complex care that frail-depressed older persons need.
Frailty can be a useful construct to detect a particularly vulnerable group within 
depressed older persons that are at risk of a more chronic course of late-life depression. 
We showed that physical frailty predicts the onset of depressed mood, as well as lower 
remission rates of depressed mood. In a clinically depressed sample we confirmed 
the adverse course of depression in the presence of frailty. 
Since frailty is a potentially reversible condition that can be targeted with specific 
interventions such as exercise, vitamin D supplementation and reduction of polyphar-
macy3, it can guide treatment. Therefore screening for frailty deserves a prominent 
place in the treatment of late-life depression. Besides screening for frailty, monitoring 
is also an important element. Nurses and clinicians should keep themselves informed 
about the frailty status of a person in order to help determine whether a symptom 
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should be accounted to depression, to frailty of perhaps another phenomenon that 
is highly prevalent in old age, such as somatic diseases. This makes the treatment of 
late-life depression complicated, and we therefore advocate disentangling depressive 
symptoms in future studies. 
In Chapter 8 we unraveled depressive symptoms into three subscales and concluded 
that depressed mood improves similarly in both frail and non-frail depressed persons. 
Motivational and somatic complaints show more improvement with increasing frailty 
status, although the overall level of these complaints remained higher over time. 
This is a finding with high clinical relevance, as it changes the perspective on the 
course of late-life depression. It should be assessed whether these remaining symptoms 
are part of the depressive disorder, or whether they are part of frailty. In the first case, 
psychiatric treatment may be intensified. When these symptoms are accounted to 
frailty, a psychiatric treatment setting is no longer indicated and interventions targeting 
frailty are more appropriate. 
From a clinical point of view, we could argue that physical frailty and depression are 
intertwined and that frailty contributes to a chronic, more severely depressed subtype. 
This asks for a treatment of late-life depression in which screening and monitoring 
of frailty are embedded. Interventions that reduce frailty may also be beneficial for 
depressive complaints, but this should be examined in future intervention studies. 
Not only intervention studies are needed, also more longitudinal research that speci-
fically studies the (reciprocal) associations between frailty and depressive disorder 
over a longer period are needed. In addition, future studies should pay attention to 
the relationship between adverse health outcomes and the individual components of 
frailty in order to determine the validity of the concept of frailty with regard to various 
health outcomes.
Back to the case-report
How can we use the findings from this thesis in the case of ms E that was described in 
Chapter 1? An important element in treatment of late-life depression is the disentangling 
of (depressive) symptoms. Late-life depression is a heterogeneous disorder and 
therefore, for each symptom it should be assessed whether it can be accounted to the 
depressive disorder, or to frailty. With this in mind, we will discuss the case of ms E.
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“I am 70 years old, but I look and feel like I am 85 years”, said ms E with a gloomy 
voice. Glancing at ms E while she shared this with me, I could only agree with 
her. I wondered, where does this discrepancy between her presentation and her 
real age come from? Why does her neighbor that has the same age still babysits 
her grandchildren and has an independent life, while ms E is obviously struggling 
with active aging? Should we consider ms E both frail and depressed?
When examined in more depth, ms E may meet the criteria for, major depressive 
disorder (or at least minor depression) and physical frailty. Frailty may be an explanation 
for the prolonged admission of ms E, as compared to previous admissions to the 
psychiatric ward for depression treatment. Furthermore, the chronic character of her 
depressive complaints may be partly accounted to the presence of frailty. It is striking 
that ms E’s mood improved, but wearily and exhaustion symptoms remained present. 
It should be carefully considered whether these remaining symptoms are abiding 
depressive symptoms that need continuation, or even intensifying of psychiatric treatment, 
or whether ms E may have been frail before she was admitted to the psychiatric ward 
with depression and these symptoms should be accounted to frailty. The latter is the 
most likely explanation, since the information that was provided by ms E’s daughter 
also points to the presence of frailty characteristics before she became depressed. 
If this is indeed the case, interventions that target frailty are in place, besides the 
continuation of the antidepressant treatment. 
All in all, the case of ms E demonstrates the complexity of treating late-life depression 
in the presence of frailty. In old age psychiatry, persons often present with comorbid 
somatic diseases and frailty that in a bad case scenario may culminate in a vicious 
cycle that ultimately leads towards adverse health outcomes and loss of independence. 
However, the good news is that when nurses and clinicians take the approach of 
unravelling symptoms, this may guide them in their choice for appropriate interventions 
that are beneficial for this vulnerable group of older persons. 
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Introductie
Depressie op latere leeftijd is een ernstige psychiatrische ziekte met grote gevolgen 
voor de persoon zelf en de omgeving.1 Dit is voor een groot deel te wijten aan het 
vaak chronische beloop van depressie en de hoge mate van terugval.2-5 Lichamelijke 
ziektes en cognitieve beperkingen komen bij depressieve ouderen vaker voor dan bij 
niet-depressieve ouderen.6-9 Dit suggereert een invloed van verouderingsmechanismen 
op het ontstaan of beloop van de ouderdomsdepressie. Normale veroudering wordt 
gekenmerkt door lichamelijke en functionele achteruitgang met de leeftijd, zoals 
botontkalking, vermindering van gezichtsvermogen, gehoor en spiermassa. Bij sommige 
mensen echter, zijn deze veranderingen nadrukkelijker aanwezig en leidt dit tot een 
verminderd welzijn en vatbaarheid voor ziektes en beperkingen.10 Frailty is een toestand 
waarbij een persoon extra kwetsbaar is voor het optreden van complicaties door een 
afname van de reservecapaciteit van het lichaam.10 Hierdoor kan zelfs een relatief 
kleine stressor ernstige gevolgen voor de gezondheid hebben. 
Het doen van onderzoek bij ouderen is complex door de verwevenheid verschillende 
begrippen zoals depressie, lichamelijke ziektes, invaliditeit en frailty. Soms worden 
deze begrippen zelfs uitwisselbaar gebruikt. In dit proefschrift worden twee van deze 
begrippen nader bekeken in relatie tot elkaar, namelijk frailty en depressie. 
Dit proefschrift bestaat uit drie delen, waarbij in het eerste deel ingegaan wordt op 
frailty als concept en op de prevalentie van frailty. In deel twee wordt gekeken naar 
het verband tussen frailty en depressie op latere leeftijd. Tenslotte wordt in deel drie 
de invloed van frailty op het beloop van depressie op latere leeftijd onderzocht. 
In hoofdstuk 1 staan de achtergronden en doelen van dit proefschrift beschreven. 
Ook wordt in dit hoofdstuk een gevalsbeschrijving gepresenteerd om de klinische 
relevantie van het onderwerp te illustreren.
We formuleerden de volgende onderzoeksvragen (de nummers van de vragen corres-
ponderen met hoofdstuknummers in dit proefschrift):
Deel I:
2. Welke operationalisaties van het concept frailty bestaan er en hoe verhoudt frailty 
 zich tot psychopathologie?
3. Wat is de prevalentie van frailty bij ouderen in de algemene bevolking?
Deel II:
4. Wat is de prevalentie van frailty bij depressieve ouderen? Kan een eventueel 
 verhoogde prevalentie onder depressieve ouderen verklaard worden door symp- 
 toomoverlap tussen frailty en depressie?
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5. Hoe verhouden depressie op latere leeftijd en frailty zich tot lichamelijke comor- 
 biditeit?
6. Bestaat er een verband tussen inflammatie (ontstekingsactiviteit in het bloed) en 
 frailty bij depressieve ouderen? 
Deel III:
7. Voorspelt frailty zowel het ontstaan als voortbestaan van depressieve klachten bij 
 ouderen in de algemene bevolking?
8. Voorspelt frailty het niet in remissie zijn van depressie na twee jaar? Heeft frailty bij 
 depressieve ouderen invloed op het beloop van (specifieke) depressieve symptomen 
 over de tijd?
Deel I: Frailty
Leeftijd is een belangrijke voorspeller voor het optreden van allerlei negatieve gezond-
heidsaspecten. Echter, met het stijgen van de levensverwachting in de laatste helft van 
de twintigste eeuw, kwam naar voren dat ook onder ouderen het risico op negatieve 
gezondheidsuitkomsten sterk verschilde. Dit heeft geleidt tot de introductie van het 
begrip frailty om de meest kwetsbare ouderen met het grootste risico op slechte 
gezondheidsuitkomsten en verlies van zelfstandigheid te identificeren. Het gebruik 
van frailty in de klinische praktijk en in onderzoek wordt beperkt door een tot op 
heden voortdurende discussie omtrent de conceptualisatie en operationalisatie van 
het begrip frailty. Deze discussie wordt gedomineerd door twee onderzoeksgroepen. 
Hierbij definieert de ene groep frailty op basis van enkel lichamelijke kenmerken 
(fysieke frailty), terwijl de andere groep een brede definitie van frailty aanhangt 
waarbij ook psychosociale componenten opgenomen worden in de definitie. 
Ondanks dit gebrek aan overeenstemming over de definitie van frailty, is frailty een 
belangrijk concept gebleken in de zorg voor patiënten met een lichamelijke ziekten, 
waarbij een groep extra kwetsbare patiënten kan worden geselecteerd voor specifieke 
interventies om het risico op complicaties door de onderliggende kwetsbaarheid 
te verlagen. Het is onduidelijk of frailty ook op deze manier kan fungeren in de 
psychiatrie. 
In hoofdstuk 2 wordt een bijdrage geleverd aan de hierboven beschreven discussie 
door een overzicht te geven van de bestaande frailty definities en de bijbehorende 
operationalisaties. Verder wordt de relatie tussen frailty en psychiatrische ziektes 
beschreven. Dit wordt gedaan middels een systematisch literatuuronderzoek. In totaal 
worden 35 operationalisaties van frailty gevonden. Hiervan gebruikten vier studies een 
enkele meting als schatting van frailty, achttien studies gebruikten een syndroom diagnose 
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van frailty en dertien studies gebruikten een score op een meetinstrument voor frailty. 
Op basis van de gevonden studies kan worden geconcludeerd dat er impliciete 
overeenstemming is over wat frailty is; namelijk een toestand van verhoogde kwets-
baarheid voor het optreden van negatieve gezondheidsuitkomsten. Hoe frailty wordt 
geoperationaliseerd loopt sterk uiteen. Een belangrijk kenmerk van de brede definities 
van frailty is de compatibiliteit met de klinische praktijk, waarin de meeste ouderen 
problemen ervaren in verschillende domeinen, en niet alleen lichamelijke problemen 
hebben. Een nadeel hiervan is echter dat door het includeren van zoveel domeinen in 
de frailty definitie, twee personen die beide frail zijn, totaal verschillende problemen 
kunnen ervaren.  
Slechts zes studies werden gevonden die de relatie tussen frailty en psychiatrische 
ziektes beschreven. In deze studies werd een verband gevonden tussen frailty en 
psychopathologie, in het bijzonder depressie. Of depressie en frailty dezelfde 
onderliggende pathofysiologische mechanismen delen, en of depressie leidt tot frailty 
of andersom, blijft onbeschreven. Het gebrek aan artikelen over frailty en psychopa-
thologie illustreert dat frailty nauwelijks aandacht krijgt in de psychiatrie. Voor dit type 
onderzoek is een fysieke frailty definitie het best toepasbaar, omdat de brede frailty 
definities psychiatrische ziektes of symptomen hiervan opnemen als onderdeel van de 
definitie. 
In hoofdstuk 3 wordt het voorkomen van frailty in de bevolking onderzocht met behulp 
van een systematische literatuurstudie. Hierbij werd rekening gehouden met het type 
definitie van frailty, alsmede met de leeftijd en het geslacht van de deelnemers. 
De gewogen prevalentie van frailty was 10.7%, gebaseerd op 21 studies met 
61,500 deelnemers in totaal. Wanneer gekeken werd naar de studies die een fysieke 
definitie van frailty gebruikten was deze prevalentie iets lager, namelijk 9.9%. Bij de 
bredere definities kwam de prevalentie hoger uit, namelijk 13.6%. Opvallend was 
het verschil in variatie binnen de prevalentiecijfers die gevonden werden, tussen 
de studies die fysieke (4.0%-17.0%) dan wel brede frailty definities (4.2%-59.1%) 
gebruikten. Hiernaast werd bevestigd dat de prevalentie van frailty stijgt met het 
oplopen van de leeftijd en hoger is bij vrouwen dan bij mannen. 
Dit betekent dat frailty veelvoorkomend is op latere leeftijd en dat de prevalentie 
hierbij sterk afhankelijk is van definitie van frailty die wordt gebruikt. De smallere 
reikwijdte van de prevalentiecijfers van frailty bij fysieke frailty definities, suggereert 
meer overeenstemming tussen onderzoekers die een fysieke frailty definitie gebruiken 
en naar alle waarschijnlijkheid een minder heterogeen begrip. In dit proefschrift 
gebruiken we dan ook de fysieke definitie van frailty van Fried en collega’s,10 waarbij 
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frailty wordt gedefinieerd als de aanwezigheid van minimaal drie van de volgende 
vijf kenmerken: gewichtsverlies, lage loopsnelheid, spierzwakte, uitputting en een 
verlaagd activiteitenniveau.  
Deel II: Frailty en depressie
In de voorgaande hoofdstukken werd geconcludeerd dat er een gebrek is aan onder- 
zoek naar frailty en depressie. Daarom hebben we in hoofdstuk 4 in een cohort 
depressieve ouderen gekeken wat de prevalentie van frailty is. Deze bleek aanzienlijk 
hoger dan de prevalentie die eerder vastgesteld werd in de algemene bevolking in 
hoofdstuk 3. Van de depressieve ouderen bleek 27.2% frail te zijn. Ook bleek dat 
depressieve ouderen met frailty een ernstiger depressie hadden dan de depressieve 
ouderen zonder frailty. Bovendien lieten de analyses zien dat er zelfs een verband is 
tussen frailty en depressie na verwijdering van overlappende items uit de depressie 
schaal. 
Omdat zowel depressie als frailty bekende risicofactoren zijn voor het optreden van 
lichamelijke ziektes,10, 11 wordt in hoofdstuk 5 beschreven of frailty een verklarende 
factor is in het verband tussen depressie en lichamelijke ziektes. Ook deze studie werd 
gedaan bij depressieve ouderen. Aangetoond werd dat depressieve ouderen meer 
lichamelijke ziektes hadden dan de niet-depressieve ouderen in de controlegroep. 
Wanneer we keken naar individuele ziekten in plaats van naar de optelsom van het 
aantal ziektes, vonden we alleen een verband tussen depressie en beroerte. 
Frailty bleek een gedeelte van de gevonden relatie tussen depressie en lichamelijke 
ziektes te verklaren. Dit suggereert dat frailty en depressie gedeelde verbanden met 
lichamelijke ziekten hebben, maar ook unieke, aan het eigen concept toebehorende 
verbanden.
Na de verbanden tussen frailty, depressie en lichamelijke ziekten bestudeerd te hebben, 
wilden we meer weten over de rol van mogelijke onderliggende mechanismen van 
frailty bij depressieve ouderen. Met de leeftijd neemt ook de mate van ontstekings- 
activiteit toe in het lichaam. Nu blijkt dat zowel bij ouderen met frailty als bij depressieve 
ouderen, verhoogde ontstekingswaardes zijn gevonden, al zijn de bevindingen bij 
depressieve ouderen minder eenduidig.12, 13 In hoofdstuk 6 wordt beschreven of er 
een verband is tussen deze ontstekingsactiviteit en frailty bij depressieve ouderen. 
Het bleek dat dit niet het geval is. Wel werd er een verband gevonden tussen de frailty 
kenmerken spierzwakte en lage loopsnelheid en ontstekingsactiviteit. Een principale 
componenten analyse liet zien dat frailty in een groep depressieve ouderen bestaat 
uit twee dimensies; de lichamelijke prestatie-dimensie (bestaande uit spierzwakte, 
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lage loopsnelheid en verlaagd activiteitenniveau) en de vitaliteits-dimensie (bestaande 
uit gewichtsverlies en uitputting). Tussen ontstekingsactiviteit en de lichamelijke prestatie- 
dimensie bleek een verband te bestaan.
Deel III: Frailty en het beloop van depressie
De beschreven hoofdstukken roepen vragen op over de gevolgen van frailty voor 
het beloop van depressie. Daarom beschrijven we in hoofdstuk 7 de invloed van 
frailty op het ontstaan en op het negen-jaars beloop van depressieve stemming op 
latere leeftijd in de algemene bevolking. We vonden dat frailty zowel de incidentie 
van depressieve stemming voorspelt, als het niet in remissie gaan van depressieve 
stemming. Ook hier hebben we gekeken naar de invloed van de losse componenten 
van frailty. Hier bleek alleen verlaagd activiteitenniveau de incidentie van depressieve 
stemming en het niet in remissie gaan van depressieve stemming te voorspellen. 
Wanneer we kijken naar wat deze bevindingen betekenen voor frailty als uni-dimen-
sioneel concept in relatie tot depressie, komen we tot een andere conclusie dan in 
hoofdstuk 6. De componenten van frailty laten namelijk consistente resultaten zien 
met betrekking tot het voorspellen van de incidentie en het beloop van depressieve 
stemming. Dit wijst op samenhang tussen de componenten van frailty in de bevolking 
met betrekking tot het ontstaan en beloop van depressieve klachten. 
Na vastgesteld te hebben dat frailty het beloop van depressieve klachten in de 
bevolking beïnvloedt, hebben we in hoofdstuk 8 gekeken of dit ook geldt voor een 
klinische depressie diagnose in een cohort depressieve ouderen over twee jaar. 
Bovendien hebben we in dit hoofdstuk ingezoomd op subschalen van een meet- 
instrument dat de ernst van depressie meet, zodat we dieper in konden gaan op het 
verband tussen frailty en het beloop van depressie op latere leeftijd. Dit meetinstrument 
heeft drie subschalen; één subschaal meet de ernst van de stemmingsklachten, de 
tweede meet de ernst van de lichamelijke depressieklachten en de derde de ernst 
van de motivationele depressieklachten. 
We vonden een verband tussen frailty en het niet in remissie zijn van depressie na 
twee jaar. Wanneer de individuele componenten van frailty werden geanalyseerd, 
vonden we een verband tussen zowel uitputting, als een verlaagd activiteitenniveau 
en depressie na twee jaar. 
Betreffende de subschalen zagen we dat de lichamelijke en motivationele depressie-
klachten sterker afnamen bij toenemende frailty. Dit kan verklaard worden doordat 
depressieve ouderen met frailty meer ruimte hadden voor verbetering. Voor de 
stemmingsklachten gold dit niet. Ondanks de sterkere verbetering van lichamelijke 
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en motivationele depressiesymptomen, bleven deze klachten bij mensen met frailty 
ernstiger. Dit kan dus ook betekenen dat het niet herstellen van de depressie verward 
wordt met frailty. Juist dit punt verdient nader onderzoek.
Conclusies
Voor het doen van onderzoek naar frailty in de ouderenpsychiatrie is fysieke frailty 
een relevant en bruikbaar begrip. In de algemene bevolking is één op de tien ouderen 
frail en voorspelt frailty zowel de incidentie als het aanhouden van depressieve 
stemming. Van de ouderen met een klinische depressie diagnose is ruim een kwart 
frail. Bovendien verklaart de aanwezigheid van frailty gedeeltelijk het bestaande 
verband tussen depressie en lichamelijke ziektes en vinden we een verband tussen 
ontstekingsactiviteit en de lichamelijke prestatie-dimensie van frailty. Verder voorspelt 
de aanwezigheid van frailty een slechter beloop van depressie over twee jaar. 
Hoewel de lichamelijke en motivationele depressiesymptomen meer verbeteren bij 
toenemende frailty, houden deze mensen toch nog meer lichamelijke en motivationele 
depressieklachten. 
De bevindingen uit dit proefschrift wijzen op een verwevenheid van frailty en depressie 
op latere leeftijd en zouden kunnen duiden op een specifiek frail-depressief subtype van 
depressie wanneer er ook sprake van frailty is. Hoewel dit subtype sterke verbanden 
heeft met een chronisch beloop van depressie, is er ook goed nieuws. Aangezien er 
zowel voor frailty als depressie behandelmogelijkheden zijn, biedt dit kansen voor de 
ontwikkeling van speciale interventies die gericht zijn op de fysieke en de psychische 
gezondheid. Toekomstig onderzoek zal moeten uitwijzen of deze interventies de 
prognose van deze bijzonder kwetsbare groep ouderen kunnen verbeteren. 
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Nu mijn proefschrift klaar is, is het tijd om terug te kijken op de afgelopen periode. 
Ik wil dan ook iedereen bedanken die heeft meegewerkt aan het onderzoek, me heeft 
gesteund, vertrouwen heeft gegeven of op een andere manier betrokken is geweest 
bij dit proefschrift. Als meest gelezen onderdeel van een proefschrift zal dit dankwoord 
ongetwijfeld zijn weg vinden naar de mensen voor wie dit met name bestemd is.
Promotoren prof. dr. Richard Oude Voshaar en prof. dr. Aart Schene – Richard, 
vanaf het begin was jij erbij betrokken. Wat zeg ik, vanaf vóór het begin. We kenden 
elkaar al van een ander onderzoek waaraan ik als onderzoeksverpleegkundige 
meewerkte. Je vroeg me of ik NESDO Nijmegen ‘zou willen doen’, met in het voor-
uitzicht een promotietraject binnen deze studie. Je speelde in op mijn ambities en 
hebt me eigenlijk vanaf nul op weg geholpen. Ik heb veel aan jouw enorme kennis 
en kunde van onderzoek gehad. Niet alleen in dat opzicht was je echt een mentor 
voor me, ook coachte je me in alles wat je moet weten van onderzoek, maar wat 
je niet uit de boeken kunt leren. Ik ben een groot fan van je en ik vind het geweldig 
om te zien dat je naast een toponderzoeker ook oprecht betrokken en benaderbaar 
bent voor grote en kleine dingen. Ik bewonder je om je liefde voor onderzoek en het 
vakgebied ouderenpsychiatrie, de bergen werk die je verzet en je vermogen om mij 
elke keer weer te inspireren tijdens onze overleggen. Het is tijd om los te laten, maar 
ik hoop dat wij nog veel zullen samenwerken. 
Aart, je sloot aan op het moment dat ik mijn laatste paper aan het afronden was. 
Vanaf dat moment was je direct betrokken bij elke stap in deze laatste fase van mijn 
promotietraject. Hier wil ik je voor bedanken. Daarnaast daagde je me uit om na 
te denken over dingen die voor mij vanzelfsprekend waren geworden en je scherpe 
opmerkingen op mijn stukken hebben echt als een kwaliteitsverhogende boost 
gewerkt. Je passie voor onderzoek is aanstekelijk en van grote waarde voor onze 
afdeling Psychiatrie en het onderzoek dat je hier opzet. Ik heb in elk geval enorm 
veel zin in dit volgende hoofdstuk.     
Copromotoren dr. Hannie Comijs en dr. Paul Naarding – Wat heb ik veel van jullie 
geleerd! 
Hannie, met jouw gedrevenheid ben je voor mij een voorbeeld van een leider in 
het wetenschappelijk onderzoek. Je hebt me laten zien hoe je vakkundig een groot 
onderzoek als NESDO opzet en draaiende houdt. De manier waarop jij dat doet 
maakt de wetenschap aantrekkelijk en toegankelijk. Jij was degene die altijd het 
overzicht behield, haarfijn aanvoelde welke afwegingen gemaakt moesten worden 
en ervoor zorgde dat ik steeds weer verder kon komen dankzij je vele en snelle input 
die ik kreeg op alle stukken die ik je in de afgelopen jaren voor heb gelegd. 
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Paul, ik ben blij dat jij mijn copromotor was. Wanneer ik zelf ondergedompeld was 
in data-analyses, zorgde je er altijd voor dat ik de klinische relevantie niet uit het oog 
verloor. Mijn promotietraject verliep erg soepel, desondanks waren er momenten dat 
er dingen tegenzaten. Je steun op die momenten heb ik zeer gewaardeerd. 
Leden van de manuscriptcommissie – Prof. dr. Olde Rikkert, prof. dr. Schuurmans 
en prof. dr. Speckens, hartelijk dank voor het kritisch lezen en beoordelen van mijn 
proefschrift.
Co-authors – Matheus Arts, Han Boter, Luigi Ferrucci, Yuri Milaneschi, Brenda Penninx, 
Robert Schoevers, Peter Verhaak and Margot de Waal thank you for the fruitful 
collaborations and your valuable input into the papers that are the result of my PhD 
project. Bedankt voor de prettige samenwerking.  
NESDO – Anna en Jasper, jullie zijn onmisbaar geweest voor het goede verloop 
van NESDO de afgelopen jaren en nog steeds, en daarmee ook voor dit promotie- 
onderzoek! Sanne en Lonneke, jullie waren mijn fijne collega-NESDO-onderzoekers! 
Ik heb veel plezier gehad in het begeleiden van jullie bij jullie analyses en het schrijven 
van de artikelen.
Collega’s van de afdeling Psychiatrie – Graag wil ik jullie bedanken voor de fijne 
en gezellige samenwerking. Ook de afdelingsleiding van de afgelopen jaren wil 
ik bedanken voor de geboden kansen en het vertrouwen dat in mij gesteld werd. 
In het bijzonder wil ik jou, Jan Buitelaar, hiervoor bedanken. Jij bent degene geweest die 
met mij en Richard de eerste plannen heeft gesmeed ten aanzien van dit promotietraject. 
Natuurlijk wil ik ook alle onderzoekscollega’s bedanken: Boudewijn, Danique, Denise, 
Geert, Jan, Janna, Janneke, Karlijn, Lianne, Marloes, Marten en Niels.
Collega’s ProPersona – Peter, Dorine en alle collega’s en secretaresses van Mentalis, 
jullie wil ik bedanken omdat jullie zoveel hebben bijgedragen aan een optimaal 
verloop van NESDO in Nijmegen. 
De intervisiemeiden – Denise, Janna, Rianne, Vanessa en Verena, onze intervisie is 
voor mij een feest van herkenning. Ik ben een beetje een vreemde eend in bijt als 
zuster tussen de psychologen maar hé, ik ben in elk geval verzekerd van grondige 
probleemanalyses en constructieve psychologische adviezen.
Mijn lieve vriendinnen – Freek (Don), je bent mijn allerbeste vriendin en dat is al 
zo sinds de kleuterschool. Wat wij samen hebben heb ik met niemand! Ellen (Kel), 
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wij gaan al meer dan twintig jaar terug en hebben zoveel meegemaakt samen. 
Bedankt dat je er voor me was in belangrijke periodes in mijn leven. Marjolijn, ik mis 
onze dagen samen in de collegebanken nog steeds. Ik hoop dat we nog veel samen 
zullen spelen met data;-) Janneke en Natalia, ik heb jullie leren kennen als vrouwen 
van de vrienden van Chris. Inmiddels voelt dat echt niet meer zo en is het vooral leuk 
dat onze mannen het ook goed met elkaar kunnen vinden!
(Oud) kamergenoten – Jullie zijn een hoofdstuk apart binnen Mijn lieve vriendinnen, 
want wat zijn jullie alle vier belangrijk voor me geworden. Dit is niet alleen terug te 
zien in de vele buiten-het-werk-dates die we hebben, maar ook in de bijnamen die 
door iedereen volledig geaccepteerd en in gebruik zijn. Vooruit dan maar, ook ik 
heb meerdere bijnamen van jullie gekregen: Rosetje – Ross – Rossi.  
Martine en Karlijn (Tini/Toni en Carlos), met jullie deelde ik mijn eerste kamer. Naast 
onze kamer deelden we lief en leed, dat we bespraken tijdens onze vele vrimibo’s 
en in de inmiddels legendarische (e)RoTiCa-chat. Successen werden altijd gevierd, 
hoe groot, klein of twijfelachtig ze ook waren. Zo was er altijd een reden voor een 
bo(rrel). En Karlijn, wat fijn dat je mijn paranimf wil zijn! 
Door een interne verhuizing wisselden we van kamer en kwam ik bij jou, Denise 
(Dennio), op de kamer. Wat een briljante ontwikkeling! Dacht ik op de ultieme kamer 
gezeten te hebben, bleek er toch kamergenoot 2.0 te bestaan. Je bent een keiharde 
werker en hebt me ontelbare keren geholpen en geluisterd naar mijn onderzoeks- 
perikelen. Dat alleen is al een lofzang waard. En ik heb nu al zin in jouw promotie! 
Janna (Sjaan), jij vulde het gat dat Denise achterliet nadat we opnieuw een interne 
verhuizing hadden. En hoe! Ik kan echt niet meer zonder onze supergezellige avondjes 
en onze Ohh wat erruuuuggggggg-chat waarin we na het werk gewoon doorkletsen 
met Denise erbij alsof we elkaar niet net al de hele dag gezien hebben! 
Familie – Allereerst mijn schoonmoeder. Ria, wat boft mijn kleinste meisje met zo’n 
toegewijde oppas-oma. Wim was vast een geweldige opa geweest. Ik hoop dat je 
hem in Lune terugziet.
En wat een geluk heb ik met mijn lieve, veerkrachtige, stokoude oma’s en opa!
 
Pap en mam, bedankt voor alles wat jullie mij meegegeven hebben. Jullie zullen 
altijd mijn thuis zijn. Pap, ik heb geen herinneringen meer aan jouw promotie aan 
de TU Twente, maar ik vind het een mooi idee dat je jouw onderzoek hier in het 
Radboud uitvoerde, net als ik. 
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Patriek en Marije, mijn lieve, levenslustige broer en schoonzus. Jullie zijn een echt 
powerkoppel en superbelangrijk voor me! Sara en Jorrit, bedankt voor zoveel 
gezelligheid de afgelopen jaren. En Sara, wat ben ik blij dat jij naast mij staat als 
paranimf! Onze mooie zussenband zal ik altijd koesteren.   
 
Lieverds! Sam, Sofie en Lune, mijn liefde voor jullie kent geen grenzen! Voor mij is 
het leven zonder kinderen eigenlijk maar zo kort geweest dat ik niet beter weet dan 
dat ik moeder ben, en dan nog wel jullie moeder! Wat een geluk. Sam en Sofie, 
dat jullie hier vandaag op de eerste rij zitten maakt mij nog het meest trots! En lief 
Luuntje, jij bent nog te klein om erbij te zijn op deze bijzondere dag. Als je groter 
bent zal ik je erover vertellen. 
Mijn allerliefste Chris, wat ben ik blij dat wij elkaar gevonden hebben. Mijn leven 
met jou te delen is voor mij het mooiste wat er is!  
Rose
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